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Although rare in the population, individuals affected by deletions or duplications of DNA 
material at 16p11.2 chromosomal region (within the region ’11.2’ in the short arm of 
chromosome 16) are at higher risk of myriad clinical features and neurodevelopmental 
disorders including intellectual disability, developmental delays, and autism spectrum 
disorder. Whether inherited or appearing for the first time in the family, this 16p11.2 copy 
number variation (CNV) seems to impact on brain structure and function that may, in turn, 
drive the profile and severity of 16p11.2 associated phenotypes. As studies of 16p11.2 CNV 
brain function are scarce, the aim of this thesis is to investigate EEG activity in (human) 
16p11.2 CNV carriers and parallel in-vivo electrophysiological activity in 16p11.2 deletion 
mouse model. Data-sharing platforms and collaborative efforts made it possible to access 
datasets of this rare population and analyse it for the purpose of this thesis. The thesis is 
comprised of three studies: 1) an investigation of visual-evoked neural variability, as 
measured by variability of intra-participant ERP and spectral power, and signal-to-noise ratio, 
in 16p11.2 CNV carriers; 2) a study of spontaneous neural activity, as measured by multi-
scale entropy and conventional spectral power, in 16p11.2 deletion carriers; and 3) a study of 
spontaneous neural activity in 16p11.2 deletion mouse model. Neural variability was mostly 
higher in 16p11.2 deletion carriers relative to typical controls and 16p11.2 duplication 
carriers. Compared to typical controls, higher entropy was found in 16p11.2 deletion carriers 
and this was associated with certain psychiatric and behavioural traits, e.g., anxiety problems. 
The 16p11.2 deletion mice showed no group differences in neural activity compared to wild-
type control mice. In conclusion, despite the lack of converging evidence from the mouse 
model, the collective 16p11.2 CNV human findings indicated that neural activity in 16p11.2 
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     16p11.2 CNV Human and Mouse  
The aim of this thesis is to investigate functional brain alterations, as revealed via EEG and 
in-vivo electrophysiology, in 16p11.2 copy number variation (CNV) human carriers and 
mouse model. Prior to discussing 16p11.2 CNV characteristics and the relevant literature, the 
following sections outline and describe what ‘16p11.2’ denotes.  
1.1   The 16p11.2 genomic address 
‘16p11.2’ could be thought of as a postcode that leads to a specific address in the genome. It 
is an abbreviated form of address that dictates the specific chromosome, chromosome-arm, 
region, and sub-region (as will be elaborated in the following paragraphs).  
The human DNA (deoxyribonucleic acid) consists of long strands of protein-coding 
and non-coding material that are ~ 2 metres long when stretched. To contain DNA into the 
nucleus of each cell, DNA is packaged into structures called chromosomes. There are 
typically 23 homologous pairs of chromosomes in human cells (i.e., 46 chromosomes per 
cell, except for gametes which have 23 chromosomes). To refer to a particular chromosome, 
the pairs have been numbered from 1 to 22 (generally from largest to smallest), with the 23rd 
pair labelled either as ‘x’ and ‘y’ or ‘x’ and ‘x’ (which determines an individual’s sex). The 
‘16’ in the genomic address of ‘16p11.2’, therefore, refers to the 16th chromosome pair 
(Figure 1.1).  
 
Figure 1.1: Karyotype of a human male. 
The blue rectangle points out chromosome 16. Courtesy: National Human Genome Research 
Institute. https://www.genome.gov/ 
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Whereas the ‘p’ in ‘16p11.2’ narrows this down to the short arm/s of chromosome 16 
(Figure 1.2). Finally, the ’11.2’ in ‘16p11.2’ further specifies a smaller region within ‘p’ 
(shaded area in Figure 1.3) and close to the centromere (the narrow region near the centre 
that separates the chromosome into short and long arms).  
 
Figure 1.2: The 16p11.2 chromosomal region. 
This figure represents chromosome 16. The bracket indicates the ‘p’ region (‘p’ stands for petit; 
meaning ‘small’ in French), which represents the short arm/s of chromosome 16. The arrow 
points to the ’11.2’ region. The black circle indicates the centromere. 
The smaller region of interest to this thesis (area outlined in Figure 1.3), within the 
16p11.2 region, spans ~ 600 thousand DNA building blocks, or base pairs (bp; from a total of 
~ 90 million bp in chromosome 16) with start and end points at ~ 29.68 and ~ 30.21 million 
bp, respectively (breakpoints 4 and 5; genome reference hg18). This region encompasses ~ 
29 genes (from a total of more than 800 genes in chromosome 16; http://www.ensembl.org; 
Figure 1.3); Many of which are highly expressed in the (human) brain (e.g., KCTD13, 
TAOK2, and SEZ6L2) and some play a role in regulating gene expression (e.g., MAPK3, 
MAZ, TBX6, HIRIP3, and INO80E; Nucleic Acids Research, 2016).  
Henceforth, any reference to ‘16p11.2’ will be in relation to the smaller region of 
interest (within 16p11.2) described here and frequently termed the ‘proximal’ 16p11.2 region 





Figure 1.3: Genes within the 16p11.2 region of interest. 
The ‘p11.2’ region is shaded in light blue. The smaller region of interest is outlined in blue, 
zoomed in to show the gene content. Genes are arranged in linear order. Courtesy: Genome 
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1.2   Role of key genes within the 16p11.2 region 
Although the roles of the genes within the 16p11.2 region and how they contribute to the 
16p11.2 CNV phenotype remain largely unknown, the likely molecular functions of certain 
key genes are summarised below.  
The KCTD13 gene (potassium channel tetramerization domain containing 13; 
Abrahams et al., 2013; Escamilla et al., 2017) has been suggested to play a role in the 
degradation of an enzyme called RhoA (Ras homolog gene family, member A). The 
degradation of RhoA regulates the formation of actin cytoskeletion (the structure that 
supports the shape of a cell among other functions) and thus leads to the formation of 
dendritic spines and enhanced synaptic transmission.  
The TAOK2 gene (thousand and one amino-acid Kinase 2; Abrahams et al., 2013; 
Richter et al., 2019) also affects RhoA activity, similar to KCTD13 – although in an opposing 
manner: TAOK2 enhances RhoA activity, whereas KCTD13 degrades RhoA. Thus, TAOK2 
and KCTD13, together, regulate RhoA activity and promotes dendritic spine formation and 
neural communication. Loss of TAOK2 was found to lead to reduced RhoA activity, 
particularly in the cerebral cortex, and reduced the formation of dendritic spines.  
The MAPK3 gene (mitogen-activated protein kinase 3; also known in the literature as 
extracellular signal-regulated kinases (ERK1); Abrahams et al., 2013; Pucilowska et al., 
2015) encodes for the MAPK/ERK pathway, which is a cascade of protein interactions in a 
cell that transfer the signal from the cell’s receptor to the cell’s DNA. In response to various 
extracellular signals, the MAPK/ERK pathway regulates cellular processes including the 
progression of the cell cycle, cell proliferation, and cell differentiation.  
The MVP gene (major vault protein; Stelzer et al., 2016; Jacque et al., 2018) encodes 
for a protein required for vault structure – a structure that carries RNA, proteins, and other 
molecules between the nucleus and cytoplasm. MVP also regulates other genes including 
STAT1 (signal transducer and activator of transcription 1 – a gene involved in immune 
function). MVP/STAT1 interactions were suggested to play a role in homeostatic plasticity, 
which is the ability of neural connections to adapt to changes in experience.  
The roles of the individual genes within the 16p11.2 region are useful to elucidate the 
link from genotype to phenotype, however, it is important to note that gene interactions 
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within the CNV region and outside may contribute to the complex and heterogeneous 
16p11.2 CNV phenotypes.  
1.3   Copy number variation at the 16p11.2 region 
Usually, a typically developing individual would carry two copies of the 16p11.2 region (and 
indeed the rest of the DNA). However, in the event of a deletion, cells would only have one 
copy of the 16p11.2 region, while in the event of a duplication, there would be three copies 
(Figure 1.4). When the deleted or duplicated regions are large (>1000 nucleotide base pairs, 
often spanning many genes and non-encoding regions), they are referred to as copy number 
variations (CNVs). Deletions and duplications occurring at the same chromosomal region 
(e.g., proximal 16p11.2) are termed reciprocal CNVs. CNVs, therefore, are a type of 
structural variation that can be pathogenic as is the case in 16p11.2 CNVs.  
 
Figure 1.4: 16p11.2 CNV. 
Rectangles indicate the ‘16p11.2’ region. The colours blue, black, green indicate deletion, 
typical, and duplication, respectively. Courtesy: Genome Decoration Page/National Centre for 
Biotechnology Information. https://www.ncbi.nlm.nih.gov/genome/tools/gdp 
CNVs may be inherited or may appear for the first time in one family member. A 
newly occurring CNV is termed a de-novo CNV. One mechanism that gives rise to de-novo 
CNVs is non-allelic homologous recombination (NAHR). Homologous recombination is the 
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process by which broken strands of DNA join with other homologous (i.e., similar or 
identical) strands of DNA. During meiosis (i.e., the process of cell division of gametes), 
homologous chromosomes, e.g., maternally- and paternally-derived chromosome 16, align 
together prior to undergoing homologous recombination. In this example, a particular region 
in the maternal chromosome 16 is exchanged with the same region in the paternal 
chromosome 16. However, in the event of a NAHR, homologous chromosomes misalign and 
therefore lead to non-allelic exchange of DNA material (i.e., exchange of similar DNA 
between two different regions in the same or different chromosome). Thus, the resulting 
daughter gametes, that underwent NAHR, have chromosomal imbalances in the form of 
either a deletion or duplication (in other words, a CNV) of the affected genetic region. 
Notably, there are certain hotspots in the genome where NAHR are more likely to occur. 
These tend to be in regions with highly similar base sequences (98.5-99%) within the 
genome, termed low copy repeats (LCRs, also known as segmental duplications). Due to this 
high sequence similarity, there is more susceptibility for errors to occur in the normal event 
of meiotic recombination.  
1.4   16p11.2 CNV prevalence and pathogenicity 
16p11.2 CNVs are rare in the population as only ~ 5 in 10,000 people carry a deletion, and 
only ~ 4 in 10,000 people carry a duplication (Kirov et al., 2014). Notably, a 16p11.2 CNV is 
not sufficient for carriers to develop difficulties and disorders, as some carriers seem 
unaffected by the CNV (i.e., 16p11.2 CNVs have incomplete penetrance; Kirov et al., 2014). 
Nevertheless, the risk for developing one or more of the possible associated disorders is 
relatively high for 16p11.2 CNV carriers (Shinawi et al., 2010; D'Angelo et al., 2016; Hanson 
et al., 2015; Niarchou et al., 2019). In addition, the consequences of this CNV are quite 
heterogenous as they vary from one individual to another in their severity and phenotypes 
(i.e., showing a high degree of pleiotropy; Girirajan and Eichler, 2010; Niarchou et al., 2019). 
This heterogeneity can be obvious in carriers within the same family and across families 
irrespective of inheritance status (i.e., inherited vs. de novo CNV). 
When inherited, the inheritance pattern is autosomal dominant (Miller et al., 2009), 
which means that there is a 50% chance that the offspring of a carrier would inherit this 
CNV. Interestingly, when comparing 16p11.2 deletion vs duplication carriers, the latter group 
are more frequently identified as inheriting the CNV. While the former group (deletion 
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carriers) have more frequent de-novo cases, i.e., a new 16p11.2 deletion case appearing in the 
family for the first time (Duyzend et al., 2016; D’Angelo et al., 2016).  
1.5   16p11.2 CNV detection 
Although studies suggest that 16p11.2 CNVs are rare in the population, it is possible that the 
frequency of these CNVs is underestimated. This is because certain people with this genotype 
may not exhibit severe or obvious phenotypes, therefore they are not detected. Whereas those 
with more severe phenotypes, especially in relation to developmental delays and psychiatric 
phenotypes such as autism spectrum disorder (ASD)1, are more likely to be referred for 
genetic screening and detected for 16p11.2 CNV. This is especially true in de-novo cases, as 
when an inherited case is detected, further screening is normally recommended for first-
degree relatives.  
Karyotyping 
There are several techniques for detecting CNVs in the DNA. Conventional karyotyping is 
the process of detecting CNVs involving at least several megabase pairs (Mbp; million base 
pairs) through a microscope (Sinclair, 2002). The chromosomes are first stained using 
standardised staining procedures that reveal characteristic dark and light bands of each 
chromosome (Figure 1.1 and Figure 1.3). However, 16p11.2 CNVs are too small to be 
visible using karyotyping alone (16p11.2 CNV = ~ 600 Kbp; thousand base pairs). Therefore, 
16p11.2 CNVs are typically detected by fluorescent in situ hybridization (FISH), comparative 
genomic hybridization (CGH), or a combination of the aforementioned techniques.  
Fluorescent in situ hybridisation 
Fluorescent in situ hybridisation (FISH) is a technique that uses fluorescent single strands of 
DNA (i.e., probes) that are complementary to the DNA sequence of interest: the 16p11.2 
region (O'Connor, 2008). Under certain conditions, these probes then bind only with their 
target matched DNA sequences, i.e., the 16p11.2 region from the DNA sample of the 
individual suspected to have a 16p11.2 CNV. Based on the absence or presence of a 
fluorescent signal, 16p11.2 deletions or duplications are identified under a microscope.  
 
1 There is some controversy regarding the terminology used to refer to ASD (Kenny et al., 2016). For this thesis, 
I made the decision to use the terms/acronym ‘ASD’ because Kenny et al. (2016) showed that it is among the 
most endorsed term across ASD communities. 
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Comparative genomic hybridisation 
With the comparative genomic hybridisation (CGH) technique (Theisen, 2008), the DNA 
sample of the suspected 16p11.2 carrier (i.e., target sample) is compared with the DNA 
sample from a typical control (i.e., reference sample) for CNVs. Probes (i.e., a single-
stranded DNA) from the target sample are labelled with green fluorescence, whereas probes 
from the reference sample are labelled with red fluorescence. The two samples are mixed and 
applied to the microarray (i.e., DNA chip; a collection of DNA probes, complementary to 
those in the two samples, attached to a solid surface typically a glass slide). The target and 
reference sample then compete to bind to the microarray. This process of binding two 
complementary single-stranded DNA and forming a double-stranded DNA via base pairing is 
termed hybridisation. The fluorescent signals are then measured by the microarray scanner 
and analysed with a dedicated computer software. Higher intensity of red indicates deletions; 
Conversely, higher intensity of green indicates duplications. A net colour of yellow indicates 
equilibrium: the target sample and reference sample bind in equal amounts to the microarray.  
Single nucleotide polymorphism array 
A single nucleotide polymorphism (SNP) refers to a variation at a single nucleotide base 
(adenine, cytosine, guanine, or thymine) in a specific locus in the genome in the population 
(with the rarer variant found in at least 1% of the population). The SNP array technique 
shares the same basic principles as CGH: 1) the use of probes marked with fluorescent dyes; 
2) hybridisation of probes to the microarray; 3) and the use of algorithms to interpret the 
intensity of fluorescent signals. Here, the target DNA sample (i.e., DNA probe from the 
suspected 16p11.2 CNV carrier) is hybridised to the SNP array. The SNP array consists of 
probes, from a reference human genome, known to contain multiple alleles2. The array 
contains two probes to represent the different alleles (AA, BB, or AB) and the location on the 
array indicates the locus of the SNP in the genome. If the target DNA sample is homozygous 
for either the A or B alleles, then the sample will hybridise to the A or B alleles, respectively 
(AA, BB). Otherwise, the sample will hybridise to the A and B alleles (AB). In the event of a 
deletion or duplication (i.e., CNVs), the alleles will be missing (A-, or -B) or duplicated 
(AAAA, AAAB, ABBB, or BBBB). As the different alleles are labelled with particular 
 
2 An allele is a variant form of a gene. If an individual carries the same variant on both chromosomes, then this 
individual is homozygous for the respective allele, typically denoted as AA or the alternative allele BB. If an 
individual carries one copy of each allele, then this individual is heterozygous for the allele AB. 
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fluorescent colours, SNPs and CNVs may be inferred via quantification of the fluorescent 
signal intensities.  
Next-generation sequencing 
Next-generation sequencing (NGS) refers to methods that determine the order of nucleotide 
bases in the DNA using advanced sequencing technologies and bioinformatics. There are 
various NGS methods, however, they share certain basic principles. These methods sequence 
sections of DNA of millions of nucleotides long in parallel. Basic steps generally involve the 
following; 1) The target DNA is fragmented into sections (the length depends on the 
technology used); 2) amplification of DNA fragments via clustering of individual fragments; 
3) The clustered/amplified fragments are then sequenced; 4) The sequences are aligned to the 
reference genome. CNVs can then be identified. In summary, 16p11.2 CNVs are rare deletion 
or duplication events of the ‘16p11.2’ region implicating approximately 29 genes. Whether 
inherited or de-novo, 16p11.2 CNV carriers present with a spectrum of traits and difficulties 
(although the clinical profile and severity vary from one individual to another). 16p11.2 
CNVs are detected, using techniques such as CGH, predominantly in clinically referred cases 
with intellectual disability. However, 16p11.2 CNV carriers are associated with numerous 
disorders, which fall under the ESSENCE umbrella acronym, as will be explained in the 
following section.  
1.6   The ESSENCE Framework  
The current section will introduce the ESSENCE approach and its relevance to 16p11.2 
CNVs, forming the basis for my rationale for adopting this approach in the current thesis.  
Defining ESSENCE 
It is not uncommon for a person presenting trait characteristics of one psychiatric disorder to 
also show traits and difficulties characteristic of another disorder or even partial traits relating 
to numerous other disorders. In fact, comorbidities and shared traits among 
neurodevelopmental and psychiatric disorders seem to be the rule rather than the exception 
(e.g., Kadesjö and Gillberg, 2001). Evidence showing overlaps between these heterogeneous 
disorders, in terms of clinical symptoms and genetic and environmental risk factors, is 
mounting (Doherty and Owen, 2014; Gandal et al., 2018; The Brainstorm Consortium, 2018). 
This gave rise to the conceptual framework behind the ‘ESSENCE’ umbrella acronym, which 
refers to Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations 
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(Gillberg, 2010). Rather than considering individual neurodevelopmental/psychiatric 
disorders as unique conditions, ESSENCE refers to them as a whole group, typically 
presenting with early impairments in some or all of the fields of 1) general development, 2) 
communication and language, 3) social inter-relatedness, 4) motor coordination, 5) attention, 
6) activity, 7) behaviour, 8) mood, and/or 9) sleep. Some examples of disorders that would 
fall under the ESSENCE umbrella acronym include ASD, attention deficit hyperactivity 
disorder (ADHD), oppositional-defiant disorder, early-onset bipolar disorder, early-onset 
schizophrenia (although it is possible that some later-onset psychiatric disorders should 
qualify as ESSENCE disorders), etc. It is important to clarify that while the ESSENCE 
framework supports merging these disorders into one large group, it is not against segregating 
these disorders into meaningful subgroups per se; Rather, it is a renewed call for researchers 
and clinicians to first approach these disorders as a large group prior to segregating them into 
meaningful ways (when it is possible to do so) for refined research and specialised 
intervention.  
16p11.2 CNV and ESSENCE 
In light of this, the current thesis conceptualises 16p11.2 CNVs as presenting with ESSENCE 
traits/disorders (as will be described in detail in later sections). This is especially suitable as 
individuals with 16p11.2 CNV vary widely in their clinical profile and impairment severity in 
ESSENCE-related traits (Girirajan and Eichler, 2010; Shinawi et al., 2010; Hanson et al., 
2015; Niarchou et al., 2019). In addition, comorbidities are common in 16p11.2 CNV carriers 
(Niarchou et al., 2019): E.g., deletion carriers were found to have an average of ~3 diagnoses 
(Hanson et al., 2015). Accordingly, it would be accurate to describe 16p11.2 CNV as 
generally relating to ESSENCE as a whole. Considering 16p11.2 CNV in this way serves as a 
useful reminder of the heterogeneous nature of this CNV, and draws attention to the potential 
relevance of literature in relation to any one of the ESSENCE disorders. Therefore, I will 
consider 16p11.2 in the context of the ESSENCE framework, in this thesis. 
Another distinction can be made between studies that adopt a phenotype-first 
approach vs a genotype-first approach to studying ESSENCE traits and disorders. A 
phenotype-first approach consists of recruiting participants based on their clinical diagnosis; 
This is contrary to the genotype-first approach, which involves grouping individuals based on 
a shared genetic mutation or deleterious variation (e.g., The Simons VIP Consortium, 2012, 
see chapter 2, Section 2.2.1) regardless of the presented variability in phenotype and 
diagnoses. This approach is consistent with the conceptual framework behind the ESSENCE 
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umbrella acronym. In that context, the current thesis follows a genotype-first approach to 
studying a group screened for 16p11.2 CNVs irrespective of their ESSENCE profile and 
severity.  
1.7   Consequences of 16p11.2 CNV 
Unlike other mutations, a CNV is a gene-dosage problem (i.e., having a smaller or larger 
number of genes than typical cells); which could result in an imbalance in the expression of 
the genes in the CNV region. For reciprocal CNVs (i.e., deletions and duplications occurring 
in the same region), it is intuitive to presume that gene-expression changes would follow a 
linear relationship (deletion < control < duplication), which ultimately leads to opposing 
phenotypes. Indeed, for 16p11.2 CNVs, gene expression in the CNV region was in line with 
gene dosage: deletions resulted in under-expression, whereas duplications resulted in over-
expression of the genes in the 16p11.2 region – with no evidence of dosage compensation 
(Blumenthal et al., 2014). Although some phenotypes associated with 16p11.2 CNV might 
exhibit a linear relationship with gene-dosage, this is probably a simplistic view. The effects 
of 16p11.2 CNVs extend beyond the genes within its region; E.g., associations were found 
between 16p11.2 CNVs and altered expression patterns outside the CNV region (Blumenthal 
et al., 2014). Additionally, the overall genetic background and environmental factors also 
play an enhancer and/or suppressive role towards the presented phenotypes and their 
directionality.  
Consequences of 16p11.2 CNV have been studied on multiple levels (e.g., chromatin 
looping interactions, Loviglio et al., 2017). However, for the purpose of this thesis, the focus 
in the following sections will be on describing 16p11.2 CNV clinical phenotypes, brain 
structure, and brain function, in addition to the relationship between these levels where 
possible. 
Genotype-phenotype models 
Despite the complexity of the impact of 16p11.2 CNVs on phenotypes, it is useful to 
categorise the relationship between 16p11.2 reciprocal CNVs and their phenotypes into the 
following theoretical models (Figure 1.5; Deshpande and Weiss, 2018).  
1.7.1.1 Additive model: opposing phenotypes 
This model represents the phenomenon, described earlier, by which 16p11.2 deletions and 
duplications, respectively, contribute to opposing phenotypes (Figure 1.5a). This relationship 
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has been observed regarding the physical features of 16p11.2 CNV carriers, as will be 
described later.  
1.7.1.2 Dominant model: unique phenotypes 
In this model, a change in the copy number in only one direction, e.g., either a deletion or 
duplication, leads to a deleterious phenotype (Figure 1.5b). Indeed, some ESSENCE 
traits/disorders seem to be mainly associated with either 16p11.2 deletion or duplication.  
1.7.1.3 U-shaped model: shared phenotypes 
In this model, the deleterious phenotype is shared between the 16p11.2 reciprocal CNVs 
(Figure 1.5c). The U-shaped model is as such because both deletions and duplications are 
associated with either an increase (U-shape) or decrease (inverted U-shape) of the same 
phenotype (therefore leading to a pathological state as it deviates from the average). As will 




Figure 1.5: Theoretical models of the impact of copy number on phenotypes. 
Here, head circumference (HC) is used as an example of a quantitative phenotype. Extreme 
forms of this phenotype are microcephaly (decreased HC) and macrocephaly (increased HC). 
X-axis indicates the deletion group (1 copy number of the ‘16p11.2’ region), control group (the 
typical amount of 2 copy numbers), duplication group (3 copies). Boxplots representing a) the 
additive model: Copy number impacts HC in an opposing manner leading to microcephaly in 
deletions and macrocephaly in duplications, vice versa. b) The dominant model: Copy number 
change in only one direction (e.g., deletion) leads to micro- or macrocephaly, whereas the 
outcome of a change in the other direction (e.g., duplication) is a HC in the typical range, or 
vice versa. c) The U-shaped model: Both deletions and duplications lead to the same atypical 
phenotype, e.g., either macro- or microcephaly.  
16p11.2 CNV ESSENCE traits and disorders 
As mentioned earlier, 16p11.2 CNV carriers can be characterised as presenting with myriad 
ESSENCE traits and disorders. Evidence is drawn from 1) studies that investigate the 
prevalence of CNVs in psychiatric populations (phenotype-genotype approach); and 2) 
studies that conduct phenotypic characterisation of individuals with 16p11.2 CNV (i.e., 
genotype-phenotype approach). From the first approach, 16p11.2 CNVs were frequently 
identified in psychiatric/ESSENCE populations, including intellectual disability and 
a) b) c) 
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developmental delay (deletion and duplication, Kaminsky et al., 2011; Weiss et al., 2008; 
Cooper et al., 2011), ASD (deletion and duplication, Walsh and Bracken, 2011; Sanders et 
al., 2011; Weiss et al., 2008; deletion, Kumar et al., 2008), schizophrenia (duplication, Zhou 
et al., 2018, Marshall et al., 2017; McCarthy et al., 2009), bipolar disorder (duplication, 
Green et al., 2016), and depression (duplication, Kendall et al., 2019; deletion and 
duplication, Degenhardt et al., 2012). From the second approach (i.e., genotype-phenotype 
approach), deep phenotypic characterisation of 16p11.2 CNV carriers also revealed high 
frequencies of a range of ESSENCE disorders and traits.  
To summarise the results of studies using the second approach, a systematic review 
was conducted in this thesis. The Scopus database was used to search for the term “16p11.2” 
within the title, abstract, and keywords of the journal articles. In addition, the reference 
lists/citations of all articles identified as highly relevant were manually checked for other 
potentially relevant papers. Abstracts of the search results (and reference list manual search) 
were screened and classified as relevant if they included the terms relating to ESSENCE 
disorders/traits such as “psychiatric”, and/or key terms relating to the process of phenotyping 
and determining disorder prevalence, such as “frequency”. Full text articles of relevant papers 
were then inspected prior to formulating the optimal inclusion criteria for the review in this 
thesis.  
A few observations were made, which formed the basis of the inclusion criteria. 1) 
Most studies lacked data of 16p11.2 CNV adults. Studies typically reported the genotype-
phenotype associations in children with 16p11.2 CNVs (Chawner et al., 2019; Niarchou et 
al., 2019; D'Angelo et al., 2016; Snyder et al., 2016; Hanson et al., 2015; Hippolyte et al., 
2015; Zufferey et al., 2012; Hanson et al., 2010; Shinawi et al., 2010; Fernandez et al., 2010; 
Rosenfeld et al., 2010). Therefore, this review only included studies reporting results relating 
to 16p11.2 CNV children. 2) Generally, the more recent the study, the larger the sample size; 
This is due to larger projects, but also due to studies combining data from previous studies 
and collaborative efforts. To avoid overlaps, the data sources and sample sizes of relevant 
studies were noted (Table 1.1). Based on this information, this review only included the most 
recent findings and prioritised reporting results of studies with larger sample sizes. 
Duplications in information between the studies mentioned in Table 1.1 were avoided (e.g., 
ADHD data reported in studies prior to Niarchou et al. (2019) including Hanson et al. (2015) 
were not presented in this review); Data regarding the specific diagnoses reported in Table 
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1.1 were extracted from the respective studies. The Search was last carried out in December 
2019. Therefore, any studies post this date are not included.  
 
Table 1.1: 16p11.2 CNV genotype-phenotype data sources and sample sizes.  
Data source  del % del (n) dup % dup (n)       
Niarchou et al. (2019) ADHD 29 63 42 48 
ECHO study Psychotic symptoms 4 5 11 7 
16p11.2 European 
Consortium 
ODD/CD 7 15 12 14 
IMAGINE-ID ASD 22 41 26 26 
Simon's VIP ID 30 61 34 36 
 

















     
      




Simon's VIP Language Disorders  46 36 
  
 
Coordination disorder 58 45 
  
 
Learning disorders  13 10 
  
 







      
Snyder et al. (2016) Phonological (articulation) Disorder  19 12 
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ECHO the Cardiff University ExperienCes of people witH cOpy number variants (ECHO) 
study (http://medicine.cf.ac.uk/psychological-medicine-neuroscience/areas-research/copy-
number-variant-research/research-projects/), IMAGINE-ID intellectual disability and mental 
health: assessing genomic impact on neurodevelopment (http://www.imagine-id.org/), Simons 
VIP Consortium the Simons Variation in Individuals Project (VIP) Consortium 
(https://www.simonsvipconnect.org/), the 16p11.2 European Consortium (contributors of the 
16p11.2 European Consortium are described in D'Angelo et al. (2016)). 
ADHD, attention deficit hyperactivity disorder; ASD, autism spectrum disorder; ODD/CD 
oppositional defiant disorder/conduct disorder; ID intellectual disability. 
 
The results of the systematic review consisting of the latest findings relating to the 
prevalence of ESSENCE disorders in 16p11.2 CNV children are presented in Figure 1.6 
(Niarchou et al., 2019; D’Angelo et al., 2016; Snyder et al., 2016; Hanson et al., 2015).  
 
 
Figure 1.6: Frequency of ESSENCE disorders in 16p11.2 CNV carriers. 
The lighter the colour, the lower the frequency of diagnoses. Note that the colour white 
indicates data is not available. The disorders are ordered in descending order in terms of the 
contrast in the frequency of diagnoses between deletion and duplication carriers (i.e., the 
prevalence of disorders at the top largely differ between deletion and duplication carriers, 
whereas disorders at the bottom are similarly prevalent in both deletion and duplication 
carriers. ADHD, attention deficit hyperactivity disorder; ASD, autism spectrum disorder; 
ODD/CD oppositional defiant disorder/conduct disorder; ID intellectual disability. 
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As shown in Figure 1.6, deletion carriers have a high frequency (> 30%) of 
phonological and language disorders, coordination disorder, intellectual disability, and 
ADHD. ASD was also prevalent (22%). Duplication carriers have high frequencies (> 30%) 
of coordination disorder, ADHD, and intellectual disability. ASD was similarly prevalent in 
duplication carriers as deletion carriers (26%). Based on the contrast in the frequencies of 
ESSENCE disorders present in 16p11.2 deletion vs duplication carriers, a dominant model 
(unique phenotypes) is more likely to apply to the following disorders (ordered in the top of 
the list of disorders in Figure 1.6), phonological disorders and language disorders. Although 
not presented in Figure 1.6 (due to the lack of data), schizophrenia is a possible phenotype 
that could be regarded as common in 16p11.2 duplication carriers (as it was not frequently 
found in deletion carriers; Zhou et al., 2018, Marshall et al., 2017; McCarthy et al., 2009).  
Most disorders, however, seem to be presenting a U-shaped model demonstrating 
shared phenotypes between 16p11.2 deletions and duplications (although examination of the 
severity of the manifested disorders would further inform the shape of this model). Due to the 
nature of this data, it is not suitable to infer any opposing phenotypes that would fall under 
the additive model.  
 A recent study (Chawner et al., 2019) examined the quantitative effect of numerous 
pathogenic CNVs collectively on ESSENCE traits. However, as the focus of this thesis is on 
16p11.2 CNVs, relevant data from supplementary files in Chawner et al. (2019) were 






Figure 1.7: Severity of ESSENCE traits in 16p11.2 CNV carriers. 
The lighter the colour, the less severe the phenotypic trait (i.e., a z-score difference of zero 
between the CNV group and controls). The traits are ordered in descending order in terms of 
the contrast of severity between deletion and duplication carriers (i.e., traits at the top have 
greater differences in trait severity between deletion and duplication carriers, whereas traits at 
the bottom have more similar severity levels, or z-scores). CAPA, child and adolescent 
psychiatric assessment; ADHD, attention deficit hyperactivity disorder; SDQ, strengths and 
difficulties questionnaire; ODD, oppositional defiant disorder; OCD, obsessive-compulsive 
disorder; ASD, autism spectrum disorder; VIQ, verbal intelligence quotient; PIQ, performance 
intelligence quotient. 
 Deletion Duplication 
Subclinical psychotic experiences (child CAPA)     
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Total CAPA symptom count     
ADHD CAPA subscale     
SDQ total (caregiver report)     
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Mood CAPA subscale     
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Conduct SDQ subscale (caregiver report)     
Emotional SDQ subscale (teacher report)     
Emotional SDQ subscale (caregiver report)     
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Sleep CAPA subscale     
Prosocial SDQ subscale (caregiver report)     
Peer SDQ subscale (caregiver report)     
Conduct SDQ subscale (teacher report)     
General functioning     
Social functioning     
Verbal reasoning     
ASD traits     
Non-verbal reasoning     
VIQ     
PIQ     
Sustained attention     
Processing speed     
Verbal knowledge     
Peer SDQ subscale (teacher report)     
Set-shifting     





Extensive cognitive and psychiatric assessments were conducted, including the Wechsler 
Abbreviated Scale of Intelligence (WASI), Child and Adolescent Psychiatric Assessment 
(CAPA), and Social Communication Questionnaire (SCQ), etc. As can be observed in Figure 
1.7, various traits are severe for deletion carriers, including hyperactivity, ASD traits, IQ, and 
verbal and motor ability. For duplication carriers, severe traits include psychotic traits, 
anxiety, ADHD, ASD, IQ, general functioning, and verbal and motor ability. Overall, traits 
are more severe in duplication carriers compared to deletion carriers. The contrast in trait-
severity is most prominent in psychotic, anxiety, and ADHD, and oppositional defiant 
disorder (ODD). Considering both diagnoses and traits, psychosis traits/ schizophrenia might 
be unique to duplication carriers, in line with the dominant model. Whereas numerous 
overlaps in trait severity and profile are present in 16p11.2 reciprocal CNVs, including social 
behaviour, IQ, working memory, motor coordination, etc. However, deep characterisation of 
the cognitive profile of 16p11.2 reciprocal CNVs revealed opposing phenotypes (Hippolyte et 
al., 2016). Deletion carriers showed severe deficits in phonology and verbal inhibition skills. 
Whereas, duplication carriers performed better in these skills than deletion carriers and 
intrafamilial controls, with the same IQ level.  
Other common characteristics identified in 16p11.2 reciprocal CNVs are mirrored 
BMI and microcephaly/macrocephaly phenotypes: 16p11.2 deletion is associated with 
obesity (Crawford et al., 2019; Owen et al., 2018; Walters et al., 2010) and macrocephaly 
(large head circumference; Shinawi et al., 2010), whereas duplication is associated with being 
underweight (Owen et al., 2018; Jacquemont et al., 2011) and microcephaly (small head 
circumference; Jacquemont et al., 2011; Shinawi et al., 2010). Animal models of 16p11.2 
CNV identified the KCTD13 gene (one of the genes within the 16p11.2 region) as a major 
driver in inducing the reciprocal head size phenotype (Golzio et al., 2012). Micro- and 
macrocephaly were attributed to decreased and increased progenitor cell proliferation (i.e., 
the process by which cells increase in number and are governed by the balance between cell 
divisions and cell loss), respectively (Golzio et al., 2012). Based on these outcomes, 16p11.2 
CNVs were suggested to impact brain structure, possibly in an opposing manner.  
16p11.2 CNV brain structural alterations 
Indeed, numerous studies reported macro-and micro brain structural alterations in 16p11.2 
CNV carriers (Table 1.2, Ahtam et al., 2019; Blackmon et al., 2018; Owen et al., 2018; 
Martin-brevet et al., 2018; Chang et al., 2016; Maillard et al., 2015; Berman et al., 2015; 
Qureshi et al., 2014; Owen et al., 2014). Altogether, the structural MRI and diffusion MRI 
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analyses (including diffusion tensor imaging techniques) demonstrate the pervasiveness of 
brain structural alterations in 16p11.2 CNV carriers. Global and regional brain areas are 









Table 1.2: 16p11.2 CNV Brain structural alterations. 
 CNV Modality Age group Tissue Results (del) Results (dup) Additive model 
Ahtam et 
al. (2019) 
del dMRI Children White 
matter 
del > ctrl: MD, AD, RD (language pathways).   
Blackmon 






N/A del > ctrl: Cortical thickness (left bank of the 
superior temporal sulcus, left cuneus, left 
postcentral, right pericalcarine, and right 
postcentral regions). 
  











del > ctrl: Thickness of corpora callosa; 
Cerebellar tonsillar ectopia, and Chiari I 
malformations. 
dup < ctrl: Thickness of corpora 
callosa; Global white matter 
volume. 
Thickness of corpora 
callosa. 















del > ctrl: Global white matter volume; 
Global grey matter volume; Grey matter 
volume and surface area (insula, calcarine 
cortex, transverse temporal gyrus). 
dup < ctrl: Global white matter 
volume; Global grey matter 
volume; Grey matter volume 
(caudate and hippocampus); Grey 
matter volume and surface area 
(superior and middle temporal 
gyri). 
Global white matter 
volume; Global grey 
matter volume; Regional 
grey matter volume 
(insula). 
     del < ctrl: Grey matter volume and surface 











del > ctrl [children]: MD, FA, AD 
(pervasive); del > ctrl [adults]: AD (internal 
capsules). 
dup < ctrl [children]: FA 
(pervasive). dup < ctrl [adult]: FA, 
AD (pervasive). 
AD. 
      dup > ctrl [children]: MD, RD 

















del > ctrl: White matter volume (forceps, 
longitudinal fasciculus, thalamic radiation, 
cingulate); Grey matter volume (anterior 
insula, putamen, caudate, superior temporal 
gyrus, supramarginal gyrus, area triangularis, 
calcarine sulcus, cuneus, inferior and middle 
occipital gyrus, lingual gyrus); FA (grey 
matter: middle temporal gyrus, lateral 
fusiform gyrus); Cortical thickness (inferior 
pre- and postcentral gyrus and supramarginal 
gyrus, superior parietal gyrus, superior 
postcentral gyrus). 
dup < ctrl: Global white matter 
volume; Grey matter volume 
(caudate, putamen). 
Grey matter volume 
(putamen). 
     del < ctrl: Grey matter volume (lobule VIII of 
cerebellar hemisphere, crus II of cerebellar 
hemisphere, middle temporal gyrus); Cortical 
thickness (middle temporal, fusiform gyrus). 
dup > ctrl: MD (grey matter: 
caudate); Cortical thickness (medial 
orbitofrontal cortex); Surface area 
(rostral middle frontal gyrus and 




del dMRI Children White 
matter 
del > ctrl: MD (arcuate fasciculus), MD and 










del > ctrl: Global white matter volume; 
Global grey matter volume; Subcortical 
volume (thalamus); Cerebellum volume; 
Surface area (brainstem). 
dup < ctrl: Global white matter 
volume; Global grey matter 
volume; Subcortical volume 
(thalamus, hippocampus); 
Cerebellum volume; Surface area 
(brainstem); Cortical thickness. 
Global white matter 
volume; Global grey 
matter volume; Thalamus 
volume; Cerebellum 
volume; Surface area 
(brainstem). 






del > ctrl: FA (white matter: corpus callosum, 
superior corona radiata, internal capsule), AD 
(corpus callosum, internal capsule, external 
capsule, brainstem), MD (internal capsule, 
external capsule). 
  
     del < ctrl: Fibre orientation dispersion.   
CNV, copy number variant; del, deletion carriers; dup, duplication carriers; ctrl, controls; dMRI, diffusion MRI or diffusion tensor imaging; sMRI, structural MRI; NODDI, 
neurite orientation dispersion and density imaging; MD, mean diffusivity; FA, fractional anisotropy; RA, radial diffusivity; AD, axial diffusivity. 
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1.7.3.1 Structural MRI findings 
Morphological measures detecting macro-alterations include brain volume, cortical thickness, 
and cortical surface area. Overall, the general directionality of results relating to these 
measures are consistent and point toward a gene-dosage effect (deletion > control > 
duplication): Deletion carriers have increased brain volume, cortical thickness, and surface 
area compared to controls and duplication carriers. Numerous studies (Table 1.2) found 
trends that suggest a linear relationship between copy number and brain structure; However, 
here, I only consider results that are significant for both reciprocal CNVs (i.e., deletion > 
control and control > duplication) and corrected for multiple comparisons. These results fall 
under the additive model described earlier, which demonstrates opposing phenotypes. 
Structural features in line with the additive model include thickness of corpus callosum, 
global white matter volume, global grey matter volume, surface area of the brainstem, 
regional grey matter volume in the insula and putamen, subcortical volume of thalamus, and 
cerebellum volume (see Table 1.2 for more detail). Notably, most of the aforementioned 
studies focused on finding opposing effects on brain structure between deletion and 
duplication carriers. Consequently, there was less emphasis on disentangling the unique 
features from the shared features in the reciprocal CNVs. Therefore, it is less clear whether 
structural alterations in other regions are in line with the dominant model (unique phenotypes 
to either deletion or duplication) or U-shaped model (shared phenotypes between deletion and 
duplication). Nevertheless, the overall findings point to pervasive structural alterations with 
overlaps (e.g., decreased grey matter volume in the superior and middle temporal gyri) and 
some unique features (e.g., Chiari type I malformation and the anatomically milder cerebellar 
tonsillar ectopia in deletions) problematic to either deletion or duplication carriers.  
1.7.3.2 Diffusion MRI findings 
In relation to micro-structural alterations detected using diffusion MRI or diffusion tensor 
imaging techniques, only two (out of five) studies examined duplication carriers in addition 
to deletion carriers (Chang et al., 2016; Maillard et al., 2015). Diffusivity metrics detecting 
micro-alterations include mean diffusivity (MD), fractional anisotropy (FA), radial diffusivity 
(RD), and axial diffusivity (AD). Diffusion MRI techniques are more sensitive to white 
matter architecture, although Maillard et al. (2015) also reported findings relating to the 
integrity of grey matter. Overall, deletion carriers consistently showed increased diffusivity 
compared to controls (Table 1.2), regardless of the diffusivity metric, implicating language 
pathways and major white matter tracts such as internal capsules and corpus callosum. 
24 
Whereas duplication carriers showed widespread increased and decreased diffusivity 
compared to controls, depending on the metric used: E.g., FA was decreased, and RD was 
increased regardless of age group (Chang et al., 2016). However, the metric that showed 
changes in line with the additive model is AD: Deletion carriers showed increased AD, 
whereas duplication carriers showed decreased AD. However, due to the small number of 
studies, it is unclear whether the reciprocal CNVs are indeed showing AD-related opposing 
effects and also whether there are alterations that fit the other models.  
1.7.3.3 Links between 16p11.2 CNV, brain structural alterations, and ESSENCE traits 
Although the consequences of 16p11.2 CNV are due to complex and indirect interactions 
between many levels, studies have found certain relationships between 16p11.2 CNV, brain 
structure, and ESSENCE traits (Table 1.3). In relation to macro-structural brain alterations, 
there were certain links with IQ, non-verbal, daily living, language, communication, and 
social skills for 16p11.2 CNV carriers (Ahtam et al., 2019; Blackmon et al., 2018; Owen et 
al., 2018). Specifically, for deletion carriers, the presence of any atypical brain structural 
feature indicated worse daily living, communication, and social skills compared with deletion 
carriers without any structural abnormality. For duplication carriers, the presence of 
decreased white matter, callosal volume, and/or increased ventricle size was associated with 
lower IQ compared with duplication carriers without these features (Owen et al., 2018). In 
addition, cortical thickness, for deletion and duplication carriers, was inversely related to 
language skills and IQ, respectively (Blackmon et al., 2018).  
In relation to microstructural alterations, associations were found with non-verbal IQ 
and language abilities for 16p11.2 CNV carriers (Chang et al., 2016; Berman et al., 2015; 
Owen et al., 2014). All the diffusivity metrics, at respective regions, showed an inverse 
relationship with non-verbal IQ in 16p11.2 CNVs. For language ability, an inverse 
relationship was found with MD and RD (diffusivity metrics of mean and radial diffusivity), 
in respective regions, for deletion carriers in particular.  
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Table 1.3: Links between 16p11.2 CNV, brain structural alterations, and ESSENCE traits. 
 CNV Modality Age Group Tissue Correlations (del) Correlations (dup) 
Ahtam et al. 
(2019) 
del  dMRI Children White 
matter 
Positive correlation between the special 
nonverbal composite (DAS-II) scores and the 
volume of the left long arcuate fasciculus 
(findings from additional volume analyses). 
 




sMRI Children and 
adults 
(collapsed) 
N/A Cortical thickness (abnormally thin) and 
cortical thickness (abnormally thick) were 
negatively correlated with CELF-4 core 
language composite scores in the left pars 
opercularis and middle temporal region, 
respectively. 
Negative relationship between total 
cortical thickness and full-scale IQ. (This 
result was similar even when the data was 
segmented into abnormally thick and thin 
cortices).  











The presence of any imaging feature indicated 
worse daily living, communication, and social 
skills compared with deletion carriers without 
any radiologic abnormalities. 
The presence of decreased white matter, 
callosal volume, and/or increased 
ventricle size was associated with 
decreased full-scale and verbal IQ scores 
compared with duplication carriers 
without these findings. 








(Both CNV groups combined): For the children, negative relationship with non-verbal IQ, 
MD, and RD in the callosal, association, and projection tracts, as well as FA in the callosal 
tracts, and MD in the global white matter. 
Berman et al. 
(2015) 
del dMRI Children White 
matter 
Negative relationship between MD, RD (left-
hemisphere arcuate fasciculus), and CELF-4 
core language scores. 
 






Negative relationship between global AD and 
non-verbal IQ. 
 
CNV, copy number variant; del, deletion carriers; dup, duplication carriers; ctrl, controls; dMRI, diffusion MRI or diffusion tensor imaging; sMRI, structural MRI; 
NODDI, neurite orientation dispersion and density imaging; MD, mean diffusivity; FA, fractional anisotropy; RA, radial diffusivity; AD, axial diffusivity; DAS-II, 
differential ability scales-early years and school age-second edition; CELF-4, the clinical evaluation of language fundamentals. 
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16p11.2 CNV brain functional alterations 
Other features of 16p11.2 CNV carriers are functional brain alterations (Table 1.4; Hudac et 
al., 2015; Steinman et al., 2016; Berman et al., 2016; Jenkins et al., 2016; LeBlanc and 
Nelson, 2016; Bertero et al., 2018; Hinkley et al., 2019). Evidence of functional brain 
alterations in 16p11.2 CNVs come from functional neuroimaging studies, including fMRI, 



















Table 1.4: 16p11.2 CNV brain functional alterations. 
 Modality Age Group Paradigm Feature del / ctrl dup / ctrl del / dup Region 
Hinkley et al. 
(2019) 






del > ctrl - del > dup Vocal production task: MOG, 
PoCG. Manual production task: 
MiFG, MeFG, and SFG.1 
    Laterality index del < ctrl - del < dup IFG, MiFG, PrCG. 
Bertero et al. 
(2018) 
fMRI Children Resting-state Functional 
connectivity 
(global) 
del < ctrl - - Medial PFC, temporal and 
parietal areas (superior and 
medial temporal gyrus, and 
temporo-parietal junctions). 




del < ctrl - - Latero-temporal cortex, inferior 
parietal lobule, superior and 




EEG Children Visual P1 amplitude - - del > dup Occipital area. 
Jenkins et al. 
(2016) 
MEG Children Auditory M100 latency del > ctrl - - Left and right STG auditory 
cortex. 
Hudac et al. 
(2015) 
EEG Children and 
adults 
(collapsed) 
Social mu power 
suppression 
del > ctrl2 dup > ctrl2,3 - Centro-parieto-occipital areas. 
del, deletion carriers; dup, duplication carriers; ctrl, controls; PFC, prefrontal cortex; PoCG, post-central gyrus (primary somatosensory cortex); PrCG, pre-
central gyrus (primary motor cortex); STG, superior temporal gyrus; MOG, middle occipital gyrus; MiFG, middle frontal gyrus; MeFG, medial superior 
frontal gyrus; SFG, superior frontal gyrus; IFG, inferior frontal gyrus. 
1 For deletion adult carriers, neural responses to both tasks were observed mainly in the PoCG (somatosensory cortex). 
2 For del and dup, there were no group differences per se, compared to controls. However, group by context interactions were observed. Del and dup showed 
an increase in mu suppression for non-social stimuli, as opposed to social stimuli as is the case in controls.  
3 Additional analysis showed that mu power suppression was initially in the typical range for duplication carriers in response to social stimuli, however, mu 
suppression decreased over time more rapidly compared to controls.  
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1.7.4.1 Clinical-focused EEG 
Based on clinical EEG reports of 16p11.2 CNV carriers, various EEG abnormalities were 
reported, e.g., generalised sharps (i.e., widespread amplitude spikes that last up to 200 ms; 
Figure 1.8; Steinman et al., 2016). Fifty-four percent and 40 percent of deletion and 
duplication carriers, respectively, present with at least one abnormal EEG feature (as detected 
by clinical neurophysiologists; Figure 1.8; Steinman et al., 2016). 
 
 
Figure 1.8: Prevalence of abnormal EEG based on clinical reports. 
Frequencies presented here were reported in Steinman et al. (2016). 
1.7.4.2 Research-focused EEG 
Even though relatively little is known in this area as only a few studies have been conducted 
on 16p11.2 CNV brain function, these studies reported atypical neural activity in response to 
different conditions (i.e., sensory, social, and speech and motor) and at fMRI resting-state 
(Table 1.4; Hudac et al., 2015; Jenkins et al., 2016; LeBlanc and Nelson, 2016; Bertero et al., 
2018; Hinkley et al., 2019).  
1.7.4.2.1 Sensory neural activity 
Sensory neural responses were examined via passive auditory (Jenkins et al., 2016) and 
visual stimuli (LeBlanc and Nelson, 2016): Tones and alternating black and white 
checkerboards were presented, respectively, to 16p11.2 CNV carriers. The outcome revealed 
some findings and trends that resemble the additive model (i.e., opposing neural activity in 
deletion vs duplication), albeit in a preliminary sense. Specifically, Jenkins et al. (2016) 
found a significant delay in the M100 response (i.e., a typical waveform elicited at ~100 ms 
post-stimulus onset in response to auditory events) in deletion carriers compared to controls, 
whereas duplication carriers showed an earlier (nonsignificant) M100 response compared to 
controls. To examine whether this delayed M100 response in deletion carriers is associated 
with white matter microstructural alterations, Berman et al. (2016) conducted secondary 
Deletion (n = 39) Duplication (n = 30)
Carrier with at least one abnormal EEG 54% 40%
Focal sharps 8% 27%
Generalized sharps 8% 7%
Focal slowing 8% 13%
Generalized slowing 8% 13%
Other abnormalities 15% 3%
Abnormalities not described 15% 7%
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analyses of the MEG and DTI datasets previously analysed by Jenkins et al. (2016) and 
Berman et al. (2015), respectively. The authors found no relationship between brain structure 
and function, supporting the view that factors other than microstructural alterations may be 
contributing to atypical auditory neural responses in 16p11.2 deletion.  
Examining the amplitude of the P1 component (i.e., the equivalent of the M100 
response, but to visual events), LeBlanc and Nelson (2016) similarly found opposing neural 
activity in deletion and duplication groups. In this case, a trend (albeit nonsignificant) of 
higher P1 amplitude in deletion compared to controls and lower P1 amplitude in duplication 
compared to controls was found. Notably, when deletion and duplication groups were 
compared to each other directly, a significant difference in P1 amplitude was found: Deletion 
carriers showed higher P1 amplitude than duplication carriers.  
1.7.4.3 Social neural activity 
In relation to neural responses to social stimuli, Hudac et al. (2015) were the first to examine 
functional brain alterations in 16p11.2 CNV carriers. The authors studied power changes in 
the mu frequency band (8–12 Hz) in response to viewing social and non-social motion. 
Typically, increased suppression of mu power is expected in response to social stimuli as 
opposed to non-social stimuli. Contrary to controls, neural responses to social and non-social 
stimuli were modulated in a reversed manner in CNV carriers; I.e., Increased mu suppression 
was observed to non-social as opposed to social stimuli, in centro-parieto-occipital areas. 
Crucially, this study (Hudac et al., 2015) also conducted a trial‐to‐trial analysis to examine 
whether the level of mu suppression varied over time between groups. They found that 
unique to duplication carriers, there was an initial typical mu response (to social stimuli), 
which then decreased over time more rapidly compared to controls. In contrast, deletion 
carriers consistently showed the pattern described earlier (i.e., increased mu suppression to 
non-social stimuli vs social stimuli). Although these results revealed ongoing dynamic 
changes to mu activity that differed between the reciprocal CNVs, it seems that both 16p11.2 
deletion and duplication impair social neural responses generally in the same direction. This 
perhaps suggests a U-shaped model of gene-dosage effects on social neural responses.  
1.7.4.4 Speech / motor neural activity 
Hinkley et al. (2019) similarly examined neural features of power suppression in 16p11.2 
CNV carriers, but in this case, the focus was on beta power suppression in response to speech 
and motor tasks. When preparing for overt speech or hand movements, beta power is 
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typically suppressed over the sensorimotor cortex. The authors found increased beta 
suppression in deletion carriers compared to controls and duplication carriers, in response to 
both tasks. In addition, left-hemispheric dominance for language (i.e., left-lateralised beta 
suppression during speech) was examined and found to be decreased in deletion carriers 
compared to controls and duplication carriers.  
1.7.4.5 Resting-state neural activity 
Using resting-state fMRI, Bertero et al.’s (2018) study further contributed to characterising 
functional brain alterations in 16p11.2 deletion carriers3. Functional connectivity (global and 
region-specific seed-based analyses) was altered in 16p11.2 deletion carriers compared to 
controls (duplication carriers were not included in this study). Specifically, deletion carriers 
showed decreased global connectivity and prefrontal connectivity with several tempo-parietal 
regions, indicating long-range neural dysfunction.  
1.7.4.6 Links between 16p11.2 CNV, brain functional alterations, and ESSENCE traits 
Links between 16p11.2 CNV, neural activity, and ESSENCE traits remain largely 
unexplored, except for a few studies focusing on certain ESSENCE traits (Table 1.5; Hinkley 
et al., 2019; Bertero et al., 2018; LeBlanc and Nelson, 2016; Jenkins et al., 2016, Berman et 
al., 2016). Unique to Hinkley et al.’s (2019) study are reports of significant correlations 
between M/EEG activity and ESSENCE traits in deletion carriers. Specifically, increased 
task-induced beta power, over region-specific sensorimotor cortices (see Table 1.5), was 
positively associated with phonological and motor impairments. The remaining 16p11.2 CNV 
studies of evoked-neural activity either did not perform brain-behaviour correlation analyses 
(i.e., Hudac et al., 2015) or did so, but found no significant results (i.e., Jenkins et al., 2016; 
Berman et al., 2016; LeBlanc and Nelson, 2016). Namely, no significant correlations were 
found between the auditory M100 latency and non-verbal IQ (Jenkins et al., 2016; Berman et 
al., 2016), social, and language skills (Jenkins et al., 2016) in 16p11.2 deletion carriers. 
Similarly, no significant links were found between visual-evoked neural activity (i.e., N1, P1, 
and N2 amplitude and latency) and IQ in deletion carriers. In contrast, using a resting-state 
fMRI paradigm, the decreased prefrontal connectivity found in deletion carriers was 
associated with social and cognitive deficits (Bertero et al., 2018). Certainly, future studies 
should focus on examining further links between these levels, especially in relation to 
 
3 Bertero et al. (2018) and Hinkley et al. (2019) were focused on deletion carriers, possibly due to the small 
number of duplication participants in the case of Hinkley et al.’s (2019) study (duplication vs control 
comparisons were not conducted). 
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spontaneous neural activity as it is possible that these links are more easily observed in a 
resting-state paradigm.  
Indeed, further 16p11.2 CNV studies are necessary to investigate neural activity, 
whether in response to sensory or other contexts, to verify gene-dosage effects on neural 
activity, and associations with behavioural and ESSENCE traits. Functional brain features 
could serve as an intermediary phenotype, or endophenotype, bridging the gap between 
genotype (i.e., 16p11.2 CNV) and phenotypes (e.g., behavioural and psychiatric traits found 
in 16p11.2 CNV carriers). In addition, using animal models of this CNV, future efforts could 
further verify findings, facilitate interpretations of the link between different levels of 
analyses, and shed light into the underlying pathophysiology.  
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Table 1.5: Links between 16p11.2 CNV, brain functional alterations, and ESSENCE traits.  
 CNV Modality Age Group ESSENCE traits Neural activity Direction of correlation 
Hinkley et al. 
(2019) 
del MEG Children and 
adults (split) 
CTOPP Task-induced beta power (picture 
naming task) over PoCG. 
Positive 
 del   PPB Task-induced beta power (picture 
naming task) over MiFG. 
Positive 
 del   CTOPP; PPB Task-induced beta power (picture 
naming task) over left and right 
MOG; SFG and MeFG.  
N/A (non-significant) 
 dup   CTOPP; PPB Task-induced beta power (picture 
naming task) over PoCG, left and 
right MOG; MiFG, SFG, and 
MeFG.  
N/A (non-significant) 
Bertero et al. 
(2018) 
del fMRI Children IQ, NVIQ PFC connectivity strength Positive 
    SRS PFC connectivity strength Negative 
LeBlanc and 
Nelson (2016)1 
del EEG Children IQ N1, P1, and N2 amplitude and 
latency 
N/A (non-significant) 
Jenkins et al. 
(2016) 
del MEG Children NVIQ, SRS, CELF-4 
core language index, 
CTOPP 
M100 latency N/A (non-significant) 
Berman et al. 
(2016) 
del MEG Children NVIQ M100 latency N/A (non-significant) 
CNV, copy number variant; del, deletion carriers; dup, duplication carriers; ctrl, controls; CTOPP, Comprehensive Test of Phonological Processing; PPB, 
Perdue Pegboard test; SRS, Social Responsiveness Scale; NVIQ, non-verbal IQ; CELF-4, the clinical evaluation of language fundamentals; PoCG; post-
central gyrus (primary somatosensory cortex); MiFG, middle frontal gyrus (over the representation of the hand in pre-motor cortex); MOG, middle 
occipital gyrus; SFG, superior frontal gyrus; MeFG, medial superior frontal gyrus; PFC, prefrontal cortex.  
1 For duplication carriers, correlation analyses between IQ and neural activity were not conducted due to the small sample size. 
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1.8   16p11.2 CNV mouse model 
Among the animal models used to study 16p11.2 CNVs are mouse models generated by three 
independent groups (Horev et al., 2011; Portmann et al., 2014; Arbogast et al., 2016). Genes 
in the (human) 16p11.2 region are conserved in the mouse, thus permitting the generation of 
genotype-based mouse models of 16p11.2 CNV (as opposed to models designed to 
recapitulate certain cognitive and behavioural deficits common to 16p11.2 CNV human 
carriers). These mouse models were engineered to carry a hemideletion or duplication of the 
mouse chromosomal region 7qF3 - which corresponds to the 16p11.2 region in humans 
(Figure 1.9).  
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Figure 1.9: The mouse chromosomal region homologous to the human 16p11.2 region. 
Courtesy: Adler, D. (1994). Mouse Idiogram. University of Washington, Seattle. 
Although highly similar, there are some small differences between the three mouse 
models with regards to their genotype and genetic background/strain. Specifically, for each 
mouse model, the particular intervals targeted to be deleted or duplicated are respectively 
flanked by the following genes, Slx1b-Sept1 (Horev et al., 2011), Coro1a-Spn (Portmann et 
al., 2014), and Sult1a1-Spn (Arbogast et al., 2016). In terms of the genetic background / 
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strain, all three models were maintained on hybrid backgrounds (i.e., C57BL/6NxSv; Horev 
et al., 2011; C5BL/6NxP2; Portmann et al., 2014; and C57BL/6NxC3B; Arbogast et al., 
2016), the latter study additionally generated 16p11.2 CNV mice on an inbred genetic 
background (i.e., C57BL/6N; Arbogast et al., 2016). Despite these differences, these models 
show similar phenotypes of relevance to 16p11.2 human CNVs. However, it is useful to keep 
in mind these differences in genotype and genetic background as possible factors that may 
influence findings.  
Although both 16p11.2 deletion and duplication mouse models were generated, the 
focus of this thesis is on the former, i.e., 16p11.2 deletion model. Henceforth, key 
behavioural, brain structural, and brain functional attributes of this model will be introduced 
with particular emphasis on the latter (i.e., mouse fMRI and in-vivo electrophysiology) and 
its relevance to 16p11.2 CNV human findings.  
16p11.2 deletion mouse model behavioural and ESSENCE traits 
Overall, 16p11.2 deletion mouse model display phenotypes similar to human 16p11.2 
deletion. The presented phenotypes and assessments as described by the independent groups 





Figure 1.10: Behavioural and ESSENCE phenotypes of the three 16p11.2 deletion 
mouse models. 
Green and red boxes respectively indicate higher, or lower, level of the particular phenotype in 
16p11.2 deletion mice compared to wild-type controls. Grey box indicates no group difference. 
White box indicates no available data. H, horizontal locomotor activity; V, vertical locomotor 
activity; C, climbing; Ci, circling; J, jumping; R, rearing; TC, time in Centre; hr, hour; 0.5, 1, 
and 3 hours retention delays for the recognition memory assessments.  
Further studies conducted additional assessments on these models, which 
supplemented and confirmed some of the findings shown in Figure 1.10. Altogether, 
behavioural and cognitive phenotypes observed in 16p11.2 deletion mice include altered 
sleep architecture, and nocturnal and diurnal hyperactivity (Lu et al., 2019; Horev et al., 
2011; Portmann et al., 2014; Arbogast et al., 2016), motor control deficits (Horev et al., 2011; 
Portmann et al., 2014; Yang et al., 2015a; Brunner et al., 2015; Arbogast et al., 2016; 
Angelakos et al., 2017), recognition and memory deficits (i.e., deficits in novel object 
recognition, object location memory, social recognition, and fear memory; Portmann et al., 
2014; Pucilowska et al., 2015; Yang et al., 2015b; Tian et al., 2015; Arbogast et al., 2016), 
social behavioural deficits (i.e., atypical ultrasonic vocalization behaviour in social settings; 
Yang et al., 2015a; duration of sniffing and other social behaviours; Arbogast et al., 2016), 
and impaired learning and cognitive flexibility (Yang et al., 2015b).   
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Certain phenotypes are observed in 16p11.2 deletion mice, but not in human carriers. 
16p11.2 deletion mice tend to show metabolic deficits opposite to that of humans (Horev et 
al., 2011; Portmann et al., 2014; Arbogast et al., 2016). Although at early postnatal age, both 
16p11.2 deletion humans and mice are born underweight, adult humans undergo a drastic 
increase in BMI (Jacquemont et al., 2011; Zufferey et al., 2012) - whereas mice either 
remained underweight or recovered to normal weight in adulthood. In addition, unique to 
Portmann et al.’s (2014) 16p11.2 deletion mouse model, hearing deficits were observed, 
whereas hearing problems were not found to be frequent in human deletion carriers. Despite 
differences in certain phenotypes between 16p11.2 deletion mice and humans, there are 
overall similarities in ESSENCE traits, and brain structural and functional alterations.  
16p11.2 deletion mouse model brain structural alterations 
Similar to human 16p11.2 deletion, alterations in brain structure have been identified in 
16p11.2 deletion mice (Figure 1.11; Horev et al., 2011; Portmann et al., 2014; Bertero et al., 
2018).  
 
Figure 1.11: 16p11.2 deletion mouse model brain structural alterations. 
Green and red boxes, respectively, indicate a higher or lower level of the particular brain 
structural feature in 16p11.2 deletion mice compared to wild-type controls. White box indicates 
no available data. Green + red indicates the presence of both higher and lower level of the 
respective feature.  
Using MRI, Horev et al. (2011) found increased brain volume in 16p11.2 deletion 
mice relative to wild-type mice in many brain regions including superior colliculus, fornix, 
hypothalamus, mammillothalamic tract, midbrain, and periaqueductal grey. Another study 
(Bertero et al., 2018) found widespread white matter microstructural alterations, i.e., 
increased fractional anisotropy (FA) in major white matter tracts, detected by DTI. These 
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results could be reflecting increased axonal thickness of corpus callosal neurons as observed 
in the same study via an electron microscope. In contrast, Portmann et al. (2014) reported 
decreased FA in the corpus callosum, although this was only observed for male 16p11.2 
deletion mice. In addition, the authors observed changes in brain volume and cortical 
thickness: increased volumes of the nucleus accumbens and globus pallidus; and increased 
and decreased cortical thickness at respective regions, e.g., motor and sensory cortices. 
Overall, these studies (Horev et al., 2011; Portmann et al., 2014; Bertero et al., 2018) provide 
converging evidence to the human 16p11.2 deletion studies (Owen et al., 2018; Chang et al., 
2016; Qureshi et al., 2014) that macro- and microstructural changes in these multiple brain 
regions are implicated in 16p11.2 deletion.  
16p11.2 deletion mouse model brain functional alterations 
Functional brain alterations have also been observed in 16p11.2 deletion mice (Table 1.5; 
Bertero et al., 2018; Lu et al., 2019). Key findings from Bertero et al.’s (2018) resting-state 
study point to fMRI functional connectivity impairments in the prefrontal cortex of 16p11.2 
deletion mice, similar to 16p11.2 deletion human findings (reported in the same study). The 
authors identified reduced long-range prefrontal connectivity with parieto-temporal areas, 
retrosplenial cortex, and thalamus in these mice (Bertero et al., 2018). The same study also 
analysed local field potential (LFP) coherence between the prefrontal and retrosplenial 
cortex. Coherence is a common EEG/LFP measure of functional connectivity between brain 
regions (i.e., this analysis measures the similarity in power spectra (power at different 
frequencies) between electrodes). The authors found reduced long-range (i.e., prefrontal and 
retrosplenial) coherence in the delta band in 16p11.2 deletion mice compared to control.  
Power spectral analysis (see Chapter 2, Section 2.2.10.2, and Chapter 3, Section 
3.2.6.3 for more detail about power spectral analysis) conducted by another study (Lu et al., 
2019) similarly found atypical neural activity in the delta frequency band in 16p11.2 deletion 
mice. Specifically, Lu et al. (2019) examined EEG activity from the parietal region during 
vigilant and sleep states (i.e., wakefulness, NREM sleep, and REM sleep) in the day-time and 
night-time. 16p11.2 deletion mice showed lower delta power during day-NREM, but higher 
delta power during night-NREM compared to wild-type mice. However, this was not 
restricted to delta frequency as atypical neural activity were also found in other frequency 
bands in Lu et al.’s (2019) study: lower theta power during day-wake, day-REM, night-wake, 
and night-REM; and higher beta power during wake-REM.  
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Altogether (based on Bertero et al.’s (2018) and Lu et al.’s (2019) studies), functional 
brain activity seems to be altered in 16p11.2 deletion mice at multiple frequency bands and 
brain regions. More studies are required to verify and expand on this, especially as only fMRI 
(prefrontal) long-range connectivity has been implicated in both 16p11.2 deletion humans 
and mice (Bertero et al., 2018).  
 
Table 1.6: 16p11.2 deletion mouse model brain functional alterations.  
Analysis Feature Results Regions 
fMRI Functional 
connectivity 




del < ctrl Parieto-temporal areas, 
retrosplenial cortex, and 
thalamus; Also along the rostro-














Delta del < ctrl (day-NREM); 
del > ctrl (night-NREM) 
Parietal cortex. 
  





Beta del > ctrl (wake-REM) 
 




1.9   Outstanding questions and thesis aim 
Accordingly, the outstanding questions that this thesis aims to answer are below:  
Is neural activity altered, as revealed via EEG variability, power, and entropy 
metrics, in 16p11.2 CNV carriers? 
Overall, prior work (Table 1.4) suggest a neural dysfunction in 16p11.2 CNV, which is more 
prominent in 16p11.2 deletions compared to duplications, in the above-mentioned contexts. 
However, other metrics of neural activity, i.e., neural variability, entropy, and power (for 
human studies), have not been investigated in 16p11.2 CNV, yet they are likely to be 
relevant. These metrics were implicated in ESSENCE disorders and might serve as reliable 
endophenotypes informing prognosis and treatment progression in 16p11.2 CNV carriers. In 
addition, no study has characterised resting-state neural activity at temporal resolutions 
higher than that of fMRI for human 16p11.2 CNV carriers, even though the resting-state 
paradigm is the most practical and feasible for clinical settings and populations. Therefore, 
work in this thesis aims to determine the nature of neural activity in 16p11.2 CNV through 
the lens of various neural dynamics unexplored in previous studies (i.e., neural variability, 
entropy, and power) yet found to be of relevance to ESSENCE disorders (e.g., ASD, ADHD). 
As such, EEG neural activity in response to visual stimuli (Chapter 2) and at rest (Chapter 
3) will be investigated in human 16p11.2 CNV.  
Does 16p11.2 dosage have an opposing effect on neural activity as per the additive 
model? 
Previous work suggest certain trends, albeit non-significant, that indicated a gene-dosage 
opposing effect (i.e., additive model) on neural activity, specifically involving the visual-
evoked P1 and auditory evoked M100 (Section 1.6.4.2.1). Therefore, research in this thesis 
aims to establish whether reciprocal 16p11.2 CNVs do indeed present with opposing neural 
activity (Chapter 2).  
Is there a relationship between neural activity and ESSENCE traits in 16p11.2 
deletion carriers? 
Two studies reported brain-behaviour associations (i.e., beta suppression and connectivity vs 
phonological, motor, and social impairments; Hinkley et al., 2019; Bertero et al., 2018; Table 
1.5) in 16p11.2 deletion. The current thesis will expand on this by examining associations 
between 16p11.2 deletion neural activity and numerous ESSENCE traits, e.g., anxiety 
problems (Chapter 3).  
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Is neural activity in 16p11.2 deletion mouse model similar to that of 16p11.2 
deletion humans?  
The only neural feature that was found to be similar between 16p11.2 deletion humans and 
mice was atypical fMRI long-range prefrontal connectivity (Section 1.7.3; Bertero et al., 
2018). This is most likely due to the small number of 16p11.2 deletion human and mouse 
studies, respectively, and the lack of parallel human-mouse studies (other than Bertero et al.’s 
(2018) fMRI study). Therefore, work in this thesis aims to establish whether 16p11.2 deletion 





 Atypical Neural Variability in Carriers of 16p11.2 Copy 
Number Variants 
2.1   Introduction 
As mentioned in Chapter 1, many studies have consistently drawn the conclusion that the 
number of 16p11.2 copies (i.e., 1 copy = deletion, 2 copies = typical control, 3 copies = 
duplication) may lead to observed opposing effects in certain phenotypes in deletion (del) 
versus duplication (dup) carriers (e.g., Shinawi et al., 2010; Jacquemont et al., 2011; Qureshi 
et al., 2014; Hippolyte et al., 2016; LeBlanc & Nelson, 2016). For example, 16p11.2 del is 
associated with atypically large brain volume, whereas dup is associated with atypically small 
brain volume (Qureshi et al., 2014). This is in line with the additive model described in 
Chapter 1; i.e., reciprocal CNVs (copy number variants) contributing to opposing 
phenotypes (see Figure 1.5a). Investigating whether particular 16p11.2 CNV phenotypes fit 
the additive, dominant, or U-shaped model (Section 1.6.1, Figure 1.5) is important because it 
connects genotype to phenotype, enabling a deeper understanding of the pathological effects 
of 16p11.2 CNVs. 
Further evidence to indications of 16p11.2 CNV additive effects on phenotypes come 
from phenotypes in the form of M/EEG activity (Jenkins et al., 2016; LeBlanc and 
Nelson, 2016; Hudac et al., 2015). As mentioned earlier (Section 1.6.4.2.1), trends, albeit 
non-significant, suggesting opposing neural activity, involving atypical P1-visual (LeBlanc 
and Nelson, 2016) and M100-auditory responses (Jenkins et al., 2016), were found in the 
reciprocal 16p11.2 CNVs. Alternatively, neural activity involving mu-power (8-12 Hz) social 
responses (described in detail in Section 1.6.4.3) revealed atypical mu suppression to non-
social stimuli (as opposed to social stimuli) in the same direction, i.e., increased mu 
suppression, in both 16p11.2 del and dup compared to controls (Hudac et al., 2015). Hence, 
suggesting a U-shaped model of copy number effects on neural responses, specifically in a 
social context. Interestingly, trial-to-trial analyses conducted in the same study, examining 
changes to mu-suppression across time, revealed subtle neural differences between the 
reciprocal 16p11.2 CNVs, countering the U-shaped model. Specifically, an initial typical mu 
response to social stimuli (i.e., increased mu) was found in dup, whereas a consistent atypical 
mu response was found in del (i.e., decreased mu to social stimuli). Indeed, further research 
using other measures of neural activity, especially trial‐to‐trial variability measures, is 
43 
warranted to verify distinct and potentially reciprocal EEG responses in 16p11.2 CNV 
carriers. 
In the ESSENCE (early symptomatic syndromes eliciting neurodevelopmental clinical 
examinations) literature (e.g., Haigh et al., 2015; Dinstein et al., 2012; Milne, 2011), 
variability measures for both M/EEG and fMRI responses have been computed to study intra-
participant trial‐to‐trial neural variability via visual, somatosensory, and auditory paradigms. 
Despite finding no differences in the mean measures of stimulus-response amplitude, these 
studies identified neural responses that were variable across single trials in the autism 
spectrum disorder (ASD) group relative to the typical group. Conducting trial‐to‐trial 
variability analyses, therefore, is useful in identifying these subtle yet significant differences 
in neural responses between ESSENCE and typical populations, which would have been 
unnoticed in measures of averaged‐trial responses. Neural variability has been increasingly 
studied in ESSENCE populations and recognized as a useful sign of atypical brain function 
and development (Pernet et al., 2011; Garrett et al., 2013; Dinstein et al., 2015; David et 
al., 2016). Overall, intra-individual variability measures and analyses (e.g., multiple M/EEG 
and fMRI variability metrics) could present a possibly unifying multimodal approach to 
studying subtle differences in heterogeneous disorders that vary in their symptomology and 
severity from one person to another, such as 16p11.2 CNVs.  
The purpose of the current study is to further determine the nature of the putative 
atypical and reciprocal EEG activity in 16p11.2 del and dup carriers. To our knowledge, no 
existing study has investigated neural variability in this population. As such the current study 
conducts novel analyses of the dataset obtained from Simons Foundation Autism Research 
Initiative (SFARI) and previously published by LeBlanc and Nelson (2016). Neural 
variability was measured via the following metrics: intra-participant response variability of 
visual evoked components (i.e., across‐trial variability in the amplitude and latency of C1, P1, 
and N1), timecourse variability, spectral power variability (i.e., across‐trial variability in 
absolute alpha power, relative alpha power, absolute beta power, and relative beta power), 
and mean signal‐to‐noise ratio (SNR). Further to these measures, we analysed mean visual 
evoked potentials and spectral power (both absolute and relative alpha and beta frequencies) 
to facilitate comparisons with other studies relating to associated disorders and similar CNVs 
(e.g. ASD, 15q, 1q). 
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2.2   Materials and Methods 
Data source  
The findings in this study represent the analyses of a previously collected dataset (LeBlanc 
and Nelson, 2016). The dataset was obtained from the Simons Foundation Autism Research 
Initiative (SFARI), which provides funding and resources to support research relating to ASD 
(https://www.sfari.org/; see Al-Jawahiri and Milne, 2017 for a review on resources available 
for autism research). SFARI’s Simons Variation in Individuals Project (SVIP; The Simons 
VIP Consortium, 2012) specifically aims to “identify and study large numbers of individuals 
sharing recurrent genetic variants known to increase the risk of developing autism spectrum 
and other neurodevelopmental disorders” (https://www.sfari.org/resource/simons-vip/). 
Datasets collected as part of SVIP, which include 16p11.2 CNV data, are available to 
approved researchers via their data request process.  
For this study, data of individuals with 16p11.2 deletion, the reciprocal duplication, 
and typically developing individuals were obtained from SFARI. Participant identification, 
recruitment, and inclusion/exclusion criteria of the SVIP have been described previously (see 
The Simons VIP Consortium, 2012; Jenkins et al., 2016; LeBlanc & Nelson, 2016). Briefly, 
eligibility criteria consisted of having a deletion or duplication of the 16p11.2 region (as 
described in Section 1.1 and Section 1.2, although note that CNVs at smaller regions within 
16p11.2 than that described in these sections are also eligible). Exclusion criteria consisted of 
having any other pathogenic CNVs or known genetic syndromes.  
The control participants analysed in this study did not undergo the Simon's VIP 
battery of assessments. LeBlanc and Nelson (2016) recruited the control group independently 
through the Boston Children's Hospital participant registry. The group consisted of typical 
individuals without any neurological or developmental disorders. 
Participants 
Data from a total of 46 participants were obtained for the current study. Seven participants 
were then excluded. Reasons for exclusions were EEG data contaminated by artefacts (n = 2) 
based on visual inspection, and/or EEG datasets with fewer than 24 clean trials. The final 
dataset analysed contained 39 participants: 20 del, 8 dup, and 11 typical controls. 
Phenotypic data including IQ scores, diagnoses, current medications, and vision 
problems were accessed from the Simons VIP Phase 1 16p11.2 dataset at SFARI Base 
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(http://www.sfari.org/resources/sfari-base). Participant information relating to age, sex, CNV 
inheritance, ASD diagnosis, Autism Diagnostic Observation Schedule -Calibrated Severity 
Score (ADOS‐CSS), and IQ scores are reported in Table 2.1. Note that the reported IQ scores 
were not adjusted for prematurity.  
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Table 2.1: Participant information. 







Sex CNV inheritance ASD diagnosisc ADOS-
CSS 
mean 
(SD)a c d 
FSIQ 
mean 
(SD)b c d 
VIQ 
mean 
(SD)b c d 
NVIQ 
mean 
(SD)b c d 
De 
novo 
Inherited unknown Yes No unknown     
del 20 69.05 
(36.93) 








    F 8 6 1 1 2 6 0     
dup 8 110 
(86.22) 













39 - 109 M 5 - - - - - - - - - - 
    F 6 - - - - - - - - - - 
ADOS-CSS, Autism Diagnostic Observation Schedule - Calibrated Severity Score; FSIQ, full-scale IQ, VIQ, verbal IQ, NVIQ, nonverbal IQ.  
aMissing data from del carriers (n = 6), dup carriers (n =1), control (n = 11).  
bMissing data from del carriers (n = 1), control (n = 11).  
cIQ and diagnosis data were extracted from diagnosis_summary.csv 
dThe reported IQ scores were not adjusted for prematurity. 
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Other diagnoses and comorbidities are reported in Table 2.2. Information regarding 
current medication was extracted from the SFARI medication questionnaire (med_child.csv); 
two del carriers were reported to have been currently taking antiepileptic medication (i.e., 
Keppra and Topamax). Additionally, vision problems were reported for eight del and four 
dup carriers in the SFARI development and medical history form (mhi_ped.csv). 
Kruskal–Wallis tests revealed that there were no significant age or sex differences 
among the three groups (χ2 (2) = 1.46, P = 0.481; χ2 (2) = 0.65, P = 0.724). Also, there were 
no significant differences in IQ scores (full‐scale IQ: χ2 (1) = 2.97, P = 0.085; verbal 
IQ: χ2 (1) = 2.34, P = 0.126; nonverbal IQ: χ2 (1) = 1.71, P = 0.191) between del and dup 
groups. Comparisons with the control group were not possible as, other than age and sex, 
participant details and phenotypic data were not available for the control group. 
 
Table 2.2: Diagnoses summarya. 
Diagnosesb del (n = 20) dup (n = 8) 
ADHD 4 1 
Anxiety disorders including OCD and 
phobia 
- 2 
Articulation disorder 9 1 
Other disruptive behaviour disorder 
(conduct/oppositional) 
3 2 
Developmental coordination disorder 12 3 
Enuresis disorder 2 - 
Language disorders 8 4 
Learning disorder 1 1 




aComorbidities or more than one diagnoses are present in this sample. 
bSeizure / epilepsy diagnoses data were extracted from the nrrg.csv file; all other diagnoses 
data were found in the diagnosis_summary.csv file.  
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Ethical approval 
The local institutional ethical review board reviewed and approved the secondary analyses 
presented here. Our request to obtain access to phenotypic and imaging data on SFARI Base 
was approved after submitting the required information and signing the joinder to the 
researcher distribution agreement (https://www.sfari.org/resource/sfari-base/). SFARI 
obtained initial ethical approval for the SVIP (IRB of record: Columbia University Medical 
Center; the Simons VIP Consortium, 2012). As part of the SVIP, approval was obtained for 
data collection on individuals with 16p11.2 deletions or duplications and for their de-
identified data to be shared with approved researchers. 
Psychometric assessments (CNV groups only) 
The Autism Diagnostic Observation Schedule-Calibrated Severity (ADOS-CSS) and IQ 
scores for 16p11.2 CNV groups were accessed from the Simons VIP Phase 1 16p11.2 dataset 
at SFARI Base (http://www.sfari.org/resources/sfari-base). 
2.2.4.1 Autism Diagnostic Observation Schedule-Calibrated Severity Score (ADOS-CSS) 
The Autism Diagnostic Observation Schedule-2 (ADOS-2; Gotham et al., 2007) is a semi-
structured assessment for diagnosing and describing autism core symptoms, based on 
observation of the individual’s behaviour in response to a series of activities. Depending on 
the individual’s chronological age and language ability, one of five ADOS modules is 
administered (e.g., toddler module is appropriate for toddlers who do not consistently use 
phrase speech, while module 4 is for verbally fluent adolescents and adults). The observed 
behaviour is then coded by a trained examiner and scored based on an algorithm to yield 
classifications of ‘non-spectrum’, ‘autism spectrum disorder’, and ‘autism’. A calibrated 
severity score (CSS; (Gotham et al., 2009) is a new metric developed from raw ADOS-2 
scores, which estimates core autism symptom severity independent of language, age, and 
intellectual ability. CSS ratings are classified as follows: ‘non-spectrum’ (ratings 1-3), 
‘autism spectrum disorder’ (ratings 4-5), and ‘autism’ (ratings 6-10). Data from six del and 
one dup carriers are missing. 
2.2.4.2 IQ 
Based on the participants’ age, intellectual and cognitive ability was measured either with the 
Wechsler Abbreviated Scale of Intelligence (WASI; Wechsler, 1999), the Mullen Scales of 
Early Learning (Mullen, 1995), or the Differential Ability Scales – Early Years & School 
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Age (DAS-II; Elliott, 2007). Standard scores for full-scale IQ, verbal IQ, and non-verbal IQ 
were obtained from SFARI. Data from one del carrier is missing.  
Stimuli and procedure 
The stimuli and procedure were as described in previous studies (LeBlanc and Nelson, 2016; 
LeBlanc et al., 2015; Varcin et al., 2016). Specifically, the presented stimuli consisted of 
black and white high contrast checkerboards of 99% with an average luminance of 80 cd/m2, 
and a phase reversal rate of 2 Hz (i.e. phase reversing from black to white and white to black 
twice per second). The size of the checker was ~60 arcminute with a spatial frequency of 0.5 
cycles/degree. Participants were seated ~60 cm from a Tobii T60 eye-tracking monitor (Tobii 
Technology, Sweden) that was 34.7 cm wide. Infant participants were seated on their 
caregiver’s lap. The stimulus was presented on the monitor by running the E-Prime software 
(Psychology Software Tools, Pittsburgh, PA) in a dark room that was sound-attenuated and 
electrically shielded. Binocular eye gaze was monitored to ensure phase-reversal occurred as 
long as the participant’s fixation gaze on the stimulus lasted for a minimum of 100 ms. 
Phase-reversal was paused when the participant’s gaze was not fixated towards the stimulus. 
Depending on the participants’ attentiveness and patience during the sessions, up to 150 trials 
were presented.  
EEG recording and pre-processing prior to the current study 
EEG was continuously recorded using a 128 channel HydroCel Geodesic Net-Version 1 
(Electrical Geodesics Inc., Eugene, OR, USA). The signal was amplified with a NetAmps 
300 amplifier and digitised at a sampling rate of 500 Hz. A total offset of 34 ms was present 
and consistent for all participants. The offset resulted from both an 18 ms amplifier offset 
(due to the anti-alias filters within the amplifier) and 16 ms DIN offset (due to a delay 
between the stimulus trigger and stimulus visual onset on the monitor). Because this offset 
was consistent for all participants, it is not expected to drive group differences. In addition, 
the time window for the P1 component used for this study has a wide range (56–132 ms post-
stimulus onset), which accounted for this offset and captured the P1 response.  
A number of pre-processing steps were conducted offline using NetStation software 
prior to obtaining the data for the current study. Firstly, the data were filtered with a bandpass 
of 0.3-30 Hz. Secondly, the data were segmented into epochs 400 ms long (100 ms baseline 
and 300 ms post-stimulus). Baseline correction was applied. ‘Bad’ channels, i.e. channels 
which recorded a noisy EEG signal, were removed. Channels were defined as bad if they: 
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were missing; measured EOG from around the eyes, had amplitude ± 150 µV; contained 
artefacts in 100% of trials. By hand-edit, trials were marked bad if more than 12 channels 
were bad (not including missing or eye channels). Trials with eye blinks, eye movements, 
large clusters of bad channels, muscle artefacts, or excessive drift, were rejected. Bad 
channels were replaced using interpolation techniques. Channels (including interpolated 
channels) were referenced to an average reference.  
EEG pre-processing conducted in the current study 
Additional pre-processing steps were conducted in the current study after obtaining the 
dataset, which consisted of rejecting obvious bad trials (three trials in total) based on manual 
visual inspection. In addition, the number of trials selected for analysis was adjusted per 
group in order to control the average number of trials analysed per group and avoid bias in 
analysis outcomes (original trial number range after participant exclusions: 24–147; original 
mean trial number for control = 67, original mean for del = 49, original mean for dup = 71; 
new trial number range: 24–97; new mean = 49 trials per group). This was done via an 
algorithm that applied a different number of trial limits per participant depending on the 
group the respective participant belonged to, which in turn was designed to result in the same 
trial number averages for all groups. 
EEG channel selection 
In accordance with previous studies (e.g., Foxe and Simpson, 2002; Milne, 2011; Gonen‐
Yaacovi et al., 2016; Arazi et al., 2017), for each participant, the channel within the occipital 
and parietal regions with the highest amplitude within the time window 60–140 ms post-
stimulus onset was selected for timecourse variability analyses and C1, P1, and N1 analyses 
(both mean and variability analyses; Table 2.3). This will be referred to as criterion 1 for 




Table 2.3: Channels selected for C1, P1, N1, and timecourse variability primary 
analyses based upon criterion 1 (peak channel for P1 responses). 
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All three groups (n = 
39) 
Control (n = 11) del (n = 20) dup (n = 8) 
58 [1] 62 [1] 58 [1] 71 [1] 
62 [1] 71 [2] 69 [1] 73 [1] 
69 [1] 74 [2] 70 [1] 74 [1] 
70 [1] 75 [3] 71 [1] 75 [1] 
71 [4] 76 [2] 74 [2] 81 [1] 
73 [1] 99 [1] 75 [4] 82 [1] 
74 [5] 
 
76 [2] 84 [1] 
75 [8] 
 













83 [2]       
84 [1]       
90 [1]       
99 [2]       
The frequency of subjects for which each channel was selected is noted in brackets. 
Reported as channel number [frequency].  
 
We also analysed the data based on an alternative criterion (criterion 2) of selecting 
the channel with the lowest C1 amplitude, highest P1 amplitude, and lowest N1 amplitude for 
the respective C1, P1, and N1 analyses (both mean and variability analyses; Table 2.4); this 
analysis produced identical variability results, in addition to certain minor differences in the 
mean ERP results (see Results Section 2.3).  
Table 2.4: Channels selected for C1, P1, N1, and timecourse variability supplementary 
analyses based upon criterion 2 (peak channel unique for each component).  
Control (n = 11) del (n = 20) dup (n = 8) 
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C1 P1 N1 C1 P1 N1 C1 P1 N1 
91 [1] 99 [1] 89 [1] 97 [1] 90 [1] 99 [2] 94 [1] 99 [1] 99 [1] 
81 [1] 76 [2] 85 [1] 96 [2] 83 [2] 96 [1] 83 [1] 84 [1] 94 [2] 
75 [2] 75 [3] 83 [1] 94 [1] 82 [4] 94 [2] 82 [1] 82 [1] 90 [1] 
74 [1] 74 [2] 82 [1] 91 [1] 81 [1] 93 [1] 75 [1] 81 [1] 88 [1] 
73 [1] 71 [2] 81 [1] 88 [1] 76 [2] 88 [1] 73 [1] 75 [1] 76 [1] 
71 [2] 62 [1] 75 [1] 83 [2] 75 [4] 84 [2] 65 [1] 74 [1] 56 [2] 
57 [1] 
 




68 [1] 74 [1] 71 [1] 76 [1] 56 [1] 71 [1] 
 
  
65 [1] 73 [2] 70 [1] 74 [1] 
   
  
56 [2] 71 [1] 69 [1] 73 [2] 
   
   
68 [3] 58 [1] 71 [1] 
   




   




   




   
The frequency of subjects for which each channel was selected is noted in brackets. Reported as 
channel number [frequency].  
 
For power analyses and SNR analyses, the average of a set of channels positioned 
above the occipital cortex was computed (Figure 2.1). 
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Figure 2.1: Electrical Geodesics Inc. (EGI) 128-channel hydrocel sensor net – version 1. 
The correspondence between the EGI 128 sensor net and the international 10–20 system. For 
power and SNR analyses, the channels circled in purple were averaged. 
Extracting C1, P1, and N1 amplitude and latency  
C1, P1, and N1 were identified for each trial and participant. Using a peak‐picking algorithm, 
which identified either the maximum or minimum amplitude within a given time window, 
negative and positive deflection points were identified in overlapping period ranges 
consistent with those previously reported by LeBlanc and Nelson (2016). C1 was identified 
as the minimum amplitude occurring in the post-stimulus period range of 0–70 ms; P1 was 
the highest amplitude in the period range of 56–132 ms; N1 was the lowest amplitude in the 
108–266 ms range. The amplitude and latency of C1, P1, and N1 were first extracted from 
every trial. Respectively, the C1, P1, and N1 average single‐trial amplitudes were then given 
by computing the median of all the single‐trial C1, P1, and N1 amplitude deflection points. 
Similarly, C1, P1, and N1 average single‐trial latencies were given by the median of all the 
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single‐trial time points at which the C1, P1, and N1 amplitude peaks (therefore, following the 
approach of Milne (2011)). 
Measures of neural variability  
Because there are many variables that have been suggested to indicate neural variability (e.g., 
Milne, 2011; Weinger et al., 2014; Haigh et al., 2016; Arazi et al., 2017; Butler et al., 2017), 
it is good practice to apply more than one measure and examine whether there is concordance 
between the metrics. Measures of neural variability examined in the current study were C1, 
P1, and N1 variability; inter-trial variability in ERP amplitude across the timecourse 
(henceforth referred to as timecourse variability); alpha and beta power variability; and EEG 
SNR. Although it could be argued that SNR is not a true reflection of inter-trial variability, it 
is often used as a proxy measure of variability, with lower SNRs interpreted as higher neural 
variability (Dinstein et al., 2012; Butler et al., 2017). Thus, SNR is provided in the current 
study for comparison with previous research. 
2.2.10.1 C1, P1, N1, and timecourse variability  
For each participant, C1, P1, and N1 variability were given by computing the median 
absolute deviation (MAD) of the single trial amplitude and latency values. Timecourse 
variability was given by computing the MAD of all 2 ms interval amplitudes across trials for 
the full length of the signal in order to investigate the precise timing of any differences in 
variability between the three groups. In other words, we computed the MAD of single‐trial 
amplitudes of each individual datapoint in the signal (encompassing all the pre-stimulus and 
post-stimulus periods; range: −100 ms, 300 ms). 
2.2.10.2 Alpha and beta power variability 
Power variability was given by computing the MAD of single‐trial absolute and relative 
alpha (8–14 Hz) and beta power (14–30 Hz) for each participant (see more detailed 
description below). These were computed from the average input of a set of occipital 
channels as indicated in Figure 2.1. 
The fast Fourier transform of the full length of each single trial data (200 datapoints) 
for each participant was computed using the ‘fft’ MATLAB function and divided by the 
number of datapoints. The signal was first zero-padded, to form a total of 1000 timepoints, 
and subtracted from the mean signal amplitude (this is done to remove the direct current 
signal). In addition, a taper was applied to the data, specifically, a hanning window, using the 
‘hann’ MATLAB function. Power spectral density (PSD) was then computed by squaring the 
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absolute of the Fourier coefficients then multiplying by two to account for the negative 
frequencies. Given the parameters of the data, i.e. sampling rate of 500 Hz and 200 datapoints 
(corresponding to 400 ms) epoch lengths, the frequency resolution was 2.5 Hz. Absolute and 
relative power were computed for the alpha (8-14 Hz) and beta (14-30 Hz) frequency ranges. 
Using the ‘trapz’ MATLAB function, trapezoidal integration for each range was conducted to 
obtain the absolute power of single trials. Prior to obtaining the relative power, the total 
spectral power was defined as the entire range between 1-30 Hz. Relative alpha and relative 
beta power were subsequently calculated as the ratio of alpha and beta power, respectively, to 
total power on each trial. To analyse power variability, again the MAD of single-trial 
absolute and relative alpha and beta power was found for each participant. Mean absolute and 
relative alpha and beta power were also measured to facilitate comparisons with other studies. 
These analyses were conducted using in-house code (code available upon request) derived 
from codes shared by Dr Mike X. Cohen (Cohen, 2014) with functions from the EEGlab 
toolbox (Delorme and Makeig, 2004). 
2.2.10.3 Signal-to-noise ratio 
SNR is the ratio of post-stimulus signal (i.e., 0 to 100 ms in the current study) strength to the 
pre-stimulus signal (i.e., −100 to 0 ms relative to stimulus time) strength (the latter 
traditionally termed as noise) and is usually expressed in decibels. The current study followed 
the same SNR formula used in Butler et al. (2017) to compute SNRs (see more detailed 
description below). 
 To compute the visual evoked potential SNR, the squared root-mean-square-
amplitude (rms) of the post-stimulus signal was divided by the squared rms of the pre-
stimulus signal and converted into decibels. The ‘post-stimulus period’ was taken from 0 ms 
to 100 ms post-stimulus onset, and the ‘pre-stimulus period’ was from -100 ms to 0 ms 
relative to stimulus time. This ensured that equal temporal segments of data before and after 










Where rms is the root-mean-square amplitude. 
This formula is also embedded as a function in MATLAB ‘snr’ version R2016a (The 
MathWorks Inc.). The SNR from the mean of a set of channels positioned above the occipital 
cortex (Figure 2.1) was computed for each trial and then averaged across trials and compared 
between groups.  
Statistical Analysis 
As sample sizes were small and the data were skewed, permutation tests (Rodgers, 1999) 
were conducted to investigate whether there were group differences in neural activity 
between the three groups. The advantage of this technique is it makes no a priori assumptions 
about the distribution of the data and uses the actual data to conduct the test. For each group 
comparison (i.e., del/control, dup/control, and del/dup), the whole group data were randomly 
permuted, this new permuted data were assigned to two groups with identical sample sizes to 
the respective original dataset. The mean difference between these two new groups was 
calculated; this procedure was then repeated 10,000 times. The actual absolute mean 
difference was compared to the randomized distribution of absolute mean differences. The P-
value is the number of (absolute) mean differences' values above the actual (absolute) mean 
difference obtained and divided by the number of iterations (10,000). This was conducted for 
each EEG averaged and variability metric described in earlier sections. To account for 
multiple comparisons, the false discovery rate (FDR) was controlled using the Benjamini–
Hochberg procedure, with q < 0.05.  
The permutation approach was also applied to correlation analyses to examine 
whether age, IQ, and autistic traits impact neural responses in 16p11.2 CNV carriers. For 
each group, the null hypothesis (r = 0) is tested by holding the X‐variable (e.g., age) constant 
and permuting the Y‐variable (e.g., P1 amplitude variability) against it. In other words, the r‐
coefficient for the respective actual X‐variable and the random permutated Y‐variable pair is 
computed, with the expectation of r = 0. This process is repeated 10,000 times, where only 
the Y‐variable is permuted. The actual absolute r‐coefficient of the respective variables were 
then compared to the randomized distribution of absolute r‐coefficients, which were produced 
by the 10,000 correlation permutations. The P‐value is the number of (absolute) r‐
57 
coefficients' values above the actual (absolute) r‐coefficients obtained and divided by the 
number of iterations (10,000). All the outcomes were corrected by controlling FDR using the 
Benjamini–Hochberg procedure, with q < 0.05. 
2.3   Results 
C1, P1, N1, and timecourse variability 
Del, dup, and control group averages and differences in the variability of C1, P1, and N1 
amplitude and latency are presented in Table 2.5 and Table 2.6. Significant differences were 
found in P1 amplitude variability (Figure 2.2A) between del and controls. Specifically, del 
showed significantly higher variability in P1 amplitude compared to controls. Also, del 
showed significantly lower variability in P1 latency compared to dup (Figure 2.2B). No other 
















Table 2.5: Variability and averaged measures of neural activity of 16p11.2 CNVs. 
 
  del Control dup 
C1, P1, N1 
variability 
C1 amplitude (µV) 15.2 [6  17.75] 12.18 [3.91  14.39] 12.11 [4.5  17.8] 
 C1 latency (ms) 21.5 [10  31] 16 [2  26] 16 [6  24] 
 P1 amplitude (µV) 17.67 [10.17  26.27] 11.01 [5.48  19.4] 13.62 [3.11  25.25] 
 P1 latency (ms) 8 [4  16] 10 [4  24] 13 [8  26] 
 N1 amplitude (µV) 19.4 [9.52  25.88] 14.54 [6  26] 17.56 [4.02  30.51] 
 N1 latency (ms) 34.5 [12  56] 32 [23  40] 42 [22  52] 
     
Power variability Absolute alpha (µV2) 13.39 [7.36  44.27] 9.01 [2.78  34.85] 8.10 [1.49  14.28] 
 Relative alpha (%) 0.09 [0.05  0.17] 0.11 [0.07  0.14] 0.08 [0.04  0.09] 
 Absolute beta (µV2) 5.36 [1.93  19.74] 3.15 [0.54  10.55] 2.28 [1.25  5.35] 
 Relative beta (%) 0.04 [0.02  0.09] 0.05 [0.03  0.06] 0.04 [0.01 0.07] 
     
SNR (dB) 4.73 [3.22  6.29] 4.89 [3.93  7.87] 4.83 [4.40  6.35] 
     
C1, P1, N1 mean C1 amplitude (µV) 0.03 [-10.23  6.48] -6.49 [-20.1  0.52] -4.54 [-7.91  -1.41] 
 C1 latency (ms) 40 [2  72] 64 [20  70] 52 [2  72] 
 P1 amplitude (µV) 23.13 [8.08  43.06] 14.42 [1.47  28.73] 10.41 [3.21  16.76] 
 P1 latency (ms) 98 [78  126] 98 [68  134] 92 [88  134] 
 N1 amplitude (µV) -10.05 [-24.53  5.83] -7.8 [-13.08  -1.34] -7.3 [-11.79  -0.53] 
 N1 latency (ms)  213 [144  268] 210 [136  250] 199 [162  268] 
     
Power mean Absolute alpha (µV2) 31.62 [18.01  98.28] 24.52 [5.95  51.55] 18.18 [3.60  35.93] 
 Relative alpha (%) 0.20 [0.14  0.35] 0.23 [0.18  0.33] 0.16 [0.12  0.23] 
 Absolute beta (µV2) 15.48 [6.09  66.96] 10.08 [1.81  22.92] 6.78 [3.40  13.38] 
 Relative beta (%) 0.10 [0.04  0.24] 0.11 [0.08  0.16] 0.09 [0.05  0.20] 
The data are reported as median [range]. Descriptives relating to significant results are in bold. 
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Table 2.6: Group differences in variability and averaged measures of neural activity of 
16p11.2 CNVs. 
   del/Control dup/Control del/dup 







C1, P1, N1 
variability 
C1 amplitude (µV) 2.92 0.048 1.45 0.437 1.48 0.330 
 C1 latency (ms) 7.25 0.010 1.45 0.702 5.80 0.020 
 P1 amplitude (µV) 6.16 0.001 2.79 0.282 3.37 0.100 
 P1 latency (ms) 0.80 0.650 5.05 0.108 5.85 0.003 
 N1 amplitude (µV) 4.01 0.080 3.15 0.368 0.86 0.724 
 N1 latency (ms) 5.61 0.154 9.66 0.021 4.05 0.372 





4.67 0.226 4.80 0.231 9.47 0.004 
 Relative alpha (%) 0.01 0.510 0.03 0.016 0.02 0.064 
 Absolute beta (µV2) 2.28 0.085 1.17 0.325 3.45 0.002 
 Relative beta (%) < 0.01 0.599 <0.01 0.950 <0.01 0.687 
        
SNR (dB) 0.23 0.556 0.04 0.931 0.27 0.400 
        
C1, P1, N1 
mean 
C1 amplitude (µV) 6.50 0.006* 2.75 0.349 3.75 0.025 
 C1 latency (ms) 18.07 0.022 9.52 0.277 8.55 0.323 
 P1 amplitude (µV) 8.65 0.010 3.06 0.359 11.71 0.0003 
 P1 latency (ms) 0.45 0.926 1.45 0.862 1.00 0.836 
 N1 amplitude (µV) 0.98 0.702 0.63 0.728 1.61 0.565 
 N1 latency (ms)  20.41 0.191 20.91 0.284 0.50 0.975 





13.87 0.067 8.22 0.225 22.09 0.003 
 Relative alpha (%) 0.02 0.208 0.07 0.003 0.04 0.019 
 Absolute beta (µV2) 7.51 0.053 2.78 0.289 10.29 0.003 
 Relative beta (%) 0.01 0.731 <0.01 0.892 0.01 0.681 
Significant results of permutation tests after correcting for FDR (significance threshold at p < 0.006) are in 
bold. *This result becomes non-significant in the secondary analysis of channel selection criterion.  
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Figure 2.2: P1 variability in 16p11.2 CNV. 
All three groups are presented similarly in both subfigures with the del group shown in blue, 
the dup group shown in green, and the typical control groups shown in black. In addition, 
participants within the CNV groups with a diagnosis of autism spectrum disorder are indicated 
in purple. (A) The left graph shows scatter plots representing the distributions (median and 
range) of intra-participant amplitude variability (MAD) of the peak P1 component, averaged 
across groups. (B) The right graph shows group distributions of latency variability of peak P1. 
Timecourse variability, that is, trial‐to‐trial variability in the amplitude of each 
individual datapoint (2 ms) in the signal (range: −100 ms, 300 ms), was also compared 
between the three groups. Compared to controls, del showed higher 2 ms‐interval trial‐to‐trial 
variability almost consecutively for the whole period between −100 and 172 ms (length of 
gaps <31 ms) and at 286 ms (see Figure 2.3 for a precise illustration of the timepoints during 
the epoch where timecourse variability was significantly greater in del than controls). No 
other differences were found in timecourse variability between the three groups. 
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Figure 2.3: Timecourse variability in 16p11.2 CNV. 
Timecourse variability in 16p11.2 CNV. The del group is indicated with blue, dup group with 
green, and control group with black. The figure shows the timecourse variability (i.e., 
variability in amplitude at each time‐point, 2 ms interval, throughout the signal) for all three 
groups. The grey shaded areas represent the durations by which del significantly differed from 
controls in amplitude (significance threshold at P < 0.029).  
Mean amplitude and latency of C1, P1, and N1 were compared between the three 
groups (Table 2.5 and Table 2.6). del showed higher C1 (i.e., lower negative peak) 
amplitude compared to controls. Note that when the channel selected for analysis was based 
on the alternative criterion of selecting the electrode showing the lowest C1 and N1 
amplitude for the respective C1 and N1 analyses, this group difference was no longer 
significant and a new result of increased C1 latency in dup compared to controls was found. 
In line with LeBlanc and Nelson (2016), del showed higher P1 amplitude compared to dup. 
No other significant differences were found. 
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Alpha and beta power variability 
Trial‐to‐trial variability in absolute and relative power within the alpha and beta frequency 
bands were compared between the three groups (Table 2.5 and Table 2.6). Variability in 
absolute alpha and beta power was significantly higher for del compared to dup (Figure 2.4A 
and Figure 2.4B). No other significant group differences were found in alpha or beta power 
variability. 
 
Figure 2.4: Alpha and beta power variability in 16p11.2 CNV. 
All three groups are presented similarly in both subfigures with the del group shown in blue, 
the dup group shown in green, and the typical control groups shown in black. In addition, 
participants within the CNV groups with a diagnosis of autism spectrum disorder are indicated 
in purple. (A) The left subfigure shows scatter plots representing the group distributions of 
intraparticipant variability of absolute alpha power (8–14 Hz). (B) The right subfigure shows 
group distributions of absolute beta variability (14–30 Hz). 
Mean absolute and relative power in the alpha and beta frequency bands were also 
compared between the three groups (Table 2.5 and Table 2.6). Relative alpha power was 
lower for dup compared to controls. Additionally, absolute alpha and absolute beta power 
were higher for del compared to dup. No significant group differences were found in mean 
alpha or beta power. 
Signal-to-noise ratio 
The analysis revealed no significant differences in SNR between the three comparisons 
(Table 2.5 and Table 2.6). 
Correlations between IQ, ADOS-CSS, and EEG measures in 16p CNV 
For each of the del and dup groups, correlation permutation tests were performed between IQ 
and ADOS‐CSS against EEG measures of interest (C1, P1, and N1 variability; alpha and beta 
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power variability; SNR; C1, P1, and N1 mean; alpha and beta power mean), respectively. No 
significant correlations were found (Table 2.7). 
Table 2.7: Correlations between IQ, ADOS-CSS, and EEG measures in 16p11.2 CNV. 
  del dup 
  IQ ADOS-CSS IQ ADOS-CSS 
C1, P1, N1 
variability 
C1 amplitude (µV) -0.45 0.38 -0.30 -0.64 
 C1 latency (ms) 0.06 0.08 0.54 -0.03 
 P1 amplitude (µV) -0.42 < 0.001 -0.49 -0.76 
 P1 latency (ms) -0.27 0.07 -0.70 0.06 
 N1 amplitude (µV) -0.59 0.11 -0.51 -0.52 
 N1 latency (ms) -0.37 -0.01 -0.4 0.52 
      
Power 
variability 
Absolute alpha (µV2) -0.67 0.29 -0.07 -0.88 
 Relative alpha (%) -0.10 -0.09 -0.04 -0.70 
 Absolute beta (µV2) -0.13 0.17 -0.54 -0.39 
 Relative beta (%) 0.21 0.05 0.16 0.70 
      
SNR (dB) 0.02 0.26 0.01 0.33 
      
C1, P1, N1 
mean 
C1 amplitude (µV) -0.01 0.23 0.14 0.21 
 C1 latency (ms) -0.49 0.74 -0.09 0.27 
 P1 amplitude (µV) < 0.001 -0.11 0.18 -0.21 
 P1 latency (ms) -0.39 -0.02 0.05 0.12 
 N1 amplitude (µV) 0.02 0.10 0.17 0.64 
 N1 latency (ms)  -0.18 -0.39 -0.46 0.28 
      
Power mean Absolute alpha (µV2) -0.64 0.18 -0.24 -0.88 
 Relative alpha (%) -0.19 -0.14 0.16 -0.70 
 Absolute beta (µV2) -0.13 0.36 -0.71 -0.76 
 Relative beta (%) 0.32 -0.01 0.05 0.76 
The reported values correspond to the r coefficient. All results are non-significant. Significance 
threshold at p < 0.003. 
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The impact of age on neural activity 
For each of the three groups, correlation permutation tests were performed between age and 
the EEG measures of interest (C1, P1, and N1 variability; alpha and beta power variability; 
SNR; C1, P1, and N1 mean; alpha and beta power mean), respectively. No significant 
correlations were found (Table 2.8). 
Table 2.8: Correlations between age and EEG variability and averaged metrics in 
16p11.2 and control groups. 
  del Control dup 
                                                        Age 
C1, P1, N1 
variability 
C1 amplitude (µV) 0.26 -0.06 -0.23 
 C1 latency (ms) 0.27 -0.36 0.02 
 P1 amplitude (µV) -0.37 <0.01 -0.57 
 P1 latency (ms) -0.47 -0.12 0.25 
 N1 amplitude (µV) -0.60 -0.16 -0.51 
 N1 latency (ms) -0.36 -0.18 -0.12 
     
Power 
variability 
Absolute alpha (µV2) -0.47 0.11 -0.42 
 Relative alpha (%) -0.30 -0.01 0.14 
 Absolute beta (µV2) 0.47 0.05 -0.38 
 Relative beta (%) 0.53 0.28 0.36 
     
SNR (dB) -0.15 -0.20 -0.55 
     
C1, P1, N1 
mean 
C1 amplitude (µV) 0.10 -0.57 0.24 
 C1 latency (ms) -0.39 0.05 0.12 
 P1 amplitude (µV) 0.04 0.36 -0.41 
 P1 latency (ms) -0.20 -0.02 0.49 
 N1 amplitude (µV) -0.19 -0.15 0.25 
 N1 latency (ms)  -0.25 0.32 0.28 
     
Power mean Absolute alpha (µV2) -0.34 0.11 -0.40 
 Relative alpha (%) -0.25 0.23 0.08 
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 Absolute beta (µV2) 0.47 0.05 -0.47 
 Relative beta (%) 0.50 0.05 0.54 
The reported values correspond to the r coefficient. All results are non-significant.  
Significance threshold at p < 0.006. 
 
The number of trials available for analysis differed for each participant which could 
potentially influence estimates of variability. Thus, to investigate whether the number of trials 
per participant was associated with variability, SNR, and/or averaged EEG measures, 
permutation correlation tests were conducted, and the outcomes were corrected using the 
Benjamini–Hochberg procedure, with q < 0.05. The results showed that there were no 
significant relationships between the EEG measures and trial number (Table 2.9). In the 
current study, the number of retained trials in the three groups were the same on average 
(mean = 49 trials per group, Kruskal–Wallis (χ2 (2) = 0.58, P = 0.748, indicates no difference 
in median). Therefore, the variable trial number per participant is unlikely to explain any 
observed group differences in any of the EEG measures of interest. 
Table 2.9: Correlations between EEG measures and trial number. 
  Trial number 
C1, P1, N1 variability C1 amplitude (µV) -0.38 
 C1 latency (ms) -0.07 
 P1 amplitude (µV) -0.43 
 P1 latency (ms) 0.02 
 N1 amplitude (µV) -0.43 
 N1 latency (ms) -0.25 
   
Power variability Absolute alpha (µV2) -0.14 
 Relative alpha (%) 0.09 
 Absolute beta (µV2) -0.23 
 Relative beta (%) 0.13 
   
SNR (dB) -0.09 
   
C1, P1, N1 mean C1 amplitude (µV) 0.14 
 C1 latency (ms) 0.05 
 P1 amplitude (µV) -0.06 
 P1 latency (ms) -0.05 
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 N1 amplitude (µV) 0.28 
 N1 latency (ms)  -0.19 
   
Power mean Absolute alpha (µV2) -0.20 
 Relative alpha (%) 0.20 
 Absolute beta (µV2) -0.25 
 Relative beta (%) 0.02 
The reported values correspond to the r coefficient. All results are non-significant. 
Significance threshold at p < 0.006.  
2.4   Discussion 
The aim of the study was to determine whether 16p11.2 CNVs show opposing atypical EEG 
signals, which could broadly indicate gene‐dosage effects (i.e., additive model) playing a 
differential role in cognitive processes and neural plasticity. Multiple measures of neural 
variability were estimated from EEG data, most of which were single‐trial intraparticipant 
analyses. Overall, our results suggest that 16p11.2 del carriers showed highly variable neural 
responses to visual stimuli, compared to controls. Variability of timecourse amplitude (i.e., 
variability in amplitude at time‐points throughout the epoch; Figure 2.3) and variability of P1 
peak amplitude were higher in del compared to controls. Compared to dup, del showed higher 
variability in absolute alpha and beta power but lower variability in P1 latency variability. 
Overall, it is unclear from our findings whether 16p11.2 dosage has an opposing effect on 
neural activity following the additive model. Despite finding significant differences in neural 
variability between del and dup, we did not find any differences between dup and controls 
(although note that we did find dup‐control group differences in mean relative alpha power). 
Differences in neural activity between del and dup are not sufficient evidence of an opposing 
effect. For a true opposing effect to be seen, we would need to show that both groups differ in 
opposing directions from the control group (i.e., del > control and control > dup, or vice 
versa). 
Is atypical neural variability unique to 16p11.2 CNVs? 
Atypical neural variability has been shown in several ESSENCE disorders including ASD 
(Milne, 2011; Dinstein et al., 2012; Weinger et al., 2014; Edgar et al., 2015; Haigh et 
al., 2015, 2016; but see Coskun et al., 2009; and Butler et al., 2017), ADHD (Woltering et al., 
2012; McLoughlin et al., 2014; Gonen‐Yaacovi et al., 2016; Sørensen et al., 2016), and 
schizophrenia (Shin et al., 2015; Haigh et al., 2016). For example, similar to the current 
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study's finding with respect to P1 variability found in del, atypically high visual evoked P1 
amplitude variability was also reported for ASD (Milne, 2011) and ADHD groups (Gonen‐
Yaacovi et al., 2016). However, Milne (2011) also found atypical P1 latency variability in 
ASD, whereas here, neither the del nor dup group showed latency variability that differed 
from the control group, although, P1 latency variability was decreased in del compared to 
dup. Further group differences between del and dup in neural variability were found in EEG 
spectral power; here, del showed higher absolute power variability, in beta and alpha bands, 
compared to dup (again, neither CNV groups differed in power variability when compared to 
controls). Woltering et al. (2012) similarly reported lower (absolute) alpha and beta power 
variability in ADHD compared to controls (Woltering et al., 2012). 
Previous studies also found higher timecourse variability in ADHD, time window: 0–
500 ms (Gonen‐Yaacovi et al., 2016), and time window: 0–600 ms (Myatchin et al., 2012), 
similar to our finding in relation to timecourse variability in del. Gonen‐Yaacovi et al. (2016) 
also computed baseline variability (pre-visual stimulus onset; time window: −200‐0 ms) and 
reported higher variability in ADHD—again consistent with our del findings. There is an 
extensive literature on the putative interactions between evoked and ongoing activity raising 
the possibility that the increased variability prior to stimulus onset contributed to that 
observed post-stimulus (Busch et al., 2009). Standard approaches to correct baseline simply 
subtract the average of the pre-stimulus period from each trial and do not take into account 
variability both in the pre-stimulus timeseries of single trials or variability across trials. As 
such, it is important to examine both ERP amplitude and variability before and after stimulus 
onset. 
Evidently, it would not be plausible to regard atypical neural variability, whether in 
the form of P1 variability, timecourse variability, or other, as distinct to 16p11.2 CNVs in 
light of the several heterogeneous disorders that show general similar variability dynamics. 
Rather, this study highlights that 16p11.2 CNVs—specifically deletions—should be added to 
the list of clinical conditions which show increased neural variability. The overall picture 
alludes to certain similarities in the behaviour of neural responses, which would be 
informative and useful for further investigations. 
Interpreting neural variability 
Although, neural variability has become a topic of interest in many research areas including 
clinical populations (Pernet et al., 2011; Garrett et al., 2013; Dinstein et al., 2015; Butler et 
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al., 2017; David et al., 2016), the interpretation of neural variability remains a challenge. 
Nevertheless, it has been widely recognized that optimal neural variability is a characteristic 
of typical and healthy brain function, facilitating learning, adaptation to a changing 
environment, and other cognitive processes (Basalyga and Salinas, 2006; Faisal et al., 2008; 
McDonnell and Abbott, 2009; Heisz et al., 2012). Deviations from the typical levels of neural 
variability in the 16p11.2 del group, therefore, could be regarded as a signature of 
neuropathology and cognitive dysfunction, as was similarly indicated in the aforementioned 
studies of related ESSENCE disorders. IQ and autism symptom severity did not relate to any 
of the neural variability and averaged measures in the current study's 16p11.2 CNV sample 
(Table 2.7). Although consistent with previous studies (LeBlanc and Nelson, 2016; Jenkins 
et al., 2016) this lack of relationship could simply be due to sample size and needs to be 
further validated in future studies with larger samples. Furthermore, neural variability could 
be related to other 16p11.2 CNV symptoms and traits, which could not be revealed via the 
phenotypic assessments used in the current and previous studies. 
Of note, a recent study suggested that neural variability (on a macro-level as measured 
by intertrial variation of the BOLD signal) is negatively related to dopamine concentration 
levels, quantified using PET (Guitart‐Masip et al., 2016). In a mouse model of 16p11.2 CNV 
(Portmann et al., 2014), dopamine‐related deficits were found in the striatum, therefore 
indicating the potential role of certain genes within the 16p11.2 region in establishing typical 
dopaminergic synaptic activity. Specifically, after tissue dissociation, single-cell gene 
expression analysis was used to first identify cell types in predefined brain regions (including 
the striatum) based on their gene expression pattern (of genes within the 16p11.2 region and 
outside). Next, the composition of the identified cells was studied and compared between 
16p11.2 del mice and control. Increased numbers of striatal medium spiny neurons with the 
dopamine D2 receptor and decreased neurons with dopamine D1 receptors in deeper cortical 
layers were found. Accordingly, a potential factor driving atypical neural variability in the 
CNV groups could be the dysregulation of dopamine levels; this, in turn, would lead to 
deficits in processes mediated by dopamine such as motivation and learning processes, 
movement, and social behaviour (Wise, 2004; Portmann et al., 2014), all of which are seen in 
16p11.2 CNV carriers and related disorders. 
The observed atypical EEG activity in 16p11.2 CNV carriers could also reflect 
cellular electrophysiological and synaptic abnormalities that influence excitatory/inhibitory 
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(E/I) neural processes. To examine cellular characteristics of 16p11.2 CNV carriers, a recent 
study used fibroblasts obtained from 16p11.2 CNV carriers and generated induced pluripotent 
stem cells, which were then differentiated into (forebrain cortical) neurons (Deshpande et 
al., 2017). Compared to neurons derived from typical controls, the authors found an increase 
in the amplitude of miniature excitatory postsynaptic currents in both del and dup (excitatory) 
neurons. As the authors suggest, the increase in amplitude may be compensating for the 
reduced density of synapses in the CNV neurons. These altered cellular properties could 
affect overall neural plasticity and connectivity, which ultimately leads to the behavioural 
symptoms related to 16p11.2 CNV carriers and possibly to the activity recorded by EEG.  
Relatedly, EEG alpha power has been associated with a mechanism that modulates 
neural E/I activity via pulsed-inhibition of on-going visual and other neural processing (for a 
review see Mathewson et al., 2011). Therefore, the observed lower (mean) relative alpha in 
dup compared to controls (in the current study) could be reflecting atypical perturbations to 
the E/I balance. Indeed, our EEG findings of atypical neural variability and alpha power in 
16p11.2 CNV carriers could signify an E/I imbalance possibly due to synaptic impairment of 
excitatory neurons (Deshpande et al., 2017), and dopaminergic neurons (Portmann et 
al., 2014).  
Limitations 
Although we addressed the issue of small sample size with randomisation techniques, larger 
datasets would have been desirable to enable examination of confounding variables, such as 
epilepsy, than was possible here. In addition, given the small sample size and the multiple 
correlational analyses (i.e., numerous metrics of neural activity vs IQ and ADOS-CSS), the 
threshold for significance was set at a conservative p < 0.003, as per the Benjamini–Hochberg 
method. Consequently, there is a risk of committing a type II error, especially as certain 
correlations with large effect sizes were present, such as between P1 amplitude variability 
and ADOS-CSS (r = -0.76) for dup (Table 2.7). Nevertheless, a conservative approach is 
necessary and appropriate for the current study given the small sample size. A further 
limitation is the lack of IQ data for the control group. As participant IQ data were not 
available for the typical control participants, it was not possible to adequately account for 
cognitive ability in this study. Although in our current sample there were no IQ differences 
between del and dup, other larger-scale phenotypic studies have reported differing IQ 
profiles, with the dup group tending to show higher IQ (Hippolyte et al., 2016) and a wider 
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range of IQ scores (D'angelo et al., 2016). A further limitation concerns the wide age ranges 
of the participants in the three groups. Consistent with LeBlanc and Nelson (2016), we found 
no effect of age on any of the EEG measures of interest (Table 2.8). Furthermore, our sample 
showed no significant group differences in age. This, however, does not preclude the 
possibility of some minor effect of maturational changes on neural variability, which might 
be better expressed in a different 16p11.2 CNV sample. 
Concluding remarks. 
The overall results, drawn from multiple measures of neural variability, strongly suggest that 
16p11.2 del carriers, in particular, show visual‐evoked neural responses that are highly 
variable compared to controls. Levels of neural variability were atypical and, thus, were 
postulated to have deviated from the optimal variability levels necessary for healthy brain 
function and cognitive processing. (Of note, despite dup carriers showing neural variability 
levels in the typical range, secondary analyses showed that relative (mean) alpha power was 
atypical and, therefore, might be indicating a related dysfunction).  
The following study (Chapter 3) will focus on 16p11.2 del carriers. Neural activity 
and potential associations with ESSENCE difficulties will be more extensively assessed. In 
order to assess this in an alternative context, the following study will analyse spontaneous 
neural activity (i.e., resting-state EEG), as opposed to evoked neural activity. This will further 
enable 16p11.2 human-mouse comparisons in relation to EEG-LFP activity at rest (Chapter 
4). 
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 Spontaneous neural activity relates to psychiatric traits in 
16p11.2 deletion carriers: a joint analysis of EEG spectral power and 
multi-scale entropy. 
3.1   Introduction  
Evidence from the study presented in Chapter 2 and indeed the 16p11.2 literature (Al-
Jawahiri et al., 2019; Hinkley et al., 2019; Bertero et al., 2018; LeBlanc and Nelson, 2016; 
Jenkins et al., 2016; Berman et al., 2016; Steinman et al., 2016; Hudac et al., 2015) suggest 
that a loss of the 16p11.2 region impacts neural activity relevant to multiple contexts, e.g., 
sensory, social. Despite this, the alteration in evoked neural activity did not seem to relate to 
any of the cognitive/psychiatric ESSENCE (early symptomatic syndromes eliciting 
neurodevelopmental clinical examinations) traits in 16p11.2 deletion carriers (del; Table 1.5) 
- although Hinkley et al. (2019) reported otherwise. Unlike the aforementioned studies, 
Hinkley et al. (2019) found that the reported increased task-induced beta power in del, over 
sensorimotor cortices, was associated with phonological and motor deficits. Conversely, as 
reported in Chapter 2 and previous studies (see Table 1.5), no links were found between 
visual and auditory evoked neural activity (i.e., neural variability measures; N1, P1, and N2 
amplitude and latency; M100 latency) and IQ, autistic-traits, and social and language ability.  
When examining spontaneous neural activity (using fMRI), however, brain functional 
alterations were found to be associated with social and cognitive impairments in 16p11.2 del 
(Bertero et al., 2018). The brain functional alterations were reduced global prefrontal 
connectivity and reduced long-range prefrontal connectivity with parieto-temporal areas in 
16p11.2 del (as described in detail in Chapter 1). As such, it is worth examining further 
properties and attributes of frontal resting-state signal (e.g., entropy) and its link to a range of 
ESSENCE traits in 16p11.2 del. 
Indeed, investigating properties such as the level of entropy, or in other words, the 
level of irregularity and unpredictability, in neural activity has been increasingly producing 
interesting findings in relation to ESSENCE disorders (for a review, see Chu et al., 2017; 
Takahashi, 2013; Yang and Tsai, 2013). With Multi-Scale Entropy (MSE) analysis (Costa et 
al., 2002; Costa et al., 2005), in particular, it is possible to quantify the level of entropy (i.e., 
irregularity) of moment-to-moment patterns of (neural/BOLD) amplitudes across different 
timescales in the signal. In simple terms, higher entropy indicates higher irregularity in the 
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signal, while lower entropy indicates a more regular, predictable pattern. MSE analysis is 
‘multi-scale’ because entropy is measured at different timescales, beginning with the 
timescale of the original signal, referred to as timescale 1, and then timescale 2 is generated 
by averaging two non-overlapping consecutive datapoints in the signal, and then three 
datapoints for timescale 3, etc, across the whole signal 
To elaborate further, MSE is more accurately conceptualised as an index of signal 
complexity. A more complex signal conveys rich information (i.e., likely meaningful/ 
biological) and is in between the two extremities of randomness and order. Single-timescale-
entropy-based approaches assign higher entropy values to more random signals and lower 
entropy to more regular signals. By considering multiple timescales, however, MSE is able to 
distinguish biological complex signals from random signals (i.e., white noise; Costa et al., 
2002; Costa et al., 2005). This is because at lower (i.e., finer/shorter) timescales, both random 
and signals with an 1/f property (i.e., pink noise; a signal common in biological systems, in 
which the power spectral density (PSD) is inversely proportional to the signal’s frequency) 
present with high entropy values, however at later timescales (i.e., higher/coarser/longer 
scales), random signals monotonically decrease in entropy compared to biological signals. 
Therefore, measuring entropy at multiple timescales is advantageous and appropriate for 
investigating neural activity.  
On a conceptual level, the general consensus is that entropy, like other neural 
measures, relates to information processing (McDonough and Nashiro, 2014; Garrett et al., 
2013). Higher entropy has been more specifically, albeit abstractly, interpreted as reflecting a 
less deterministic system capable of facilitating dynamic neural communication and 
switching between different cognitive states (Mišić et al., 2015; Mišić et al., 2011; Vakorin et 
al., 2011; Liang et al., 2014). Accordingly, it would be expected that entropy and functional 
connectivity (FC: a measure of neural synchrony between different brain regions, and 
therefore reflecting neural communication) are positively related: with higher entropy levels, 
there would be higher FC between the respective brain regions. However, studies that 
examined this MSE-FC relationship suggest a more complicated interpretation that is 
timescale dependent (Figure 3.1; Wang et al., 2018; Ghanbari et al., 2015; McDonough and 
Nashiro, 2014). In the case of MSE and FC both measured from fMRI data, a negative and 
positive relationship was found at lower (Figure 3.1a) and higher timescales (Figure 3.1b), 
respectively (McDonough and Nashiro, 2014). It is important to note that fMRI’s lower 
temporal resolution, compared to EEG and LFP, means that fMRI entropy levels at high 
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timescales are equivalent to EEG/LFP entropy levels at mid or lower timescales. Hence, this 
should be considered when interpreting and comparing MSE-FC studies. With MSE-local 
field potential (LFP) and FC-fMRI correlations (Figure 3.1c and Figure 3.1d; Wang et al., 
2018), a positive relationship at each respective timescale was reported. In addition, the 
strength of the relationship progressively increased with higher timescales (r = 0.44, r = 0.51, 
r = 0.54, r = 0.56, r = 0.45, therefore portrayed as a positive relationship across timescales in 
Figure 3.1c and Figure 3.1d). Using simulated neural data (i.e., neural mass modelling),  a 
similar positive trend was observed; in addition, the MSE-FC relationship at timescales in the 
lower range was best described as an inverted U-shape, or a quadratic function at respective 
time-scale bins (in the lower range), yet the relationship could be described as positive across 
timescales (with the r-coefficient increasing in strength from lower to higher timescales; r = 
0.24, r = 0.34, r = 0.44, r = 0.72, r = 0.79, r = 0.65 Figure 3.1e and Figure 3.1f; Wang et al., 
2018). Interestingly, the MSE-FC relationship might be different for individuals presenting 
with ESSENCE disorders. For instance, a negative relationship was found between MSE-
MEG and FC-MEG at any timescale and brain region in individuals with ASD (Figure 3.1g 
and Figure 3.1h; Ghanbari et al., 2015). For timescales in the lower range, the strength of the 
negative correlation progressively increases (r = -0.46, r = -0.65, r = -0.82). This trend is also 
found for timescales in the higher range although to a lesser extent as the rate of decrease is 
relatively lower (r = -0.40, r = -0.53). However, this trend does not form a continuum from 
lower to higher scales. It was not clear, however, whether a trend towards a negative MSE-
FC relationship would be equally apparent across timescales (i.e., not only at individual 
categories of timescales but across all timescales)4.  
 
 
4 Note that although essentially similar to what has been described earlier in relation to MSE analysis, 
some of the aforementioned studies (e.g., Wang et al., 2018) analysed MSE in the frequency domain as opposed 
to the time domain. As MSE is sensitive to changes in the frequency content of the signal in a predictable 
manner, the impact of MSE on timeseries in the time-domain and its equivalence in the frequency domain could 
be deduced (Figure 3.1C and Figure 3.1D). Therefore, for the sake of consistency, the relevant literature has 
been and will henceforth be discussed in the context of entropy at time-domain timescales rather than entropy at 




Figure 3.1: Conceptual representation of the relationship between MSE, functional 
connectivity, frequencies, and local and long-range neural processing. 
Subfigures (a, b, c, d, e, f, g, h, i, j) show the relationship between entropy and functional 
connectivity for respective modalities (e.g., fMRI, LFP). Subfigures (i) and (j) describe the 
relationship between entropy at lower timescales and higher timescales, respectively, with 
power, and neural processing range (i.e., short-range vs long-range). For subfigure (i), entropy 
at lower timescales (downward arrow) reflects power at higher frequencies and, to a lesser 
extent, lower frequencies (double arrows, one upward to indicate higher frequencies and 
downward arrow indicates lower frequencies). Entropy at lower timescales and, hence, higher 
frequencies further reflect local neural processing (subfigure indicating local connections). For 
subfigure (j), Entropy at higher timescale (upward arrow), reflects power at lower frequencies 
(downward arrow), and long-range neural processing (subfigure indicating long-range 
activity). 
Notably, MSE relates to the frequency domain as it is sensitive to changes in the 
frequency content of the signal (Figure 3.1i and Figure 3.1j). MSE’s coarse-graining 
procedure, in which time-series with growing timescales are generated from the original 
time-series, essentially acts as a low-pass filter (i.e., a filter that passes low frequencies and 
attenuates higher frequencies; Courtiol et al., 2016; Govindan et al., 2007; Kaffashi et al., 
2008; Valencia et al., 2009). Due to the coarse-graining effect, lower timescales contain 
activity from both higher frequencies and lower frequencies (Figure 3.1i), whereas higher 
timescales contain lower frequencies (Figure 3.1j; Courtiol et al., 2016; Takahashi et al., 
2010; Mizuno et al., 2010). Therefore, it is more likely that lower timescales reflect local 
neural processing (Figure 3.1i) and higher timescales reflect longer-range neural processing 
(Figure 3.1j; Mizuno et al., 2010, Vakorin et al., 2011; McIntosh et al., 2014). This 
observation is supported by evidence of associations between MSE at lower timescales and 
higher timescales with metrics of local and distributed entropy, respectively (McDonough 
and Nashiro, 2014, McIntosh et al., 2014, Vakorin et al., 2011).  
As mentioned earlier, atypical entropy has been implicated in various ESSENCE 
disorders found in 16p11.2 del (Table 3.1). Both resting-state and task-related paradigms 
showed atypical MSE patterns in the clinical group. Both higher and lower entropy have been 
found in ESSENCE disorders (relative to typical controls) in a manner that is task- (e.g., 
Mišić et al., 2015), timescale-, and brain region-dependent (e.g., Ghanbari et al., 2015). 
Accordingly, these studies (Table 3.1) suggest that whether higher or lower entropy, atypical 
entropy levels in ESSENCE could be indicative of a pathological state involving a 
dysfunction in neural temporal coordination. For example, compared to controls, higher 
entropy was found in ASD at higher timescales in the occipital, parietal, and temporal areas 
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at resting-state (Takahashi et al., 2016), while lower entropy at higher timescales was found 
in a face and chair detection task (Catarino et al., 2011) in the same brain areas. In addition, 
Milne et al., (2019) found lower overall entropy in ASD at resting-state across all timescales 
and brain regions. Other ESSENCE disorders that have shown atypical MSE (Table 3.1) 
include epilepsy and seizures (Bosl et al., 2017; Lu et al., 2015), ADHD (Chenxi et al., 2016), 
Schizophrenia (Takahashi et al., 2010), Alzheimer’s (Yang et al., 2013; Mizuno et al., 2010) 
and Tourette’s syndrome (Weng et al., 2017).  
In addition to the dependence of MSE on task, timescale, and brain region, evidence 
showed that MSE levels are age-dependent in a manner following an inverted U-shaped 
curve: MSE increases at lower scales from childhood to adulthood and then decreases at 
higher scales in old age (McIntosh et al., 2014; Milne et al., 2019). This pattern, however, is 
not present in ESSENCE disorders as no relationship was found between MSE and age in 
ASD in one study (Milne et al., 2019), while an atypical MSE maturation was found in 
another study (Takahashi et al., 2016).  
Other than group differences in neural entropy, several resting-state studies found that 
certain changes in neural entropy levels were related to psychiatric traits in ESSENCE 
disorders (Table 3.1). Overall, these studies suggest that MSE is sensitive to neural changes 
in ESSENCE disorders, including changes to the developmental trajectory of age-related 
neural change in ESSENCE disorders, and may be related to specific traits and symptoms 
that occur in ESSENCE disorders.  
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Table 3.1: MSE of M/EEG neural activity in ESSENCE disorders. 
ESSENCE Study Analysis method Paradigm Key findings MSE link with ESSENCE 
ASD Milne et 
al. (2019) 
MSE Resting-state Lower entropy in ASD (MSE value computed by 
collapsing over scale factor and electrodes (frontal, 
centro-parietal, occipital)). 
 
Atypical MSE development: For controls, MSE at 
lower scales positively correlated with age and 
MSE at higher scales negatively correlated with 
age. Whereas for ASD, no relationship between 
MSE and age was found.  
No relationship between MSE and 
psychiatric traits (SRS-2, RBQ-2A, BAIT, 
ASRS Screener).   
Bosl et al. 
(2017) 
Modified MSE Resting-state Higher entropy in ASD at frontal, occipital, left 
temporal areas at all scales.  
- 






Lower entropy in ASD (possibly across all scales) 






MSE Free watching 
of videos 
without sound. 
Higher entropy in ASD at higher scales over the 
occipital, parietal, and temporal areas. 
 
Atypical MSE development: For controls, MSE 
positively correlates with age at around scale 10 in 
occipital, temporal, parietal areas. For ASD, MSE 
positively (weakly) correlates with age at lower 
scales in central area.  
MSE (at higher scales in fronto-central 
area) was negatively correlated with 








along the scales). 
Resting-state Lower entropy in ASD in delta band over frontal 
areas, and in alpha band over occipital-parietal 
areas. Also, higher entropy in ASD in delta 
(parietal areas), theta (central and temporal areas) 
and gamma (frontal-central boundary areas). 
MSE across frequencies was both 
negatively and positively correlated with 
symptom severity (social responsiveness 
scale (SRS)). 
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to test mental 
flexibility 
An interaction between task and group at many 
regions (e.g., prefrontal, parietal, etc.); the ASD 
group showed higher entropy at higher scales in 
one task, and higher entropy at lower scales in 
another task. The control group showed the 
opposite contrast in both tasks.  
Activation of the identified regions 
correlated with faster reaction times in 
controls – but not in ASD.  
Bosl et al. 
(2011) 
Modified MSE Resting-state Lower entropy in high-risk ASD group (HRA) 
across all scales and brain areas. A model showed 






MSE Face and chair 
detection task. 
Lower entropy in ASD at higher scales over 
temporal, parietal, and occipital areas. 




Bosl et al. 
(2017) 
Modified MSE Resting-state Higher entropy in absence epilepsy across all brain 
areas at all scales.  
- 
Lu et al. 
(2015) 
MSE and CI 
(estimating area 
under MSE curve 
by integrating 







MSE: lower entropy in most scales in neonates with 
later epilepsy (epilepsy group) compared to typical 
controls and those without later epilepsy (seizures 
group). (Brain areas not specified).   
 
CI: lower entropy in epilepsy group compared with 
controls or seizures group over central areas. 
- 









Higher entropy in ADHD in delta band and lower 
entropy in alpha at longer scales mainly over 
frontal and central areas. 
Longer reaction time of ADHD group 
compared to controls during interference 
trials.  
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MSE Resting-state Higher entropy in the drug-naive SZ group at 
higher scales in frontal, central, and temporal areas.  
 
Using antipsychotic treatment, this higher entropy 
in SZ was lowered to the typical controls’ level in 
frontal and central areas. However, entropy levels 
in temporal areas tended to remain higher.  
No relationship between MSE and 
psychiatric traits (BPRS) pre- and during 
treatment. No relationship between MSE 
and medication dose.  
Alzheimer’s Yang et 
al. (2013) 
MSE Resting-state Lower entropy in AD at lower scales over fronto-
central, temporal, and occipito-parietal areas. 
Higher entropy at higher scales over the same areas. 
MSE correlated with cognitive function 
(MMSE) and psychiatric traits (NPI). 
Over temporal, parietal, and occipital 
areas, MSE at lower scales was positively 
correlated with cognitive function, while 
MSE at higher scales was negatively 
correlated with cognitive function. Over 
various brain areas, MSE at lower scales 
was negatively correlated with psychiatric 
traits, while MSE at higher scales was 
positively correlated with psychiatric 
traits, especially sleep changes.  
Mizuno et 
al. (2010) 
MSE Resting-state Lower entropy in AD at lower scales in frontal 
areas. Higher entropy at higher scales at frontal, 
central, parietal, and occipital areas. 
MSE at higher scales was negatively 






CI (estimating area 
under MSE curve 
by integrating 
entropy values of 
all scales); MSE 
(separate CI of 
scales grouped into 
4 groups). 
Resting-state Lower CI in Tourette’s syndrome in central, 
parietal, and occipital areas.  
 




ASD, Autism Spectrum Disorder; ADHD, Attention Deficit Hyperactivity Disorder; SZ, Schizophrenia; AD, Alzheimer’s Disorder; SRS, Social Responsiveness 
Scale; RBQ-2A, Adult Repetitive-Behaviours Questionnaire; BAIT, Beck Anxiety Inventory-Trait; ASRS Screener, WHO Adult ADHD Self-Report Scale Screener, 
Part A; ADOS, Autism Diagnostic Observation Schedule; HRA, High Risk ASD group; CI, Complexity Index; BPRS, Brief Psychiatric Rating Scale; MMSE, Mini 
Mental State Examination; NPI, Neuropsychiatric Inventory. 
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To our knowledge, no study to date investigated whether EEG neural activity is 
altered for 16p11.2 del at rest, whether using entropy-based approaches or complementary 
conventional power approaches. As fronto-parietal spontaneous neural activity has been 
particularly implicated in 16p11.2 del and linked with cognitive and social traits (Bertero et 
al., 2018), the current study will focus solely on 16p11.2 del. This will also maintain 
consistency with the study conducted in the next chapter on 16p11.2 del mouse model. Thus, 
the purpose of the current study is twofold; 1) To determine whether fronto-parietal 
spontaneous EEG activity is altered in 16p11.2 del, using both MSE and power analyses 
(including low-to-high frequency ratio (LHR)); 2) To identify changes in neural dynamics 
that are related to ESSENCE traits in 16p11.2 del carriers. Hence, this study tests the 
following hypotheses in relation to 16p11.2 del: 1) Neural activity, as reflected by entropy 
and power measures, is atypical; 2) There is a relationship between neural entropy and 
ESSENCE traits.  
3.2   Methods 
Participants  
Data source is as described in Chapter 2, Section 2.2.1. Resting-state data from a total of 39 
participants were obtained from the SVIP consortium for the current study. Data from five 
participants were excluded; these exclusions were either based on entropy values identified as 
extreme outliers (n = 4) or EEG files with signals greatly contaminated by artefacts on visual 
inspection (n = 1). The remaining 34 participants were analysed in this study: 22 del and 12 
typical controls.  
Participant information relating to age, sex, CNV inheritance, number of diagnoses, 
and IQ scores are reported in Table 3.2. The diagnoses in the current sample are listed in 







Table 3.2: Participant information.  







Sex CNV inheritancea FSIQ 
mean 







Inherited unknown   
del 22 67.09 
(45.70) 
10 - 183 M 
12 
7 2 3 80.95 
(16.18) 
2.30 [0 - 
5] 
    F 10 8 1 1   
Ctrl 12 69.67 
(22.68) 
39 - 109 M 6 - - - - -  
    F 6 - - - - -  
FSIQ, full-scale IQ.  
aCNV inheritance data were obtained from the file svip_subjects.csv 
bMissing data from del carriers (n = 2), typical group (n = 12).  
cIQ data and the number of diagnoses were extracted from the file diagnosis_summary.csv 
dThe reported IQ scores were not adjusted for prematurity. 
 
Table 3.3: Diagnoses in 16p11.2 del carriers. 
Diagnosis del (n = 22) 
ADHD 3 
Coordination disorder 12 
Language disorder 9 
Learning disorder 1 
Intellectual disability 4 
Behaviour disorder 3 
Borderline intellectual functioning 2 
ASD 3 
Enuresis disorder 1 
Articulation disorder 8 
Each 16p11.2 del carrier may have more than one diagnosis.  





Note that, the reported IQ scores were not adjusted for prematurity. Information 
regarding current medication was extracted from the SFARI medication questionnaire 
(med_child.csv); two del carriers were taking medication for anxiety and epilepsy/ seizures 
(i.e., diazepam (Valium) and topiramate (Topamax)).  
Mann-Whitney U test revealed that there was no significant age difference between 
the two groups (U = 108.50, p = 0.397); and a Chi-Square test showed no association 
between group and sex (χ2(1) = 0.06, p = 0.800). Other than age and sex, participant details 
and phenotypic data were not available for the typical control group. Therefore, IQ 
comparisons between del and controls were not possible. 
Ethical approval 
The current study has been ethically approved as described in Chapter 2, Section 2.2.3. 
EEG recording and pre-processing prior to current study 
EEG was recorded using a 128 channel HydroCel Geodesic Net (Electrical Geodesics Inc., 
Eugene, OR, USA). The signal was amplified with a NetAmps 300 amplifier and digitised at 
a sampling rate of 500 Hz. Spontaneous EEG was collected for 2 to 12 minutes during which 
participants rested and watched silent videos on a Tobii T60 eye-tracking monitor (Tobii 
Technology, Sweden; Note that eye-tracking data was not collected). The monitor was 34.7 
cm wide and was positioned at a distance of ~ 60 cm from the participants’ seat. Infant 
participants were seated on their caregiver’s lap. 
EEG data were previously pre-processed offline, using NetStation software, by 
collaborators of the SVIP project. A number of pre-processing steps were conducted prior to 
obtaining the data for the current study. The data were filtered with 1 Hz high pass and 60 Hz 
notch filter. Missing channels and eye channels were marked bad. Also, excessively noisy 
channels were marked bad and replaced using interpolation techniques. Channels (including 
interpolated channels) were referenced to an average reference.  
 EEG pre-processing conducted in the current study 
Additional pre-processing steps were conducted by the current authors after obtaining the 
dataset. For each participant, a channel was identified as bad if more than 10% of its 
datapoints were outside of the predefined range [-150 uV, 150 uV]. If a particular channel 
was bad for more than 4 participants, then the channel was removed for all participants. 
Under this criterion, 68 channels out of 129 channels were removed for all participants. The 
83 
remaining channels that were bad for each respective participant were removed and 
interpolated using the ERPLAB function erplab_interpolateElectrodes (Lopez-Calderon and 
Luck 2014). On average, the number of channels interpolated for the respective participant 
was 4.44 [range: 0 - 18]. Therefore, for all participants, a montage of 61 channels was 
retained (15 channels at frontal, parietal, and temporal regions; 16 channels at the occipital 
region). For the current study, the channels selected for analyses are those corresponding to 
the frontal and parietal regions in order to maintain consistency with the following study 
described in the next chapter (Chapter 4). The signal was then detrended.  
Behavioural and psychiatric assessments 
Child Behaviour Checklist for ages 1.5-5 (CBCL), Social Responsiveness Scale (SRS), 
Autism Diagnostic Observation Schedule-Calibrated Severity Score (ADOS-CSS), and IQ 
participant data were accessed from the Simons VIP Phase 1 16p11.2 dataset at SFARI Base 
(http://www.sfari.org/resources/sfari-base). 
3.2.5.1 Child Behaviour Checklist for Ages 1.5-5 (CBCL) 
The CBCL/1.5-5 (Rescorla, 2005) is an assessment of parent or caregiver report of 
behavioural and psychiatric problems in preschool children. The assessment contains 99 
statements, which describes child problems, such as ‘aches or pains without medical cause’ 
and ‘acts too young for age’. The respondent is asked to indicate whether the statements are 
‘not true’ (0), ‘somewhat or sometimes true’ (1), or ‘very true or often true’ (2), either 
presently or within the past two months. The CBCL/1.5-5 identifies the following seven 
empirically-based syndromes based on the summed scores of items of the respective 
syndrome: aggressive behaviour, anxious/depressed, attention problems, emotionally 
reactive, somatic complaints, withdrawn, and sleep problems. The CBCL/1.5-5 also yields 
five DSM-oriented categories: affective problems, anxiety problems, attention-
deficit/hyperactivity problems, pervasive developmental problems, and oppositional defiant 
problems. In addition, two aggregate broad-band scales can be derived by grouping items that 
comprise certain syndromes; these two global groupings are labelled as internalising 
problems and externalising problems. Finally, the sum of all CBCL 1.5-5 items yields a ‘total 
problems’ score. The clinical range for the syndromes and DSM-oriented scales is defined as 
T-scores ≥ 70, and the borderline clinical range is T-scores between 65 and 69. For the 
broadband and total problems scores, the clinical range is T-scores ≥ 64, and the borderline 
range is T-scores between 60 and 63. For the current paper, T-scores of each DSM-oriented 
scale and T-scores of the syndromic scale ‘sleep problems’ were taken for correlational 
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analyses with the EEG measures of interest. Data from six del carriers are missing. CBCL 
severity in the current sample is shown in Table 3.4.  











 50 51 66 64 52 59 
 70 50 51 52 50 88 
 63 54 70 64 59 51 
 56 57 66 50 52 51 
 50 50 50 50 50 50 
 60 60 86 57 64 56 
 50 50 50 51 50 50 
 60 50 68 57 59 59 
 52 50 51 50 50 50 
 77 57 77 67 52 70 
 52 51 59 64 55 51 
 70 50 66 52 51 50 
 67 50 72 57 50 56 
 51 50 59 54 50 62 
 77 70 72 76 80 88 
 72 70 72 71 73 64 
Frequency of 
carriers in the 
borderline or 
clinical range.   
6 2 10 3 2 3 
Data from six deletion carriers are missing. Red indicates T-scores > 64, i.e., borderline 






3.2.5.2 The Social Responsiveness Scale (SRS) 
The SRS (Costantino and Gruber, 2005) quantifies severity of social and communication 
difficulties related to autism spectrum disorder. It is a questionnaire designed to be 
administered to the parent or teacher who has routinely observed the child in a usual social 
setting. For 65 items, the respondent is asked to rate statements about the child’s behaviour 
the past six months, by indicating ‘not true’ (0) to ‘almost always true’ (3). In addition to the 
total score, the SRS yields five subscales: social awareness, social cognition, social 
communication, mannerisms, and social motivation. Increasing scores indicate higher 
severity of social difficulties. For the correlation analyses, the T-scores of the total SRS 
scores were studied. Data from nine del carriers are missing. 
3.2.5.3 Autism Diagnostic Observation Schedule-Calibrated Severity Score (ADOS-CSS) 
As described in Chapter 2, Section 2.2.4.1. Data from nine del carriers are missing. 
3.2.5.4 IQ 
As described in Chapter 2, Section 2.2.4.2. Data from two del carriers are missing. 
EEG measures 
3.2.6.1 Multiscale entropy 
Multiscale entropy (MSE) analysis was performed on scales 1-20 for a continuous EEG 
signal of 60,000 data-points (2 minutes; 500 Hz sampling rate). From the whole signal of 
length <10 minutes, the chosen two-minute segment range was from 8000 to 68,000 data-
points. (This range allows the exclusion of the first 16 seconds of recording in order to avoid 
potentially contaminated data due to participant movement and other artefacts).  
The following software and toolboxes were used for the analyses, MATLAB (The 
MathWorks Inc.), EEGlab toolbox (Delorme and Makeig, 2004), and multiscale entropy 
toolbox (http://www.psynetresearch.org/tools.html – Liang et al., 2014). The MSE method 
measures sample entropy (SampEn; Richman and Moorman, 2000) on multiple timescales 
(Costa et al., 2005; Costa et al., 2002). MSE consists of two main steps as follows.  
1) From the original EEG time-series {x1, x2, …, xN}, multiple time-series, e.g., 20 
timeseries, are constructed through a coarse graining process. The process involves averaging 
neighbouring data-points within non-overlapping windows which increase in length as per 
the determined scale factor (i.e., from 1 to 20 scales in the current study, where 1 signifies the 
original time-series and 20 refers to a window size of 20 data-points). The length of each 
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constructed time-series, therefore, corresponds to N/τ, where N is the length of the original 
time-series and τ is the scale factor. For example, for timescale 3 and N = 60,000 datapoints, 
then the length of the timeseries for timescale 3 is 60,000/3 = 20,000 datapoints. The below 
equation describes the coarse-graining process; Each element, j, of a coarse-grained time-
series {y (τ)} is calculated as such:   
 
2) Then, SampEn is calculated for each coarse-grained time-series {y (τ)}. SampEn 
measures the regularity of a signal: low entropy signifies high regularity and high entropy 
indicates irregularity (and possibly high complexity). SampEn is defined as the negative 
natural logarithm of the conditional probability that within a given time-series {y (τ)}, similar 
sequences of data-points of length m will still match at m+1, while excluding self-matches. 
SampEn, therefore, is calculated according to the equation:  
SampEn (m, r, N) = - ln (A/B) 
 
Where m denotes sequence length; r is the similarity criterion or the tolerance range – 
two data-point sequences are considered matched if their amplitude falls within the similarity 
criterion, which is usually defined as 20 percent multiplied by the standard deviation of the 
original time-series; N is the length of the original time-series.  
 
A = the number of matched pairs for m+1/ the number of all probable pairs for m+1 
B = the number of matched pairs for m/ the number of all probable pairs for m 
 
Based on previous M/EEG studies (e.g., Takahashi et al., 2016; Ghanbari et al., 2015) 
and recommendations by Richman and Moorman (2000), the following MSE parameters 
were chosen: m was set to 2 and r = 0.20. MSE was first determined for each channel and 
then averaged over frontal and parietal brain areas, in line with Takahashi et al. (2016). For 
each brain region, entropy of scales 1-20 was averaged into four bins: timescales of 1-5, 6-10, 
xi 
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11-15, and 16-20. The data was further reduced for correlation analyses; Entropy was 
averaged into two bins of timescales 1-10 and 11-20 per region (frontal and parietal).  
3.2.6.2 Complexity index 
The complexity index (CI) is another measure of entropy as described by Costa et al. (2005). 
For each channel, CI was computed by estimating the area under the MSE curve via 
integrating entropy values of all scales. A trapezoidal numerical integration was applied via 
the ‘trapz’ function in MATLAB. The average CI was calculated over channels at the frontal 
and parietal areas, respectively.  
3.2.6.3 Power spectral density 
Power Spectral Density (PSD) of each channel was computed as per Welch’s method using 
the ‘pwelch’ MATLAB function. The signal was first detrended and subtracted from the 
mean signal amplitude. In accordance with Welch’s method, the signal (60,000 data-points or 
2 minutes) was divided into segments of equal length (2-second segments in this case or 1000 
datapoints) with a 50% overlap. Given a sampling rate of 500 Hz and N = 1000 data-points 
per segment, the resultant frequency resolution was 0.5 Hz. Each segment was windowed 
with a Hamming window and modified periodograms (PSDs of each Hamming window) 
were estimated. The final PSD was obtained by averaging the periodograms of all segments.  
Absolute and relative power were then computed for the following frequency bands: 
delta [2-4 Hz], theta [4-8 Hz], alpha [8-14 Hz], beta [14-30 Hz], and gamma [30-50 Hz]. 
Absolute power of each frequency band was obtained via the trapezoidal integration method, 
using the ‘trapz’ MATLAB function. Prior to obtaining the relative power, the total spectral 
power was defined as the entire range between 1-50 Hz (due to a notch filter applied at 60 
Hz). Relative power at each frequency band was subsequently calculated as the ratio of 
power of the respective frequency band to the total spectral power defined earlier. Relative 
power of each frequency band was averaged separately over the frontal and parietal brain 
regions.  
3.2.6.4 Low-to-high frequency ratio 
Low-to-high frequency ratio (LHR) was measured by taking the ratio of absolute delta power 
to the absolute beta power for each the frontal and parietal regions.  
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Statistical analyses 
Permutation tests (Rodgers, 1999) were conducted to investigate whether there were group 
differences in neural activity (for each EEG power and entropy metric described in earlier 
sections) in the frontal and parietal regions between del carriers and controls. This was 
conducted, as described in detail in Chapter 2, Section 2.2.11. To account for multiple 
comparisons, the false discovery rate (FDR) was controlled using the Benjamini-Hochberg 
procedure, with q < 0.05. 
We also applied the permutation approach to Spearman’s correlation analyses to 
examine whether age, IQ, and psychiatric traits (CBCL, ADOS-CSS, and SRS) impact neural 
responses in 16p11.2 del carriers (method as described in Chapter 2, Section 2.2.11). All the 
outcomes were corrected by controlling the FDR using the Benjamini-Hochberg procedure, 
with q < 0.05. As IQ, CBCL, ADOS-CSS, and SRS data were not available for the control 
group, permutation correlation analyses were conducted for only the del group (n = 22). 
However, phenotypic data for each respective assessment were missing for some participants. 
Namely, out of 22 participants, data for IQ, CBCL, ADOS-CSS, and SRS only included 20, 
16, 13, and 13 del participants, respectively. From these participants, outliers were identified 
and removed. Specifically, prior to conducting permutation correlation analyses, Cook’s 
distance was measured to indicate influential data-points (observations) that should be 
marked as outliers. Data-points with Cook’s distance larger than three times the mean Cook’s 
distance were marked as outliers (range: 0-3) and removed from the datasets prior to 
conducting correlation analyses.   
3.3   Results 
Multiscale entropy 
Significant group differences (p ≤ 0.010) were found in MSE at all the respective timescales 
in the frontal region (Table 3.5; Figure 3.2). Specifically, MSE was higher for del than 
controls. No group difference was found in MSE at any timescale bin for the parietal region. 
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Figure 3.2: MSE group differences in the frontal and parietal regions. 
a) MSE group differences in the frontal region. b) MSE group differences in the parietal region. 


























Complexity index  
CI was compared between del and controls at the frontal and parietal regions, respectively. CI 
was significantly higher for del compared to controls (p ≤ 0.010) at the frontal region (Table 
3.5). No significant group difference in CI was found at the parietal region.  
 
Table 3.5: Neural MSE and CI of 16p11.2 del and control groups. 
  Control del Actual 
difference 
P-value 
Parietal MSE scale 1-5 0.76 [0.42  0.82] 0.89 [0.3  1.13] 0.16 0.030 
 MSE scale 6-10 1.02 [0.49  1.23] 1.23 [0.52  1.52] 0.21 0.022 
 MSE scale 11-15 1.18 [0.55  1.41] 1.36 [0.59  1.7] 0.20 0.045 
 MSE scale 16-20 1.26 [0.61  1.53] 1.45 [0.64  1.84] 0.20 0.050 
 CI 20.37 [9.79  23.9] 23.94 [10.42  28.7] 3.76 0.028 
      
Frontal MSE scale 1-5 0.55 [0.24  0.74] 0.69 [0.3  1.09] 0.19 0.010 
 MSE scale 6-10 0.77 [0.29  1.1] 1.07 [0.36  1.35] 0.27 0.003 
 MSE scale 11-15 0.92 [0.34  1.26] 1.26 [0.42  1.54] 0.29 0.003 
 MSE scale 16-20 1.04 [0.38  1.36] 1.37 [0.46  1.65] 0.31 0.004 
 CI 15.65 [5.89  21.32] 21.21 [7.33  26.44] 5.09 0.003 
The data are reported as median [range]. Significant group differences (p ≤ 0.010) are in bold. 
 
Power spectral density  
Group differences in relative power within each frequency band (delta, theta, alpha, beta, and 
gamma) at each of the frontal and parietal regions were examined (Table 3.6). All results 
were non-significant.  
Low-to-high frequency ratio 
No significant group differences were found in LHR at either frontal or parietal regions 
(Table 3.6).  
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Table 3.6: Power (%) and LHR (%) of 16p11.2 del and control groups. 
  Control del Actual 
difference 
P-value 
Parietal δ 0.46 [0.36  0.78] 0.41 [0.25  0.71] 0.06 0.141 
 θ 0.24 [0.16  0.37] 0.25 [0.19  0.38] 0.02 0.243 
 α 0.15 [0.04  0.27] 0.15 [0.06  0.34] 0.02 0.427 
 β 0.08 [0.02  0.12] 0.09 [0.02  0.21] 0.02 0.177 
 γ 0.04 [0.01  0.11] 0.04 [0.01  0.19] < 0.01 0.774 
 δ/β 6.50 [3.23  67.63] 4.55 [1.78  38.76] 4.77 0.316 
      
Frontal δ 0.55 [0.47  0.74] 0.5 [0.36  0.7] 0.06 0.047 
 θ 0.24 [0.18  0.32] 0.27 [0.19  0.38] 0.03 0.055 
 α 0.1 [0.05  0.16] 0.12 [0.05  0.19] 0.02 0.082 
 β 0.06 [0.02  0.1] 0.07 [0.02  0.12] 0.01 0.313 
 γ 0.03 [0.01  0.1] 0.03 [0.01  0.08] 0.01 0.444 
 δ/β 10.63 [5.37  64.37] 7.99 [4.29  28.77] 6.50 0.071 
The data are reported as median [range]. All results are non-significant. Significance threshold at 
p ≤ 0.010. 
 
The impact of age on MSE, PSD, and LHR 
To assess the impact of age on EEG measures of interest over the frontal and parietal regions, 
correlation permutation tests were performed separately for del and control groups. 
Specifically, correlations were performed between age and the following EEG measures: 
lower scale MSE and higher scale MSE; power of delta, theta, alpha, beta, and gamma bands; 
and LHR. No significant correlations were found between age and any of these EEG 




Table 3.7: Correlations between MSE, power, LHR, and age.  
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  Control  del  
                                                               Age 
Parietal MSE lower scale -0.39 0.36 
 MSE higher scale -0.56 0.31 
    
Frontal MSE lower scale 0.08 0.30 
 MSE higher scale -0.22 0.08 
    
Parietal δ 0.46 -0.25 
 θ 0.004 -0.43 
 α 0.09 -0.1 
 β 0.11 0.25 
 γ -0.24 -0.14 
 δ/β 0.27 -0.44 
    
Frontal δ 0.42 -0.16 
 θ 0.02 0.09 
 α -0.21 -0.12 
 β -0.51 0.47 
 γ -0.23 -0.32 
 δ/β 0.57 -0.55 
The reported values correspond to the rs coefficient. All results are non-significant. 
Significance threshold at p < 0.014. 
 
Correlations of EEG measures with ESSENCE traits 
Correlation permutation tests were performed to examine correlations between MSE, power, 
and LHR measures against behavioural and psychiatric assessments in the del group (Table 
3.8 and Table 3.9). Overall, strong correlations were found between frontoparietal EEG 
measures and most of the CBCL traits (p ≤ 0.006). Entropy at lower timescales correlated 
positively with pervasive developmental, ADHD, and oppositional defiant problems; whereas 
entropy at higher timescales correlated positively with anxiety problems. In terms of power, 
strong correlations with anxiety, pervasive developmental, and oppositional defiant problems 
were found; these correlations were negative with lower-frequency power, and positive with 
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higher-frequency power, that is, as CBCL traits’ severity increased, lower-frequency power 
decreased, but higher-frequency power increased, respectively. The same CBCL-subscales, 
i.e., anxiety, pervasive developmental, and oppositional defiant problems, showed strong 
negative correlations with LHR. No significant correlations were found between any of the 
EEG measures and CBCL-affective problems, CBCL-sleep problems, ADOS-CSS, SRS, or 
IQ. 
 
Table 3.8: Correlations between MSE and ESSENCE traits in 16p11.2 del. 
 Parietal Frontal 
 Lower scale Higher scale Lower scale Higher scale 
CBCL-affective 
problems a 
0.59 0.16 0.59 0.39 
CBCL-anxiety 
problems a 




0.71 0.64 0.69 0.48 




0.80 0.66 0.67 0.60 
CBCL-sleep 
problems a 
0.40 0.26 0.36 0.21 
CBCL-total 
problems a 
0.22 -0.12 0.34 0.28 
ADOS-CSS b -0.27 -0.13 -0.11 -0.13 
SRS c -0.06 -0.24 0.03 -0.22 
IQ d 0.59 0.16 0.59 0.39 
The reported values correspond to the rs coefficient. Significant results (p ≤ 0.006) are in bold.  
a Data from six deletion carriers are missing.  
b Data from nine deletion carriers are missing. 
c Data from nine deletion carriers are missing. 
d Data from two deletion carriers are missing. 
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Table 3.9: Correlations between power, LHR, and ESSENCE traits in 16p11.2 del. 
 Parietal Frontal 
 δ θ α β γ δ/β δ θ α β γ δ/β 
CBCL-affective problems a -0.30 0.19 0.19 0.63 0.62 -0.53 -0.26 0.30 0.06 0.64 0.40 -0.47 
CBCL-anxiety problems a -0.78 0.50 0.68 0.22 0.22 -0.86 -0.80 0.54 0.77 0.26 -0.04 -0.78 
CBCL-pervasive 
developmental a 
-0.80 0.56 0.59 0.50 0.52 -0.82 -0.70 0.83 0.63 0.24 0.01 -0.44 
CBCL-ADHD a -0.63 0.18 0.40 0.59 0.61 -0.68 -0.45 0.52 0.33 0.21 0.37 -0.53 
CBCL-oppositional defiant 
a 
-0.65 0.27 0.45 0.60 0.59 -0.83 -0.72 0.54 0.38 0.39 0.03 -0.68 
CBCL-sleep problems a -0.40 -0.04 0.24 0.65 0.43 -0.66 -0.35 0.24 0.10 0.34 0.29 -0.46 
ADOS-CSS b -0.14 -0.46 0.28 0.54 0.08 -0.47 -0.28 -0.24 -0.07 0.66 0.58 -0.34 
 
SRS c 0.21 -0.36 -0.10 0.42 0.64 -0.52 0.15 -0.18 -0.17 0.52 0.56 -0.37 
IQ d 0.27 -0.17 -0.21 -0.12 -0.28 0.21 0.29 0.36 -0.34 -0.12 -0.36 0.17 
The reported values correspond to the rs coefficient. Significant results (p ≤ 0.006) are in bold.  
a Data from six deletion carriers are missing.  
b Data from nine deletion carriers are missing. 
c Data from nine deletion carriers are missing. 
d Data from two deletion carriers are missing. 
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3.4   Discussion 
The aims of the current study were 1) to determine whether fronto-parietal spontaneous 
neural activity, indexed by oscillatory power and MSE, in 16p11.2 del carriers was altered 
compared to typical controls; and 2) to establish whether fronto-parietal spontaneous neural 
activity is related to ESSENCE traits in 16p11.2 del carriers. The main findings are 1) MSE 
and CI were higher for del than controls at all respective timescales over the frontal region, 
but not the parietal region; 2) No significant group differences were found in LHR or relative 
power within each respective frequency band and brain region; 3) Overall strong associations 
were found between MSE, CI, relative power in delta, theta, and alpha frequency bands, 
LHR5, and several CBCL traits (e.g., anxiety problems). Together, these results suggest a 
specific dysfunction in frontal spontaneous neural activity that seems to strongly reflect or 
impact on a wide array of ESSENCE traits.  
Taking the ESSENCE approach of considering interrelated psychiatric disorders 
together, certain commonalities emerge in neural entropy between these disorders and 
16p11.2 del. Similar to 16p11.2 del, higher spontaneous entropy in fronto-central brain areas 
has been found in various ESSENCE disorders (Table 3.1). Notably, the current study found 
higher entropy in del at both lower and higher timescales compared to controls, as jointly 
reflected by CI and MSE analyses. This is reminiscent of findings previously reported in 
relation to ASD and absence epilepsy (Bosl et al., 2017) where an overall higher entropy at 
resting-state was also found compared to controls. Findings from many other studies, though, 
suggest that it is more common in ESSENCE disorders for there to be timescale-dependent 
variations in the level of entropy, compared to typical controls (Table 3.1). Higher 
spontaneous fronto-central entropy has been more frequently observed at higher timescales in 
particular (ASD; Ghanbari et al., 2015; Schizophrenia; Takahashi et al., 2010; Alzheimer’s; 
Yang et al., 2013; Mizuno et al., 2010). This implies that ESSENCE disorders, in the 
aforementioned studies, showed atypical long-range spontaneous neural processing involving 
the fronto-central region, as it has been suggested that neural entropy at lower and higher 
timescales respectively reflect local/shorter-range and longer-range neural processing 
(McDonough and Nashiro, 2014, McIntosh et al., 2014, Vakorin et al., 2011). In contrast, we 
speculate that the findings in the current study suggest that there is a disruption in both 
 
5 Because the outcomes from relative power analyses of respective frequencies and LHR are similar, these will 
be mainly discussed altogether as one category.  
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shorter- and longer-range neural processing involving the frontal brain region and possibly 
affecting the default mode network and/or other resting-state networks.  
In 16p11.2 del, Bertero et al. (2018) only implicated long-range neural dysfunction 
(equivalent of entropy at higher timescales) involving the prefrontal cortex, as revealed with 
functional connectivity fMRI analysis. As described earlier, Bertero et al. (2018) found 
reduced prefrontal long-range connectivity in 16p11.2 del. In light of the relationship 
between MSE and functional connectivity (Figure 3.1), specifically when examined using 
MEG, LFP, and simulated data (which arguably are more comparable to EEG data compared 
to fMRI in terms of temporal resolution), the higher entropy found in the current study might 
translate to hyperconnectivity – therefore conflicting with some of Bertero et al.’s (2018) 
findings. Nevertheless, it is clear, from the current study’s findings together with Bertero et 
al.’s (2018), that functional frontal neural activity at resting-state is altered in 16p11.2 del, 
especially in relation to long-range neural activity.  
 It is unclear, however, how this altered neural activity might lead to the numerous 
ESSENCE traits found in 16p11.2 del. An interesting hypothesis that might explain a 
potential link on a conceptual level comes from Misic et al.’s (2015) ASD study. In Misic et 
al.’s (2015) study, ASD participants showed typical MEG entropy activity when compared to 
the control group in response to tasks designed to test mental flexibility; however looking 
more closely at MSE during the respective mental flexibility tasks, it seemed that for the 
ASD group, higher entropy at higher scales was employed for one task and higher entropy at 
lower scales for the other. While the control group showed opposite entropy activity in terms 
of timescales at each task. A related finding in the same study is that higher entropy at the 
identified task-related regions was associated with faster reaction times in controls – but not 
in ASD. Therefore, the authors suggested the observed findings could be due to the 
misappropriation of neural resources to perform the respective mental flexibility tasks. 
Keeping this view in mind, perhaps the current study’s higher frontal entropy in del was due 
to a functional brain reorganisation, which altered neural networks involving the frontal 
region. This higher entropy might reflect a compensatory mechanism that is misallocating 
neural resources and therefore leading to an overall atypical information processing within 
resting-state networks. A compensatory mechanism that misallocates neural resources likely 
impacts a wide range of processes leading to numerous ESSENCE traits that vary in severity.  
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Indeed, neural activity (in the form of entropy and complementary LHR power 
metrics) might be a marker of a compensatory mechanism affecting a range of ESSENCE 
traits. In support of this view, neural activity was found to be strongly associated with 
ESSENCE traits (as measured via the Child Behaviour Checklist (CBCL)) in this study, even 
though most of del carriers in this sample did not reach the CBCL cut off for the clinical 
range (with the exception of pervasive developmental problems:10 out of 16 carriers are in 
the borderline or clinical range; Table 3.4). Notably, despite the lack of group differences in 
power and LHR in the current study, results from correlation analyses showed strong links 
between entropy, power, LHR, and CBCL traits in del. These correlations were 
complementary and in line with the view that higher entropy and lower LHR might reflect 
similar or complementary mechanisms. Specifically, with higher entropy and lower LHR 
(note that LHR = delta/beta power, therefore a lower LHR means delta power was lower than 
beta power), there was a reciprocal increase in ESSENCE traits. In other words, entropy was 
positively associated with CBCL severity (Table 3.8); while LHR was negatively correlated 
to CBCL severity (Table 3.9). Altogether, these associations signify a compensatory 
mechanism and possible impairment in neural processing in del, which may be impacting 
various ESSENCE traits that have been accounted for in the CBCL. These include pervasive 
developmental problems, ADHD problems, oppositional-defiant problems, and anxiety 
problems. It is beneficial, therefore, to take the ESSENCE approach and consider the wide 
spectrum of difficulties via instruments such as CBCL, as opposed to focusing on a particular 
disorder or trait, in this (i.e., 16p11.2 del) and other related CNVs (e.g., 1q21.1 CNV) or even 
idiopathic psychiatric disorders (e.g., ASD).  
As mentioned earlier, entropy at lower timescales carries information from both lower 
and higher frequencies, while entropy at higher timescales reflects information from lower 
frequencies (Courtiol et al., 2016; Takahashi et al., 2010; Mizuno et al., 2010). Accordingly, 
it is interesting that no group differences in either relative power or LHR were found in this 
study while finding group differences in entropy. Especially since both entropy and LHR 
measures have been interpreted as reflecting cognitive flexibility at a higher conceptual level 
(e.g., Misic et al., 2015). Specifically, higher entropy and lower LHR, respectively, might 
similarly reflect the brain’s adaptability to switch between cognitive states. Based on that 
perspective, the current study’s finding of higher entropy in del, therefore, was expected to be 
complemented by a lower LHR in 16p11.2 del compared to controls, which was not the case. 
This could indicate, therefore, that entropy, relative to power, is a more sensitive measure 
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useful for capturing certain properties of neural information processing in 16p11.2 del, not 
possible by conventional power analyses alone. This view is further supported by previous 
studies conducting joint entropy and power analyses (Misic et al., 2015; Catarino et al., 
2011). For example, distinct aspects of neural activity (e.g., activation of distinct brain 
regions/pathways) were revealed in the respective analyses in Misic et al.’s (2015) study. In 
addition, Catarino et al. (2011), similar to the current study, found no group differences in 
EEG power between ASD and controls, while group differences in entropy were observed 
(i.e., lower entropy over temporo-parietal and occipital areas in ASD).  
It is worth pointing out that in most prior work, LHR has been shown to be higher in 
ADHD (Barry et al., 2003), though studies have also reported negative findings (Arns et al., 
2018; Loo et al., 2013; Kitsune et al., 2015). As only three participants in the current study 
were diagnosed with ADHD (Table 3.3), it was not possible to examine whether the 16p11.2 
del carriers with an ADHD diagnosis would show similar contrasts with typical controls in 
LHR to that of idiopathic ADHD. In relation to the LHR-anxiety correlation in 16p11.2 del, it 
was found to be negatively correlated in the current study (indicating higher levels of anxiety 
with lower LHR); This finding is in congruence with Putman et al.’s (2010) study that 
showed a negative correlation between LHR and anxiety, although in typical participants. 
Interestingly, LHR has been linked with the regulation of interactions between cortical-
subcortical systems, i.e., frontal cognitive inhibitory processes vs. limbic motivation/reward-
seeking behaviour (Knyazev et al., 2007). Relatedly, atypical spectral power in ASD has been 
widely interpreted as reflecting an imbalance in neural excitatory/inhibitory processes 
(Rubenstein and Merzenich, 2003). Keeping these concepts in mind, it is possible to assume 
with caution that a similar picture is the case in 16p11.2 del (whether as part of a 
compensatory mechanism or otherwise), even though this is a reductionist view and the 
overall pathophysiology is undoubtedly complex.  
Evidence drawn from 16p11.2 del mouse studies suggests a possible dysregulation 
and interplay between multiple neurotransmitter and neuromodulator systems (Stoppel et al., 
2018; Wang et al., 2018; Walsh et al., 2018; Panzini et al., 2017; Portmann et al., 2014), 
which could be contributing to an excitation/inhibition imbalance. Although 16p11.2 del 
mice showed no difference in the availability of GABAergic receptors (i.e., GABAA 
receptors and GABAA α5 subunit quantified using autoradiography) in any brain region 
compared to wild-type control mice (Horder et al., 2018), another study found that 
administration of R-baclofen (GABAB receptor agonist) improved cognitive and social 
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performance in 16p11.2 del mice (Stoppel et al., 2018). In relation to excitatory activity, 
glutamatergic (NMDA receptor) hypofunction in the prefrontal cortex was identified in 
16p11.2 del mice, as revealed by electrophysiological recordings (Wang et al., 2018).  
In addition to the aforementioned neurotransmitter systems, serotonin (5-HT; Walsh 
et al., 2018; Panzini et al., 2017) and dopamine (as explained in Chapter 2; Portmann et al., 
2014) have also been implicated in 16p11.2 del and in behavioural deficits of relevance to 
16p11.2 del, such as social, cognitive, and anxiety problems (Lee and Goto, 2018; Zhang and 
Stackman, 2015; Albert et al., 2014). Walsh et al. (2018) found that the deletion of the mouse 
equivalent 16p11.2 region, specifically from 5-HT neurons induced social deficits and 
reduced dorsal raphe 5-HT neuronal excitability, as identified via electrophysiological 
recordings. In addition, using optogenetic techniques, Walsh et al. (2018) bidirectionally 
modulated the release of 5-HT from dorsal raphe neurons projecting to the nucleus 
accumbens in 16p11.2 del mice, which in turn influenced social behaviour. Specifically, 
activation of dorsal ralphe 5-HT neurons in the nucleus accumbens rescued social deficits 
exhibited by 16p11.2 del mice, and vice versa. Surprisingly, reduced 5-HT activity in 
16p11.2 del mice did not impact anxiety-related behaviours in Walsh et al.’s (2018) study. 
Nevertheless, 5-HT dysregulation could be a key driver impacting the excitation/inhibition 
balance, which in turn contributes towards pathology in 16p11.2 del.  
Relatedly, evidence from a previous study (Takahashi et al., 2010; Table 3.1) 
suggests that higher entropy might relate to atypical dopaminergic and/or serotonergic 
activity (in humans). Specifically, Takahashi et al. (2010) studied EEG MSE activity in drug-
naïve schizophrenia (SZ) participants pre- and post-treatment with antipsychotics 
(comparisons between pre-treatment SZ vs typical controls were also conducted). The 
treatment involved typical antipsychotics, i.e., dopamine antagonists (dopamine receptor 
response blocking), in addition, a few participants received atypical antipsychotics, i.e., 
dopamine-serotonin antagonists. Takahashi et al. (2010) found increased entropy at higher 
timescales in fronto-centro-temporal areas in SZ (pre-treatment) compared to controls. This is 
somewhat similar to the findings in the current study as higher entropy was found at higher 
timescales (but also lower timescales) in fronto-central areas in 16p11.2 del compared to 
controls. Notably, Takahashi et al. (2010) also found that this higher entropy in SZ was 
lowered to the control participants’ level in fronto-central areas in response to antipsychotic 
treatment. In other words, the observed atypically high entropy observed in SZ was reversed 
in response to medications which act on attenuating dopaminergic and, to a lesser extent, 
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serotonergic activity. Thus, the identified atypical neural entropy in 16p11.2 del, in the 
current study, along with the observed strong links between neural activity and psychiatric 
traits, could, therefore, signify an excitation/inhibition imbalance, driven by multiple 
neurotransmitter systems including dopamine and 5HT, in 16p11.2 del.  
Overall, the current study established that 16p11.2 del carriers present with atypical 
neural activity as revealed with entropy measures. Neural entropy levels were consistently 
higher in the frontal region for del relative to typical controls at all timescales. Hence, this 
implicates interactions between local and long-range neural processing at resting-state 
networks. Whether reflecting a compensatory or dysfunctional mechanism, neural activity in 
del was strongly associated with ESSENCE traits, including anxiety, pervasive 
developmental, ADHD, and oppositional defiant problems. To better interpret these results 
and understand the underlying pathology or compensatory system, 16p11.2 deletion animal 
models are valuable. Atypical neural activity on a system level, as is the case in the current 
study, might be reflecting atypical neural activity on a cellular level – such as the 
excitation/inhibition imbalance in 16p11.2 del mice, as described earlier. Accordingly, to 
make it more possible for future studies to draw parallels from 16p11.2 del mouse models, 
the following study in this thesis will repeat the same analyses already conducted in this 
chapter but with 16p11.2 deletion mice.  
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 Spontaneous neural activity in 16p11.2 deletion mouse model 
4.1   Introduction 
Parallel human and mouse studies are necessary and valuable for investigating neural activity 
in 16p11.2 del. The 16p11.2 del mouse model can be used to support findings relating to 
human 16p11.2 del. Different aspects of atypical EEG/LFP features in humans and mice were 
described in previous studies (as described in Chapter 1, in addition to the studies conducted 
in this thesis, Chapters 2 and 3). However, it is unclear whether there are common EEG/LFP 
features between 16p11.2 del humans and mice, due to the small number of studies and lack 
of studies addressing this question. Identifying the common EEG/LFP features is a means to 
finding reliable features that more likely reflect 16p11.2-related pathophysiology. From a 
different perspective, human-mouse comparisons could also determine whether the atypical 
EEG features are conserved across species (with a loss of 16p11.2). After identifying the 
conserved EEG/LFP features, the mouse model can be used to investigate the reversibility of 
these features and associated phenotypes. This can be done with optogenetic techniques and 
drug treatments, among other experimental techniques not applicable to human participants. 
Using optogenetic techniques, Walsh et al. (2018) showed that social deficits were rescued in 
16p11.2 del mice by manipulating the activity of dorsal raphe serotonergic neurons. A similar 
approach could be applied to examine whether isolating and activating specific neurons in 
16p11.2 del could modulate the aberrant EEG/LFP features and restore normal signal features 
in these mice. This would, in turn, inform future studies on possible underlying mechanisms 
responsible for the aberrant signal observed in 16p11.2 del humans (and mice) and their 
associated phenotypes/pathophysiology. As a result, these studies would improve efforts on 
interpreting EEG activity and related findings for 16p11.2 del humans.   
Of relevance to human-mouse parallel studies is to recognise that it is feasible to 
compare EEG data with LFP data. This is because EEG and LFP signals have similar 
properties and come from relatively similar sources in the brain (Buzsaki et al., 2012; Cohen, 
2017). Essentially, EEG and LFP recordings capture the extracellular electric currents 
resulting from the (electrochemical) interaction between neurotransmitters and receptors at 
the dendrites of the receiving neurons, thousands to millions of neurons. For these 
postsynaptic potentials to be detected, neurons need to act in synchrony and be aligned in 
parallel (otherwise the dipoles formed by neighbouring neurons, due to the electric positive 
and negative flow of ions across the membrane of each neuron, will cancel each other out). 
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Spatially, EEG samples a relatively large spatial area of neural activity from 
superficial layers of the cortex, while LFP samples neighbouring neural activity to the 
inserted electrode from deeper layers (i.e., down to layers V or VI). Based on the above-
mentioned properties and because of their abundance, pyramidal neurons are considered to be 
the main contributors to the EEG/LFP signals. However, all ionic currents from cellular 
processes of neurons and glial cells, excitatory and inhibitory, from different areas of the 
brain contribute to the EEG/LFP signal. Temporally, EEG and LFP data are similar in terms 
of their temporal resolution, i.e., milliseconds, which is an important feature that makes 
parallel analyses plausible.  
An obvious distinction, however, between EEG and LFP is the impact of the data-
collection methodology on the signal. LFP activity is recorded invasively from within brain 
tissue (i.e., metal microelectrodes are inserted into the brain), whereas EEG activity is 
recorded at the scalp – therefore the soft and hard tissues distort the signal and act as a low-
pass filter, capturing < ~ 130 Hz. In contrast, the former method of inserting an electrode 
within the brain captures a clearer broadband signal, which contains LFP activity (< ~ 130 
Hz) and multiunit activity (MUA; > ~ 200 Hz). MUA activity represents action potentials or 
spikes (which are usually at higher frequencies relative to synaptic events) detected from 
neurons near the electrode. This spike activity could be clustered based on the temporal width 
of the spike waveforms: wide-spiking, putative excitatory neurons, and narrow-spiking, 
putative inhibitory interneurons (e.g., Lazaro et al., 2019). Certainly, data obtained invasively 
from within the brain contains more information, contrary to EEG, in relation to spike 
activity and the relationship between unit and system-level neural activity. However, other 
than in exceptional cases such as during surgery for treating epilepsy, it is not possible to 
collect LFP/MUA activity from humans. Hence, it is useful to conduct parallel EEG-human 
and LFP-mouse analyses.  
The aforementioned similarities between EEG and LFP signals (i.e., similar properties 
and presumed electrogenesis) gives cause for expecting parallel EEG-human and LFP-mouse 
studies to show similar signal features. For example, if the CNV human group showed a 
particular atypical feature in their EEG activity, then a similar LFP feature would be expected 
in the CNV mouse group. These EEG-LFP features could, in turn, be interpreted in a similar 
way and linked with further evidence from 16p11.2 del mouse studies investigating the 
underlying pathology on other levels.  
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Based on prior work (described in detail in the introductory Chapter 1), prefrontal 
long-range (fMRI) connectivity has been implicated in both 16p11.2 del humans and mice 
(Bertero et al., 2018). However, the literature only consisted of two studies (Lu et al., 2019; 
Bertero et al., 2018) and only one of them conducted parallel analyses (Bertero et al., 2018). 
Thus, more studies are required to verify and expand on this finding. With this in mind, EEG 
neural dynamics in human 16p11.2 del was first investigated in the previous study in this 
thesis (Chapter 3), using MSE and power analyses. Briefly, there was higher entropy 
recorded over frontal electrodes in 16p11.2 del humans compared to typical controls, despite 
not finding group differences in power at any frequency band, higher entropy was found at 
both lower and higher timescales. It was therefore concluded that 16p11.2 del impacts short-
range and long-range neural processing.  
The aim of this study is to determine whether LFP entropy and power features are 
atypical in 16p11.2 del mice, and whether these features follow a similar pattern to that 
observed in 16p11.2 del humans (Chapter 3). Based on the human results from Chapter 3, 
the current study tests the following hypothesis: 1) no group differences will be found in 
power features in either electrode, i.e., frontal and retrosplenial; whereas 2) group differences 
will be found in entropy features, specifically, 16p11.2 del mice will show higher entropy at 
all timescales at the frontal electrode compared to controls.  
4.2   Methods 
Data source 
Data re-analysed in the current study were obtained from Alessandro Gozzi’s lab (Functional 
Neuroimaging Laboratory, Instituto Italiano di Tecnologia). Only a prior LFP coherence 
analysis of this data was previously conducted for the previous publication (Bertero et al., 
2018) as such, all the analysis presented here is novel.  
Animals 
The 16p11.2 del mice (also known as 16p11.2df; Horev et al., 2011; MGI: J:176335) and 
control wild-type mice were obtained from Jackson Laboratories (stock no. 013128). The 
16p11.2 del mouse model was engineered by the deletion of one copy (heterozygous for a 
deletion) of a region on mouse chromosome 7 (m7qF3; ~390 kb; Horev et al., 2011), which is 
homologous to the human 16p11.2 region.  
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The mice were bred locally (in Prof Alessandro Gozzi’s lab) and housed by sex, with 
temperature maintained at 21±1°C and humidity at 60±10%, as described in Bertero et al. 
(2018).  
The LFP mouse data of 16p11.2 del (n = 6; female = 1) and control littermates (n = 6; 
female = 3) was previously collected as described in Bertero et al. (2018) and re-analysed in 
the current study. The age range was 11 to 13 weeks old, corresponding to young mature 
adult mice, and the mean body weight was 25.3± 1.1 grams.  
Ethical approval  
All in-vivo animal studies were conducted in accordance with the Italian Law (DL 26/214, 
EU 63/2010, Ministero della Sanità, Roma) and the recommendations in the Guide for the 
Care and Use of Laboratory Animals of the National Institutes of Health. Animal research 
protocols were also reviewed and consented to by the animal care committee of the Istituto 
Italiano di Tecnologia. All surgical procedures were performed under anaesthesia. 
In-vivo electrophysiology 
LFP recordings were conducted under halothane sedation (halothane dose of 0.7% - 1%). 
Using two electrodes implanted in the anterior cingulate cortex (will be referred to as frontal 
cortex, henceforth) and retrosplenial cortex, LFP signals were recorded for approximately 10 
minutes, with a sampling rate of 1500 Hz and a notch filter at 50 Hz. Details regarding 
animal preparation and surgery are previously described (Bertero et al., 2018). 
To ensure that the sampling rate was identical to the human EEG data described in 
Chapter 3, the mouse data were resampled to 500 Hz and, as with the human EEG data, 
detrended (MATLAB function, ‘detrend’). Thus, each animal’s dataset contained 300,000 
datapoints (10 min *60 sec *500 Hz). For every dataset, only artefact-free segments of a total 
length of two minutes (60 sec *500 Hz *2 min = 60,000 datapoints) were selected for 
analysis. Within the whole signal (i.e., ~10 minutes), one of the three possible 2-min ranges 
(i.e., 3 – 5 min (datapoints 100,000 – 160,000); 6 – 8 min (datapoints 180,000 - 240,000); or 
7 – 9 min (data points 205,690 - 265,690)) were identified as artefact-free based on visual 
inspection of each plotted dataset (Figure 4.1). The respective selected 2-min range of each 








Figure 4.1: LFP signals from frontal and retrosplenial channels of 16p11.2 del and control mice. 
Both subfigures show the entire timecourse of the LFP for each mouse with shading to illustrate the artefact-free portion of data that was selected 
for analysis. The top subfigure (a) specifies signal from the frontal electrode, while the bottom subfigure (b) specifies signal from the retrosplenial 
electrode. Black indicates control mice; blue indicates del mice 
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LFP measures 
4.2.5.1 Multi-scale entropy 
The MSE measure is previously described in Chapter 3. The analysis parameters were 
consistent with analyses carried out on human EEG (Chapter 3), i.e., signal length and sampling 
rate, number of timescales, entropy sequence length (m), and similarity criterion (r). MSE 
analysis (timescales 1-20) was conducted for a continuous LFP signal of 60,000 datapoints (2 
minutes; 500 Hz sampling rate). Further entropy parameters were m = 2 and r = 0.2 (Takahashi 
et al. 2016; Ghanbari et al. 2015; Richman and Moorman, 2000). MSE of each channel, frontal 
and retrosplenial, were computed separately. Entropy of scales 1-20 was averaged per channel 
into four groups consisting of averaged entropy scales 1-5, 6-10, 11-15, and 16-20.  
Secondary analyses were also conducted with the same analysis parameters as described 
above but with the addition of a bandpass filter (0.5 – 40 Hz) applied to the signal, as this pre-
processing step was performed in Bertero et al.’s (2018) study (which conducted LFP coherence 
analysis on the same datasets analysed in the current study, as mentioned earlier). Because the 
outcome of the secondary analyses produced highly similar results, the current study reports the 
results of only the primary analyses.  
4.2.5.2 Complexity index 
The complexity index (CI) measure is previously described in Chapter 3. CI was computed 
separately for frontal and retrosplenial electrodes.  
4.2.5.3 Power spectral density 
Details on how Power Spectral Density (PSD) was computed and how relative power was 
extracted are previously described in Chapter 3. The frequency bands were segmented as such, 
delta [2-4 Hz], theta [4-8 Hz], alpha [8-14 Hz], beta [14-30 Hz], and gamma [30-40 Hz]. Prior to 
obtaining the relative power, the total spectral power was defined as the entire range between 1-
40 Hz (due to notch filters applied at 50 Hz). Relative power of each frequency band of each 
channel, frontal and retrosplenial, was then computed.  
The effect of MSE on power 
As mentioned earlier, previous authors (e.g., Courtiol et al., 2016; Takahashi et al., 2010) 
showed evidence indicating that the MSE method essentially acts as a low-pass filter with 
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entropy at lower timescales mainly representing higher frequency content and entropy at higher 
timescales representing lower frequency content. Similar to prior work, the current study, 
therefore, investigated how the MSE method, specifically the step involving coarse-graining of 
the original signal into multiple timescales, affects power content of high and low frequencies 
within the signal. LFP mouse signal (n = 1; 60,000 data-points) of the frontal channel was first 
coarse-grained into 20-timescales. PSD of time-series at each timescale was computed as 
described earlier with the same parameters, i.e., window length of 2 seconds with 50% overlap. 
The sampling rate and the number of datapoints per segment, however, were adjusted for each 
coarse-grained timeseries.   
Statistical analyses 
















4.3   Results 
MSE, CI, power, and LHR 
The results of the permutation tests performed to examine group differences in MSE (Figure 
4.2), CI, and PSD metrics are presented in Table 4.1. No significant results were found despite 
the medium to large effects sizes for some of the comparisons (Table 4.1). Secondary analyses 
similarly showed no significant results.  
Table 4.1: MSE, CI, power, and LHR of 16p11.2 del and control mice comparisons. 
  Frontal Retrosplenial 
  Mean 
difference 
P-value Cohen’s d Mean 
difference 
P-value Cohen’s d 
MSE        
 Scale 1-5 0.14 0.267 0.59 0.15 0.136 0.76 
 Scale 6-10 0.01 0.930 0.05 0.04 0.652 0.27 
 Scale 11-15 0.04 0.499 0.34 < 0.01 0.940 0.04 
 Scale 16-20 0.03 0.561 0.29 < 0.01 0.996 < 0.01 
CI        
 CI 0.20 0.895 0.07 0.84 0.480 0.41 
Power        
 δ 0.13 0.178 0.72 0.04 0.500 0.35 
 θ 0.09 0.243 0.59 0.02 0.622 0.24 
 α 0.03 0.155 0.73 0.01 0.507 0.32 
 β 0.02 0.448 0.37 0.01 0.539 0.31 
 γ < 0.01 0.795 0.13 0.01 0.259 0.59 
 δ/β 2.04 0.138 0.79 0.54 0.415 0.45 




Figure 4.2: MSE group differences at frontal and retrosplenial electrodes. 
a) Frontal electrode. b) Retrosplenial electrode. Error bars: 95% confidence intervals. Blue 
























The effect of MSE on power 
To aid interpretations of power and MSE results, the current study examined the effect of MSE 
on power (Figure 4.3). By observing the power spectral density (PSD) of each timeseries (i.e., 
signal at each timescale), a general progressive decline in power was found as the frequency 
increased. More importantly, consistent with previous studies (Courtiol et al., 2016; Takahashi et 
al., 2010), the current study found that power at higher frequencies gradually reduces as the 
timescale increases (as can be seen by observing all the timeseries, Figure 4.3). This confirms 










Figure 4.3:Power spectral density of each coarse-grained timeseries in units of a) microvolts and b) decibels. 
This was conducted for timescale (or factor) 1 to 20. 
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4.4   Discussion 
A 16p11.2 del mouse model (Horev et al., 2011) was used in the current study to capture the 
impact of a loss of 16p11.2 on spontaneous neural activity across species. We conducted LFP 
analyses paralleling the human EEG analyses (Chapter 3) of neural entropy and spectral 
power. This comparative perspective would help in identifying converging evidence to the 
16p11.2 human results and improving interpretations of the observed EEG alterations in 
humans. In this study, however, the 16p11.2 del mouse results were inconsistent with the 
human results; Neural dynamics, as measured by MSE and power metrics, were in the typical 
range in 16p11.2 del mice, as no group differences were found compared to wild-type mice.  
The lack of consistency between the present study’s 16p11.2 mouse results and the 
previously reported human results (Chapter 3) could be attributed to a number of factors. A 
hemideletion of 16p11.2 might not impact humans and mice in the same way in terms of their 
phenotypic profile and severity. As shown in Chapter 1, although 16p11.2 humans and mice 
share similar phenotypes (e.g., cognitive and motor deficits), there are also some differences 
(e.g., body weight and hearing problems). It may be the case that sensitivity to gene dosage at 
16p11.2 differ between humans and mice (Hiroi, 2018). Unlike 16p11.2 del humans, nearly 
half of 16p11.2 del mice are expected not to survive as pups (Horev et al., 2011; Portmann et 
al., 2014). Perhaps, the mice that do survive engage compensatory mechanisms and exhibit 
mild changes in LFP entropy and power, relative to wild-type mice, that the current study 
was not able to detect in this sample. Consequently, EEG/LFP activity in humans and mice 
might not display similar patterns or reflect analogous dysfunctions in this case.  
The mouse genetic background and strain might also play a role in modulating the 
observed neural activity and other phenotypes. 16p11.2 del mice under a hybrid genetic 
background of C57BL/6NxC3B displayed social interaction deficits, whereas these deficits 
were not found in mice with an inbred genetic background of C57BL/6N (see Chapter 1, 
Figure 1.10; Arbogast et al., 2016). Similarly, in a mouse model of Angelman syndrome, 
LFP delta power activity was dependent on the mouse genetic background (Sidorov et al., 
2017); Higher delta power was found in mice under a particular genetic background (i.e., 129 
background), but not in mice under the other background (i.e., C57BL/6). It is possible, 
therefore, that 16p11.2 del mice under a different genetic background than that in the current 
study, i.e., hybrid C57BL/6NxSv, would display more pronounced changes in LFP neural 
dynamics relative to control mice. This is in line with the notion that a deleterious CNV, such 
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as 16p11.2 del, may not be sufficient for the CNV-associated phenotypes to appear 
(Forsingdal et al., 2019; Girirajan et al., 2010). The absence, severity, and variability of 
phenotypes associated with 16p11.2 del could be largely influenced by genetic background 
(Girirajan et al., 2012; O'Donovan and Owen, 2016); This includes interactions between 
16p11.2 del, single nucleotide polymorphisms, single nucleotide variants, and other CNVs.  
In spite of the aforementioned considerations and limitations, two recent studies 
observed differences in neural activity in 16p11.2 del mice relative to controls, as described 
earlier (Lu et al., 2019; Bertero et al., 2018). Bertero et al. (2018) found reduced prefrontal-
retrosplenial LFP coherence (i.e., a measure of functional connectivity), within the delta 
frequency range, in 16p11.2 del mice.  
Prior work (as described in Chapter 3 and summarised in Figure 3.1) suggested that 
there is a relationship between functional connectivity and neural entropy. For this reason 
(and because the LFP data re-analysed in the current study are the same as the data analysed 
and presented by Bertero et al. (2018)), it is surprising that the current study’s findings did 
not show any concordance with Bertero et al.’s (2018) results. Nevertheless, evidence that 
connectivity and entropy features relate does not necessitate that features in relation to both 
measures could always be detected concurrently.  
In relation to Lu et al.’s (2019) study, the authors found atypical EEG activity during 
awake and sleep states in delta, theta, and beta frequency bands in 16p11.2 del mice (as 
mentioned in Chapter 1). The discrepancy between the current study (i.e., no group 
differences in power) and Lu et al.’s (2019) findings could be due to the electrode position 
and depth. The current study recorded LFP activity from the anterior cingulate cortex and 
retrosplenial cortex, whereas Lu et al. (2019) recorded EEG activity from the parietal region. 
Accordingly, future studies should examine EEG/LFP mouse activity at these and other brain 
areas to verify whether neural activity is altered at some sites, but not others in 16p11.2 del 
mice.  
In addition to the aforementioned considerations, future studies should take into 
account the testing ages of both humans and mice. Neural entropy in 16p11.2 del could 
impact humans and mice differently at specific ages. Prior work has shown that neural 
entropy dynamics are age-dependent in typically developing humans (McIntosh et al., 2014); 
It might be the case that disruptions of neural entropy are more pronounced at specific ages 
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not represented in the current mouse sample (age in the current sample ranges between 11 to 
13 weeks, corresponding to young mature adults).  
Although the small sample size in the current study is typical of mouse studies, it is 
possible that a larger sample would have been needed to reveal group differences mirroring 
that of humans (Chapter 3). Perhaps, the mouse sample (n = 6 del; n = 6 control) is not 
sufficiently powered to show any significant effects. This might be the case as we found 
medium to large effect sizes for the entropy and, surprisingly, power measures (Table 4.1), 
suggesting that group differences might become apparent with a larger sample. Interestingly, 
there seems to be a trend of higher entropy at lower timescales (timescale 1-5) at the 
prefrontal electrode as shown in Figure 4.2, partly supporting our human results (Chapter 3; 
although higher entropy was found at all timescales in 16p11.2 del humans). Indeed, power 
analysis confirmed that even with the EEG variables with large effect sizes (e.g., Frontal 
MSE scales 1-5: 0.59; and Frontal low to high frequency ratio (LHR): 0.79, Table 4.1), 
sample sizes of 30 and 17, respectively, for each the del and control mice groups, were 
required to achieve a statistical power of 60% for detecting an effect.  
Notably, to further establish the link between neural activity and behavioural 
phenotypes in 16p11.2 del, it is essential to conduct 16p11.2 del mouse studies that 
investigate this link, analogous to human studies. Prior work in this thesis showed a strong 
neural-behaviour link (e.g., entropy and anxiety levels) in 16p11.2 del humans (Chapter 3). 
Therefore, investigating the relationship between LFP activity and anxiety behaviour (in 
addition to other psychiatric traits) in 16p11.2 del mice could reveal interesting results. 
The presented work is the first study to investigate neural entropy in 16p11.2 del mice 
and directly compare 16p11.2 mouse LFP with human EEG data. The lack of group 
differences in neural entropy in 16p11.2 del mice, despite our previous human results 
reported in Chapter 3, should be verified and further investigated in future studies. Studying 
human and mouse in parallel is important for contributing converging evidence to 16p11.2 
del human studies and identifying reliable and conserved EEG/LFP features across species. 
This enables future studies to test the reversibility of EEG/LFP features and consider 
potential drug treatments. Equally, future studies could form links between the shared 
atypical EEG/LFP activity between humans and mice, and dysfunctions observed at other 
levels in mouse studies. This, in turn, would help in better interpreting the EEG 16p11.2 del 
findings.
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 General Discussion 
5.1   Answers to the outstanding questions presented in the introductory chapter 1.  
After reviewing the literature, this thesis identified key outstanding questions pertaining to 
neural activity in 16p11.2 CNV carriers – these questions were presented in the introductory 
chapter and are listed below. The aim of this thesis, therefore, was to answer the below 
research questions. To this end, three studies were conducted that collectively answered these 
questions and produced novel findings, which could inform future research on 16p11.2 
CNVs.  
Is neural activity altered, as revealed via EEG variability, power, and entropy 
metrics, in 16p11.2 CNV carriers? 
The studies conducted in this thesis showed that neural activity was indeed altered in 16p11.2 
CNV (human) carriers. Using EEG, neural activity was investigated in response to visual 
stimuli (i.e., black and white contrast-reversing checkerboards) and at resting-state (i.e., eyes-
open condition). For the former, electrodes selected for analyses were placed on the occipital 
region, whereas for resting-state / spontaneous neural activity, frontal and parietal electrodes 
were analysed, separately. Numerous EEG metrics of neural activity, which have been 
previously implicated in ESSENCE disorders, were considered. For visual-evoked neural 
activity, metrics included variability (i.e., variability in C1, P1, and N1 single-trial amplitude 
and latency, and timecourse variability; alpha and beta power single-trial variability; signal-
to-noise ratio (SNR)) and conventional ERP and power (i.e., mean C1, P1, and N1 amplitude 
and latency; mean alpha and beta power) metrics. For spontaneous neural activity, metrics 
included entropy (i.e., multiscale entropy (MSE) and complexity index (CI)) and power (i.e., 
delta, theta, alpha, beta, and gamma power; low-to-high frequency ratio (LHR)) metrics. 
Overall, neural activity was altered in the reciprocal 16p11.2 CNVs. For del, altered neural 
activity was revealed via certain variability and entropy metrics – but not power (in relation 
to del/ctrl comparisons). For dup, a specific alteration in power was found, with no changes 
in variability (in addition, entropy was not investigated for dup). Namely, neural variability 
(as observed via variability of timecourse amplitude and variability of P1 peak amplitude) 
and entropy (as observed via MSE at any timescale and CI), at occipital and frontal regions, 
respectively, were identified to be higher in del compared to controls. For dup, there was 
lower evoked alpha power compared to controls.  
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Does 16p11.2 dosage have an opposing effect on neural activity as per the additive 
model? 
Opposing neural activity in the reciprocal 16p11.2 CNVs were not identified in the current 
thesis as there were no significant group differences in neural activity that were in line with 
the additive model (i.e., del > control and control > dup, or vice versa). Yet, it is important to 
acknowledge that opposing neural activity might be present in the reciprocal 16p11.2 CNVs, 
yet it was not revealed in this thesis due to limitations such as sample size. Non-significant 
trends that might suggest opposing neural activity, however, were observed via certain 
metrics, which showed significant group differences between del and dup groups (but not 
against controls). These include, P1 latency variability (del < control < dup), absolute alpha 
and beta variability (del > control > dup), P1 (mean) amplitude (del > control > dup), and 
absolute (mean) alpha and beta power (del > control > dup). Nevertheless, these trends are 
not sufficient evidence of an opposing effect in neural activity in the reciprocal 16p11.2 
CNVs.  
Is there a relationship between neural activity and ESSENCE traits in 16p11.2 
deletion carriers? 
Certain relationships were observed between neural activity and ESSENCE traits in 16p11.2 
del in this thesis. Correlation analyses were conducted between resting-state neural activity 
(as measured via entropy, power (including LHR) metrics) and ESSENCE traits (as extracted 
via numerous assessments) in 16p11.2 del. For these analyses, assessment scores of IQ, 
autism spectrum-related traits (Autism Diagnostic Observation Schedule-Calibrated Severity 
Score (ADOS-CSS)), social traits (Social Responsiveness Scale (SRS)), and a range of 
behavioural and psychiatric problems in children (Child Behaviour Checklist for ages 1.5-5 
(CBCL) subscales), were used to capture ESSENCE problems. For the latter assessment, i.e., 
the CBCL, five DSM-oriented subscales and one syndrome subscale were extracted: affective 
problems, anxiety problems, pervasive developmental problems, ADHD problems, 
oppositional defiant problems, and sleep problems. In relation to neural activity metrics, 
entropy was segmented into two categories, i.e., entropy at lower timescales and entropy at 
higher timescales; power was assessed at each frequency band, from delta up to gamma, in 
addition to LHR (delta to beta ratio). Overall, higher entropy was strongly associated with 
higher severity of ESSENCE problems. Specifically, entropy at lower timescales was 
positively correlated with pervasive developmental, ADHD, and oppositional defiant 
problems; whereas entropy at higher timescales was positively correlated with anxiety 
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problems. With regards to power-ESSENCE correlations, decreased lower-frequency power, 
and increased-higher frequency power, respectively, were strongly associated with increased 
severity of ESSENCE problems. Specifically, lower-frequency power (i.e., delta) was 
negatively correlated with anxiety, pervasive developmental, and oppositional defiant 
problems. Whereas, higher-frequency power (i.e., alpha, but also theta) was positively 
correlated with the same CBCL-subscales. Also, these subscales were negatively associated 
with LHR (as would be expected given the aforementioned power-ESSENCE correlations). 
Surprisingly, no significant correlations were found between neural activity and other 
ESSENCE traits, such as the CBCL-affective problems and sleep problems, ADOS-CSS, 
SRS, or IQ.   
Is neural activity in 16p11.2 deletion mouse model similar to that of 16p11.2 
deletion humans?  
The current thesis did not identify similar neural activity between the 16p11.2 del mouse 
model and 16p11.2 del human carriers. In-vivo electrophysiological activity, captured via 
frontal and retrosplenial electrodes, were examined in Horev et al.’s (2011) mouse model of 
16p11.2 del. Specifically, analysis of LFP entropy and power features, in line with the human 
16p11.2 del analysis in this thesis, was conducted. No group differences were found in either 
entropy or power metrics between 16p11.2 del mice and control wild-type mice. However, it 
is important to note that there were medium to large effect sizes for entropy and power, 
indicating that there may be group differences that would become apparent with a larger 
sample. Trends indicated that 16p11.2 del mice showed higher entropy at lower timescales at 
the frontal electrode. Hence, this is partly congruent with the 16p11.2 del human results of 
higher entropy at all timescales at the frontal region.   
5.2   Interpretation of findings 
Overall, the findings from human subjects in this thesis indicate that deletion or duplication 
of the 16p11.2 region impacts neural activity. Despite trends suggestive of certain opposing 
neural activity in the reciprocal 16p11.2 CNVs, these trends were non-significant and were 
not representative of opposing neural activity as defined in this thesis. The results, therefore, 
indicate that gene-dosage impacts neural activity in 16p11.2 del vs dup carriers in unique yet 
non-opposing manners. Whether loss or excess of 16p11.2 dosage, neural activity at the 
occipital area was altered (as shown in Chapter 2). Therefore, this altered neural activity 
might involve sensory processing and, generally, cognitive processes related to learning and 
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adaptation to a changing environment – as EEG variability measures have been regarded as a 
proxy for these processes. 16p11.2 del further showed neural alterations in fronto-central 
areas (Chapter 3). This was interpreted as implicating short and long-range information 
processing (via atypical entropy at lower and higher timescales, respectively) involving 
fronto-central areas. Taken together, atypical neural activity in 16p11.2 CNV seems to be 
pervasive, extending to many brain regions and neural features associated with various 
cognitive and other processes.  
Thus, the observed neural alterations could be reflecting a general dysfunction or 
compensatory mechanism/s that impacts a range of processes leading to various ESSENCE 
traits with varying severity. Indeed, this thesis showed strong links between neural activity 
and ESSENCE problems in 16p11.2 del, regardless of the severity level of these problems. 
These included anxiety, pervasive developmental, ADHD, and oppositional defiant problems. 
Accordingly, the observed neural alterations could be viewed as possible endophenotypes 
reflecting the dysfunction or compensatory mechanism/s that is impacting the mentioned 
ESSENCE traits.  
Several lines of evidence implicate various neurotransmitter and neuromodulator 
systems in 16p11.2 CNV. Certainly, the dysregulation and interplay between multiple 
neurotransmitter systems could generate a net E/I imbalance (and might represent the above-
posited compensatory mechanism or general dysfunction). Although EEG mainly captures 
activity from superficial cortical sources, it is also possible that certain deeper sources 
contributed to the observed signal (as discussed in Chapter 4). Therefore, the E/I imbalance 
reflected in the EEG might not be solely restricted to cortical E/I.  
Evidence in support of this view of an overall E/I imbalance could be drawn from 
previous 16p11.2 CNV mouse studies (described earlier in this thesis) as multiple systems 
were implicated. These studies found abnormalities in the GABAergic (Stoppel et al., 2018), 
glutamatergic (Wang et al., 2018), dopaminergic (Portmann et al., 2014), and serotonergic 
systems (Walsh et al., 2018; Panzini et al., 2017).  
The findings in this thesis further support this view of an overall E/I imbalance. The 
observed EEG features in 16p11.2 CNV carriers in this thesis, including increased neural 
variability and entropy (for del) and decreased alpha power (for dup), have been previously 
linked with dysregulation in the above-mentioned neurotransmitter systems in typical and/or 
ESSENCE populations (e.g., Takahashi et al., 2010; as have been described in Chapter 2 and 
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Chapter 3). In addition, these neural features were associated with certain ESSENCE traits, 
in this thesis, such as anxiety, ADHD, and pervasive developmental problems (including 
ASD-related traits), which were previously linked with E/I imbalance and dysregulations in 
the above-mentioned systems. As such, it is possible that an overall E/I imbalance 
implicating multiple neurotransmitter systems are contributing to the observed EEG signal 
and ESSENCE traits in 16p11.2 CNV carriers.  
That being said, it is important for future studies to confirm these interpretations, 
which, in this thesis, are meant to represent early efforts for findings links between different 
levels of analyses. Future parallel 16p11.2 CNV human-mouse studies should further 
elucidate these links and disentangle the currently-presented simplified and unifying theory 
of an overall E/I imbalance.  
5.3   Key limitations and strengths of this thesis 
Key limitations and strengths of this thesis will be acknowledged here. The small sample size 
is a limitation in the current thesis as it generally increases the likelihood of type I (i.e., false 
positives) and type II errors (i.e., false negatives) occurring in the studies conducted here. 
With the awareness of the trade-off between type I and type II errors, the current thesis 
prioritised avoiding type I errors. The rationale for this decision is the assumption that effect 
sizes for most of the comparisons conducted in the current thesis are sufficiently large, as 
group differences in neural activity especially for 16p11.2 del have been observed in prior 
studies with similarly small sample sizes (median sample size and range for del: 19 [8, 35]; 
Hinkley et al., 2019; Bertero et al., 2018; LeBlanc and Nelson, 2016; Jenkins et al., 2016; 
Hudac et al., 2015). Hence, it was assumed that the large effect sizes would make the 
occurrence of a type II error less likely. Therefore, avoiding a type I error was prioritised. To 
this end, the current thesis applied randomisation statistical techniques (as described in 
Chapter 2, Section 2.2.11) and conservative significance thresholds that vary as defined by 
the Benjamini-Hochberg method (computed based on the raw p-values’ rank, total number of 
tests, and the false discovery rate, which was set at 5% in this thesis). Using this conservative 
approach is a strength of this thesis, as the results were narrowed down with the purpose of 
solely presenting significant and likely reliable results.  
Conversely, it is possible that a type II error was committed, especially given that 
certain correlations with large effect sizes were present in this thesis (see Chapter 2, Table 
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2.7). For example, P1 amplitude variability was strongly correlated with ADOS-CSS for dup 
(r = -0.76), however, it was deemed non-significant as per the conservative significance 
threshold of p < 0.003 in line with the result of the Benjamini-Hochberg method. Although 
note that the Benjamini-Hochberg method allows for greater statistical power in the expense 
of increased numbers of type I errors compared to the Bonferroni correction (i.e., significance 
threshold divided by the number of tests) – although this depends on how the parameters are 
defined. In other words, compared to familywise error rate methods, such as the Bonferroni 
correction, the Benjamini-Hochberg method is less stringent in preventing type I errors, 
which makes it generally more favourable in terms of balancing the possible occurrence of 
type I and type II errors.  
A further limitation is that datasets analysed in this thesis were not collected by the 
current author. Novel analyses were conducted of secondary datasets previously collected by 
SFARI partners and other researchers (i.e., Alessandro Gozzi’s lab). Some of these datasets 
(i.e., EEG resting-state data analysed in Chapter 3) were not examined prior to this thesis. 
The disadvantage of studying secondary data is that various aspects relating to data collection 
protocol are pre-set, including study design, data length, sampling rate, quality-checks, etc. 
Therefore, it was not possible for the current author to alter certain data parameters and 
inspect data quality at the source. However, this was not an issue for the current thesis as the 
previous researchers involved in data collection shared their meta-data and study protocol 
with the current author. More importantly, the advantages of data-sharing and collaborative 
efforts outweigh the costs, especially in the case of rare populations such as 16p11.2 CNV 
carriers. Data-sharing and analysis of secondary data is a more cost-effective and efficient 
strategy. In addition, this strategy enables the contribution of various researchers with 
different skills to provide deeper analyses and converging evidence. Indeed, a strength of this 
thesis is that work here contributes to the deep characterisation of 16p11.2 CNV using 
datasets available for future efforts to test the reliability of current findings and provide 
converging evidence.   
Another strength of this thesis is the combination of human participants and mouse 
model to study neural activity in 16p11.2 CNV. Parallel human-mouse studies are valuable 
for numerous reasons as discussed in Chapter 4 and essential for advancing research on 
mechanisms implicated in 16p11.2 CNVs. However, behavioural and cognitive data for the 
mouse samples were not available. Therefore, analyses linking neural activity with 
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ESSENCE traits were not possible for the mouse samples. As such, the human-mouse 
comparative approach was limited to neural activity.  
As the current thesis focused on analysing EEG/LFP data, the high temporal 
resolution provided by these neuroimaging modalities allow for interpretations of the current 
findings as relating to mechanisms/neurotransmitter systems that operate in similarity high 
temporal scales. However, the low spatial resolution relative to other neuroimaging 
modalities, e.g., fMRI, makes it challenging to determine links between neural pathways 
implicated in 16p11.2 CNV and the observed neural activity. However, EEG source 
localisation algorithms are increasingly improving and might be worthwhile to gain spatial 
information. Alternatively, future studies could incorporate parallel EEG/LFP-fMRI analyses, 
which collectively would be very informative.  
Further limitations to the current thesis due to the small sample size include the lack 
of examination of possible confounding factors such as seizure susceptibility/epilepsy and 
current medication use. Although a minority of participants had seizure/epilepsy diagnoses 
(for study 1: n = 3 del and n = 1 dup) and were currently taking medications for anxiety and 
epilepsy (study 1: n = 2 del; study 2: n = 2 del), these factors impact the EEG signal to some 
extent. Nevertheless, these only represent a very small minority of the overall sample and 
analyses in this thesis were based on group averages and conservative significance 
thresholds.  
Another possible limitation to this thesis was that the presented hypotheses were 
broad. Certainly, it was challenging to convincingly propose hypotheses with high specificity, 
therefore it was deemed more appropriate to do otherwise. Previous studies of neural activity 
in 16p11.2 CNV are only the aforementioned few, therefore, formulating specific hypotheses 
would not be possible in this case. Nevertheless, with broad hypotheses and a conservative 
approach, this thesis contributed to this literature by conducting novel analyses assessing 
16p11.2 CNV neural activity using multiple metrics – which is a strength of this thesis. Based 
on this rationale, a recommendation would be for future studies to use a more data-driven 
quantitative approach to examine neural activity in 16p11.2 CNV, as will be discussed in the 
next section.  
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5.4   Future work  
The natural progression from the studies conducted in this thesis would be to use more 
advanced analysis approaches that would address some of the main limitations mentioned 
above and provide advantages not possible with the current techniques. Over the past four 
years, there has been an exponential increase in the advancement and application of machine 
learning (ML) techniques, such as in research fields of robotics and medicine, but also 
outside of research such as in websites predicting a visitor’s interests, smartphones 
identifying objects in images, and email platforms predicting email replies. ML entails an 
algorithm that develops a mathematical model with the ability to update its parameters, based 
on sample data (denoted training data), for the purpose of refining the model to the best 
possible parameters that could classify or predict patterns on a new set of data (note that this 
is performed without explicit instructions on how the model should learn from the training 
data). Among the ML techniques contributing to this boom in the use of ML is deep neural 
networks6 (DNN; LeCun et al., 2015).  
Novel applications of DNNs have been increasingly examined with EEG data in 
various research areas, e.g., seizure detection and prediction, cognitive and affective 
monitoring, and brain-computer interfaces (for a review see Roy et al., 2019). The increasing 
interest in DNN-EEG application is evident as there are more publications in the first seven 
months of 2018 than 2010 to 2016 altogether (Roy et al., 2019). As such, several advantages 
of using DNNs for EEG research were observed in these studies (Roy et al., 2019). Thus, 
DNNs could be especially useful for EEG research relating to 16p11.2 CNVs.  
Some of the key advantages of using DNNs for 16p11.2 CNV EEG research are as 
follows. Based on a recent review (Roy et al., 2019), DNNs consistently outperformed 
conventional statistical techniques (including older ML techniques) in their classification or 
predictive accuracy. Of note, this was observed in research relating to ESSENCE disorders; 
For example, studies reported accuracies of > 80% for detecting epileptic discharges (Hao et 
al., 2018) and predicting ASD diagnosis (Jayawardana et al., 2019). Evidently, it would be 
valuable to conduct DNN-EEG analysis for 16p11.2 CNVs.  
 
6 A deep neural network (DNN) is an algorithm with multiple layers of neurons (or operations) between the 
input layer and output. Each layer extracts more complex information from input data and previous layers. DNN 
finds the best mathematical manipulation to turn the input into the output whether it be a linear relationship or 
non-linear. 
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Although the current thesis investigated various EEG features (e.g., variability, 
power, entropy), there are further numerous mathematical techniques for analysing EEG 
signals and extracting features. This makes the task of identifying the key features that most 
likely fit the criteria of an endophenotype for 16p11.2 CNVs and related ESSENCE traits 
challenging. DNNs (especially with model architectures of convolutional neural networks 
(CNN), recurrent neural networks (RNN), a hybrid of the two, or more advanced networks) 
solve this problem by automatically extracting salient features from the EEG signal. Whether 
using raw or pre-processed data, DNNs have been successful in extracting meaningful 
features and were reported to achieve good performance (Roy et al., 2019). As opposed to 
researchers training for years to learn how to conduct various mathematical techniques for 
signal analysis, DNNs automatically extract meaningful features not restricted to a particular 
technique. Although it is not possible to observe the features that were extracted by DNNs 
because of how the model operates, there is a technique (i.e., Inceptionism; Mordvintsev et 
al., 2015) that could be applied at a later step that shows the most impactful features. 
Alternatively, if researchers are solely interested in particular features extracted manually, 
then certain algorithms could be used to select salient features prior to feeding them as input 
into the DNN model. Even in this case, DNNs are more likely to find patterns within the 
features that are impactful for high performance on the classification/prediction task.  
Although ML techniques are commonly perceived as only applicable when large 
datasets are available, recent advances made certain ML techniques, i.e., transfer learning 
involving DNNs, particularly useful for tackling the problem of small sample sizes (Tan et 
al., 2018). In psychology, transfer of learning (also denoted knowledge transfer) refers to the 
cognitive capability of humans to transfer learning from one context to another (Nokes-
Malach and Richey, 2015). In other words, the notion refers to the ability to generalise what 
has been learned from one context and apply it to a novel context. Similarly, transfer learning 
in ML refers to the technique of taking a model that was refined and trained for a particular 
dataset and task (base model) and then re-using it as the base for a different yet related task 
(target model). This is possible because features extracted at early stages in the model are 
more generic, and hence more generalisable, as opposed to later stages where the model 
becomes more specialised for the particular task. This is akin to the visual system where 
lower visual areas (primary visual cortex; V1) processes edges and forwards this information 
to higher visual areas that ultimately detect complex shapes. Therefore to apply transfer 
learning, the lower level parameters of the base model is maintained, whereas the higher level 
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model parameters are altered when trained on the new dataset/ target task. Indeed, the transfer 
learning technique has already produced highly accurate results, e.g., dermatologist-level 
detection of skin cancer from images (Esteva et al., 2017; this study used a base model that 
was pretrained on images of 1000 object categories, e.g., person, dog, chair, etc. 
(http://www.image-net.org), and then for the purpose of fine-tuning the model for the target 
task of detecting skin cancer, the model was next trained on a smaller dataset of images of 
skin lesions). As opposed to requiring a large dataset in the same domain as the target task to 
train the model, datasets from different yet related domains (e.g., data of images) are 
combined to train the model in the transfer learning technique. Alternatively, if related 
datasets to the target task were unavailable, it is also possible to obtain a model (without 
acquiring the data) that was previously trained on related datasets. Indeed, researchers are 
increasingly sharing EEG datasets and pretrained models (e.g., GitHub, code sharing 
platform; See Roy et al., 2019 and Al-jawahiri and Milne, 2017 for EEG databases). 
Therefore, research relating to 16p11.2 CNVs and other rare CNVs or disorders, where large 
datasets are difficult to acquire, would greatly benefit from using transfer learning.  
Thus, due to the aforementioned benefits of using DNNs (including higher 
performance, automatic feature extraction, and reduced demand of large datasets via transfer 
learning), this thesis recommends future EEG-DNN research in 16p11.2 CNVs. Using DNNs, 
the target task for the model would be to identify 16p11.2 CNV participants and predict their 
ESSENCE traits based on their EEG activity. In line with the ESSENCE framework, the 
(base) training datasets could include EEG signals of various ESSENCE disorders - along 
with 16p11.2 CNVs (for the target model)7. Relatedly, a recent study showed that there is a 
considerable overlap in the psychiatric problems observed in 16p11.2 CNVs and several 
other CNVs (Chawner et al., 2019), e.g., 1q21.1 (proximal duplication, and distal deletion 
and duplication), 2p16.3 (deletion), 15q11.2 (deletion), 15q13.3 (deletion and duplication), 
16p11.2 (distal deletion), and 22q11.2 (duplication). Given this overlap, there is a strong 
rationale for further including these CNVs to train (possibly for the target model) a DNN 
model.  
 
7 Note that the main requirement for conducting transfer learning is for the base training and target training 
datasets to be in the same domain, i.e., EEG data. 
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5.5   Concluding remarks 
This thesis investigated EEG activity in human 16p11.2 CNV carriers and in-vivo 
electrophysiological activity in 16p11.2 deletion mouse model. The studies conducted here 
were made possible due to data-sharing platforms and collaborators (i.e., SFARI and Dr 
Alessandro Gozzi’s lab at the Istituto Italiano di Tecnologia). Indeed, these data-sharing 
initiatives are of great benefit to the advancement of research in this and other areas. Unique 
to this thesis is the approach of conducting parallel 16p11.2 human EEG-mouse LFP 
analyses. However, positive findings were not found in the latter (i.e., 16p11.2 del mice) 
despite the literature indicating otherwise. Overall, findings from the human subjects, in this 
thesis, contributed further evidence to the 16p11.2 CNV literature pertaining to the atypical 
nature of neural activity in 16p11.2 CNV. Using various metrics of neural activity, atypical 
evoked and spontaneous activity was identified in 16p11.2 CNV, and the latter was related to 
numerous ESSENCE traits. Future work should further verify and expand on these findings.  
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